TW200946563A - Liquid crystal aligning agent and liquid crystal display element - Google Patents
Liquid crystal aligning agent and liquid crystal display element Download PDFInfo
- Publication number
- TW200946563A TW200946563A TW098108523A TW98108523A TW200946563A TW 200946563 A TW200946563 A TW 200946563A TW 098108523 A TW098108523 A TW 098108523A TW 98108523 A TW98108523 A TW 98108523A TW 200946563 A TW200946563 A TW 200946563A
- Authority
- TW
- Taiwan
- Prior art keywords
- liquid crystal
- crystal alignment
- polymer
- group
- alignment agent
- Prior art date
Links
- 239000004973 liquid crystal related substance Substances 0.000 title claims abstract description 232
- 239000003795 chemical substances by application Substances 0.000 title claims abstract description 75
- 229920000642 polymer Polymers 0.000 claims abstract description 104
- 150000004985 diamines Chemical class 0.000 claims abstract description 88
- 150000001875 compounds Chemical class 0.000 claims abstract description 69
- GTDPSWPPOUPBNX-UHFFFAOYSA-N ac1mqpva Chemical compound CC12C(=O)OC(=O)C1(C)C1(C)C2(C)C(=O)OC1=O GTDPSWPPOUPBNX-UHFFFAOYSA-N 0.000 claims abstract description 61
- 125000006158 tetracarboxylic acid group Chemical group 0.000 claims abstract description 35
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 claims description 34
- 239000002253 acid Substances 0.000 claims description 34
- LJZVDOUZSMHXJH-UHFFFAOYSA-K ruthenium(3+);triiodide Chemical compound [Ru+3].[I-].[I-].[I-] LJZVDOUZSMHXJH-UHFFFAOYSA-K 0.000 claims description 32
- 229910021603 Ruthenium iodide Inorganic materials 0.000 claims description 31
- 125000000962 organic group Chemical group 0.000 claims description 16
- 229920000656 polylysine Polymers 0.000 claims description 16
- 108010039918 Polylysine Proteins 0.000 claims description 14
- 229910052707 ruthenium Inorganic materials 0.000 claims description 12
- 125000004432 carbon atom Chemical group C* 0.000 claims description 11
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 claims description 9
- 125000000217 alkyl group Chemical group 0.000 claims description 8
- 125000002345 steroid group Chemical group 0.000 claims description 7
- 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 4
- 125000004151 quinonyl group Chemical group 0.000 claims description 4
- 229910052799 carbon Inorganic materials 0.000 claims description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- 125000006367 bivalent amino carbonyl group Chemical group [H]N([*:1])C([*:2])=O 0.000 claims 1
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims 1
- 229920005575 poly(amic acid) Polymers 0.000 abstract description 26
- 206010047571 Visual impairment Diseases 0.000 abstract description 15
- 239000007788 liquid Substances 0.000 abstract description 5
- 150000003949 imides Chemical class 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 109
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 68
- 238000003786 synthesis reaction Methods 0.000 description 48
- 230000015572 biosynthetic process Effects 0.000 description 46
- 238000000034 method Methods 0.000 description 44
- 239000002904 solvent Substances 0.000 description 42
- 239000000758 substrate Substances 0.000 description 42
- -1 alicyclic tetracarboxylic acid Chemical class 0.000 description 39
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 description 38
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 30
- 230000018044 dehydration Effects 0.000 description 29
- 238000006297 dehydration reaction Methods 0.000 description 29
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 26
- 238000006243 chemical reaction Methods 0.000 description 22
- 238000007363 ring formation reaction Methods 0.000 description 22
- 210000002858 crystal cell Anatomy 0.000 description 19
- 238000000576 coating method Methods 0.000 description 18
- 239000003960 organic solvent Substances 0.000 description 17
- 239000011248 coating agent Substances 0.000 description 16
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 13
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Substances C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 13
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 13
- CBCKQZAAMUWICA-UHFFFAOYSA-N 1,4-phenylenediamine Chemical compound NC1=CC=C(N)C=C1 CBCKQZAAMUWICA-UHFFFAOYSA-N 0.000 description 11
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 11
- 108010094020 polyglycine Proteins 0.000 description 11
- 229920000232 polyglycine polymer Polymers 0.000 description 11
- 238000011156 evaluation Methods 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 9
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 8
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 8
- 108010026466 polyproline Proteins 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- 150000001412 amines Chemical class 0.000 description 7
- 239000003054 catalyst Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 239000012024 dehydrating agents Substances 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- DIOQZVSQGTUSAI-UHFFFAOYSA-N n-butylhexane Natural products CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 6
- 229910052757 nitrogen Inorganic materials 0.000 description 6
- 229920000768 polyamine Polymers 0.000 description 6
- 229920000954 Polyglycolide Polymers 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000012044 organic layer Substances 0.000 description 5
- 239000004633 polyglycolic acid Substances 0.000 description 5
- VLDPXPPHXDGHEW-UHFFFAOYSA-N 1-chloro-2-dichlorophosphoryloxybenzene Chemical compound ClC1=CC=CC=C1OP(Cl)(Cl)=O VLDPXPPHXDGHEW-UHFFFAOYSA-N 0.000 description 4
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 4
- OLQWMCSSZKNOLQ-UHFFFAOYSA-N 3-(2,5-dioxooxolan-3-yl)oxolane-2,5-dione Chemical compound O=C1OC(=O)CC1C1C(=O)OC(=O)C1 OLQWMCSSZKNOLQ-UHFFFAOYSA-N 0.000 description 4
- RHRNYXVSZLSRRP-UHFFFAOYSA-N 3-(carboxymethyl)cyclopentane-1,2,4-tricarboxylic acid Chemical compound OC(=O)CC1C(C(O)=O)CC(C(O)=O)C1C(O)=O RHRNYXVSZLSRRP-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- MHZGKXUYDGKKIU-UHFFFAOYSA-N Decylamine Chemical compound CCCCCCCCCCN MHZGKXUYDGKKIU-UHFFFAOYSA-N 0.000 description 4
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 4
- 239000004988 Nematic liquid crystal Substances 0.000 description 4
- LGRFSURHDFAFJT-UHFFFAOYSA-N Phthalic anhydride Natural products C1=CC=C2C(=O)OC(=O)C2=C1 LGRFSURHDFAFJT-UHFFFAOYSA-N 0.000 description 4
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 4
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 4
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 4
- 150000008064 anhydrides Chemical class 0.000 description 4
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Chemical compound C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 4
- JHIWVOJDXOSYLW-UHFFFAOYSA-N butyl 2,2-difluorocyclopropane-1-carboxylate Chemical compound CCCCOC(=O)C1CC1(F)F JHIWVOJDXOSYLW-UHFFFAOYSA-N 0.000 description 4
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 4
- 235000019341 magnesium sulphate Nutrition 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 230000001681 protective effect Effects 0.000 description 4
- 239000000565 sealant Substances 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- XOLBLPGZBRYERU-UHFFFAOYSA-N tin dioxide Chemical compound O=[Sn]=O XOLBLPGZBRYERU-UHFFFAOYSA-N 0.000 description 4
- 125000005591 trimellitate group Chemical group 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 229930188620 butyrolactone Natural products 0.000 description 3
- 238000004440 column chromatography Methods 0.000 description 3
- 239000012043 crude product Substances 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000012299 nitrogen atmosphere Substances 0.000 description 3
- 125000004433 nitrogen atom Chemical group N* 0.000 description 3
- 150000002923 oximes Chemical class 0.000 description 3
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 230000035484 reaction time Effects 0.000 description 3
- 238000006798 ring closing metathesis reaction Methods 0.000 description 3
- 238000004528 spin coating Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000003971 tillage Methods 0.000 description 3
- 229910021642 ultra pure water Inorganic materials 0.000 description 3
- 239000012498 ultrapure water Substances 0.000 description 3
- 229910052727 yttrium Inorganic materials 0.000 description 3
- VWQVUPCCIRVNHF-UHFFFAOYSA-N yttrium atom Chemical compound [Y] VWQVUPCCIRVNHF-UHFFFAOYSA-N 0.000 description 3
- RFFLAFLAYFXFSW-UHFFFAOYSA-N 1,2-dichlorobenzene Chemical compound ClC1=CC=CC=C1Cl RFFLAFLAYFXFSW-UHFFFAOYSA-N 0.000 description 2
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 2
- RRQYJINTUHWNHW-UHFFFAOYSA-N 1-ethoxy-2-(2-ethoxyethoxy)ethane Chemical compound CCOCCOCCOCC RRQYJINTUHWNHW-UHFFFAOYSA-N 0.000 description 2
- DCTOHCCUXLBQMS-UHFFFAOYSA-N 1-undecene Chemical compound CCCCCCCCCC=C DCTOHCCUXLBQMS-UHFFFAOYSA-N 0.000 description 2
- HPYNZHMRTTWQTB-UHFFFAOYSA-N 2,3-dimethylpyridine Chemical compound CC1=CC=CN=C1C HPYNZHMRTTWQTB-UHFFFAOYSA-N 0.000 description 2
- UWCWUCKPEYNDNV-LBPRGKRZSA-N 2,6-dimethyl-n-[[(2s)-pyrrolidin-2-yl]methyl]aniline Chemical compound CC1=CC=CC(C)=C1NC[C@H]1NCCC1 UWCWUCKPEYNDNV-LBPRGKRZSA-N 0.000 description 2
- FPZWZCWUIYYYBU-UHFFFAOYSA-N 2-(2-ethoxyethoxy)ethyl acetate Chemical compound CCOCCOCCOC(C)=O FPZWZCWUIYYYBU-UHFFFAOYSA-N 0.000 description 2
- SBASXUCJHJRPEV-UHFFFAOYSA-N 2-(2-methoxyethoxy)ethanol Chemical compound COCCOCCO SBASXUCJHJRPEV-UHFFFAOYSA-N 0.000 description 2
- HCGFUIQPSOCUHI-UHFFFAOYSA-N 2-propan-2-yloxyethanol Chemical compound CC(C)OCCO HCGFUIQPSOCUHI-UHFFFAOYSA-N 0.000 description 2
- YEYKMVJDLWJFOA-UHFFFAOYSA-N 2-propoxyethanol Chemical compound CCCOCCO YEYKMVJDLWJFOA-UHFFFAOYSA-N 0.000 description 2
- UENRXLSRMCSUSN-UHFFFAOYSA-N 3,5-diaminobenzoic acid Chemical compound NC1=CC(N)=CC(C(O)=O)=C1 UENRXLSRMCSUSN-UHFFFAOYSA-N 0.000 description 2
- HLBLWEWZXPIGSM-UHFFFAOYSA-N 4-Aminophenyl ether Chemical compound C1=CC(N)=CC=C1OC1=CC=C(N)C=C1 HLBLWEWZXPIGSM-UHFFFAOYSA-N 0.000 description 2
- BEKFRNOZJSYWKZ-UHFFFAOYSA-N 4-[2-(4-aminophenyl)-1,1,1,3,3,3-hexafluoropropan-2-yl]aniline Chemical compound C1=CC(N)=CC=C1C(C(F)(F)F)(C(F)(F)F)C1=CC=C(N)C=C1 BEKFRNOZJSYWKZ-UHFFFAOYSA-N 0.000 description 2
- JCRRFJIVUPSNTA-UHFFFAOYSA-N 4-[4-(4-aminophenoxy)phenoxy]aniline Chemical compound C1=CC(N)=CC=C1OC(C=C1)=CC=C1OC1=CC=C(N)C=C1 JCRRFJIVUPSNTA-UHFFFAOYSA-N 0.000 description 2
- FUASIVJEPLQPAI-UHFFFAOYSA-N 4-[4-(4-pentylcyclohexyl)cyclohexyl]phenol Chemical compound C1CC(CCCCC)CCC1C1CCC(C=2C=CC(O)=CC=2)CC1 FUASIVJEPLQPAI-UHFFFAOYSA-N 0.000 description 2
- KMKWGXGSGPYISJ-UHFFFAOYSA-N 4-[4-[2-[4-(4-aminophenoxy)phenyl]propan-2-yl]phenoxy]aniline Chemical compound C=1C=C(OC=2C=CC(N)=CC=2)C=CC=1C(C)(C)C(C=C1)=CC=C1OC1=CC=C(N)C=C1 KMKWGXGSGPYISJ-UHFFFAOYSA-N 0.000 description 2
- HYDATEKARGDBKU-UHFFFAOYSA-N 4-[4-[4-(4-aminophenoxy)phenyl]phenoxy]aniline Chemical group C1=CC(N)=CC=C1OC1=CC=C(C=2C=CC(OC=3C=CC(N)=CC=3)=CC=2)C=C1 HYDATEKARGDBKU-UHFFFAOYSA-N 0.000 description 2
- NVKGJHAQGWCWDI-UHFFFAOYSA-N 4-[4-amino-2-(trifluoromethyl)phenyl]-3-(trifluoromethyl)aniline Chemical group FC(F)(F)C1=CC(N)=CC=C1C1=CC=C(N)C=C1C(F)(F)F NVKGJHAQGWCWDI-UHFFFAOYSA-N 0.000 description 2
- YGYCECQIOXZODZ-UHFFFAOYSA-N 4415-87-6 Chemical compound O=C1OC(=O)C2C1C1C(=O)OC(=O)C12 YGYCECQIOXZODZ-UHFFFAOYSA-N 0.000 description 2
- DGQOZCNCJKEVOA-UHFFFAOYSA-N 5-(2,5-dioxooxolan-3-yl)-7-methyl-3a,4,5,7a-tetrahydro-2-benzofuran-1,3-dione Chemical compound C1C(C(OC2=O)=O)C2C(C)=CC1C1CC(=O)OC1=O DGQOZCNCJKEVOA-UHFFFAOYSA-N 0.000 description 2
- YCZUWQOJQGCZKG-UHFFFAOYSA-N 9h-carbazole-3,6-diamine Chemical compound C1=C(N)C=C2C3=CC(N)=CC=C3NC2=C1 YCZUWQOJQGCZKG-UHFFFAOYSA-N 0.000 description 2
- MRABAEUHTLLEML-UHFFFAOYSA-N Butyl lactate Chemical compound CCCCOC(=O)C(C)O MRABAEUHTLLEML-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 239000004593 Epoxy Substances 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 2
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- QLBRROYTTDFLDX-UHFFFAOYSA-N [3-(aminomethyl)cyclohexyl]methanamine Chemical compound NCC1CCCC(CN)C1 QLBRROYTTDFLDX-UHFFFAOYSA-N 0.000 description 2
- DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 2
- OYTKINVCDFNREN-UHFFFAOYSA-N amifampridine Chemical compound NC1=CC=NC=C1N OYTKINVCDFNREN-UHFFFAOYSA-N 0.000 description 2
- 229960004012 amifampridine Drugs 0.000 description 2
- 238000005576 amination reaction Methods 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- HOPRXXXSABQWAV-UHFFFAOYSA-N anhydrous collidine Natural products CC1=CC=NC(C)=C1C HOPRXXXSABQWAV-UHFFFAOYSA-N 0.000 description 2
- 150000004984 aromatic diamines Chemical class 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- HFACYLZERDEVSX-UHFFFAOYSA-N benzidine Chemical compound C1=CC(N)=CC=C1C1=CC=C(N)C=C1 HFACYLZERDEVSX-UHFFFAOYSA-N 0.000 description 2
- 239000004305 biphenyl Substances 0.000 description 2
- 235000010290 biphenyl Nutrition 0.000 description 2
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 2
- 239000001191 butyl (2R)-2-hydroxypropanoate Substances 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- VKIRRGRTJUUZHS-UHFFFAOYSA-N cyclohexane-1,4-diamine Chemical compound NC1CCC(N)CC1 VKIRRGRTJUUZHS-UHFFFAOYSA-N 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 2
- DIOQZVSQGTUSAI-NJFSPNSNSA-N decane Chemical class CCCCCCCCC[14CH3] DIOQZVSQGTUSAI-NJFSPNSNSA-N 0.000 description 2
- 229940019778 diethylene glycol diethyl ether Drugs 0.000 description 2
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 2
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000003822 epoxy resin Substances 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- ZRALSGWEFCBTJO-UHFFFAOYSA-N guanidine group Chemical group NC(=N)N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
- DCAYPVUWAIABOU-UHFFFAOYSA-N hexadecane Chemical compound CCCCCCCCCCCCCCCC DCAYPVUWAIABOU-UHFFFAOYSA-N 0.000 description 2
- NAQMVNRVTILPCV-UHFFFAOYSA-N hexane-1,6-diamine Chemical compound NCCCCCCN NAQMVNRVTILPCV-UHFFFAOYSA-N 0.000 description 2
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine hydrate Chemical compound O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 2
- 150000002430 hydrocarbons Chemical group 0.000 description 2
- XAOGXQMKWQFZEM-UHFFFAOYSA-N isoamyl propanoate Chemical compound CCC(=O)OCCC(C)C XAOGXQMKWQFZEM-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- KQSABULTKYLFEV-UHFFFAOYSA-N naphthalene-1,5-diamine Chemical compound C1=CC=C2C(N)=CC=CC2=C1N KQSABULTKYLFEV-UHFFFAOYSA-N 0.000 description 2
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 2
- DPBLXKKOBLCELK-UHFFFAOYSA-N pentan-1-amine Chemical compound CCCCCN DPBLXKKOBLCELK-UHFFFAOYSA-N 0.000 description 2
- 238000006068 polycondensation reaction Methods 0.000 description 2
- 229920000647 polyepoxide Polymers 0.000 description 2
- 229920002098 polyfluorene Polymers 0.000 description 2
- 229920001721 polyimide Polymers 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- ZSLKNYNUPNHOLY-UHFFFAOYSA-N purine-2,7-diamine Chemical compound NC1=NC=C2N(C=NC2=N1)N ZSLKNYNUPNHOLY-UHFFFAOYSA-N 0.000 description 2
- VHNQIURBCCNWDN-UHFFFAOYSA-N pyridine-2,6-diamine Chemical compound NC1=CC=CC(N)=N1 VHNQIURBCCNWDN-UHFFFAOYSA-N 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 2
- XFNJVJPLKCPIBV-UHFFFAOYSA-N trimethylenediamine Chemical compound NCCCN XFNJVJPLKCPIBV-UHFFFAOYSA-N 0.000 description 2
- RSJKGSCJYJTIGS-UHFFFAOYSA-N undecane Chemical compound CCCCCCCCCCC RSJKGSCJYJTIGS-UHFFFAOYSA-N 0.000 description 2
- FHBXQJDYHHJCIF-UHFFFAOYSA-N (2,3-diaminophenyl)-phenylmethanone Chemical compound NC1=CC=CC(C(=O)C=2C=CC=CC=2)=C1N FHBXQJDYHHJCIF-UHFFFAOYSA-N 0.000 description 1
- YFORDJRKPMKUDA-UHFFFAOYSA-N 1,1'-biphenyl;cyclohexane Chemical compound C1CCCCC1.C1=CC=CC=C1C1=CC=CC=C1 YFORDJRKPMKUDA-UHFFFAOYSA-N 0.000 description 1
- UOCLXMDMGBRAIB-UHFFFAOYSA-N 1,1,1-trichloroethane Chemical compound CC(Cl)(Cl)Cl UOCLXMDMGBRAIB-UHFFFAOYSA-N 0.000 description 1
- AGGJWJFEEKIYOF-UHFFFAOYSA-N 1,1,1-triethoxydecane Chemical compound CCCCCCCCCC(OCC)(OCC)OCC AGGJWJFEEKIYOF-UHFFFAOYSA-N 0.000 description 1
- AVQQQNCBBIEMEU-UHFFFAOYSA-N 1,1,3,3-tetramethylurea Chemical compound CN(C)C(=O)N(C)C AVQQQNCBBIEMEU-UHFFFAOYSA-N 0.000 description 1
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- MQQRFOXFIPBFOV-UHFFFAOYSA-N 1,2-dimethylcyclobutane-1,2,3,4-tetracarboxylic acid Chemical compound OC(=O)C1(C)C(C(O)=O)C(C(O)=O)C1(C)C(O)=O MQQRFOXFIPBFOV-UHFFFAOYSA-N 0.000 description 1
- YJTKZCDBKVTVBY-UHFFFAOYSA-N 1,3-Diphenylbenzene Chemical group C1=CC=CC=C1C1=CC=CC(C=2C=CC=CC=2)=C1 YJTKZCDBKVTVBY-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- KJDRSWPQXHESDQ-UHFFFAOYSA-N 1,4-dichlorobutane Chemical compound ClCCCCCl KJDRSWPQXHESDQ-UHFFFAOYSA-N 0.000 description 1
- UWFRVQVNYNPBEF-UHFFFAOYSA-N 1-(2,4-dimethylphenyl)propan-1-one Chemical compound CCC(=O)C1=CC=C(C)C=C1C UWFRVQVNYNPBEF-UHFFFAOYSA-N 0.000 description 1
- CGSKOGYKWHUSLC-UHFFFAOYSA-N 1-(4-aminophenyl)-1,3,3-trimethyl-2h-inden-5-amine Chemical compound C12=CC=C(N)C=C2C(C)(C)CC1(C)C1=CC=C(N)C=C1 CGSKOGYKWHUSLC-UHFFFAOYSA-N 0.000 description 1
- FJLUATLTXUNBOT-UHFFFAOYSA-N 1-Hexadecylamine Chemical compound CCCCCCCCCCCCCCCCN FJLUATLTXUNBOT-UHFFFAOYSA-N 0.000 description 1
- HASUCEDGKYJBDC-UHFFFAOYSA-N 1-[3-[[bis(oxiran-2-ylmethyl)amino]methyl]cyclohexyl]-n,n-bis(oxiran-2-ylmethyl)methanamine Chemical compound C1OC1CN(CC1CC(CN(CC2OC2)CC2OC2)CCC1)CC1CO1 HASUCEDGKYJBDC-UHFFFAOYSA-N 0.000 description 1
- JPZYXGPCHFZBHO-UHFFFAOYSA-N 1-aminopentadecane Chemical compound CCCCCCCCCCCCCCCN JPZYXGPCHFZBHO-UHFFFAOYSA-N 0.000 description 1
- YEUIMZOJSJEGFM-UHFFFAOYSA-N 1-cyclohexyl-n,n-bis(oxiran-2-ylmethyl)methanamine Chemical compound C1OC1CN(CC1CCCCC1)CC1CO1 YEUIMZOJSJEGFM-UHFFFAOYSA-N 0.000 description 1
- BMVXCPBXGZKUPN-UHFFFAOYSA-N 1-hexanamine Chemical compound CCCCCCN BMVXCPBXGZKUPN-UHFFFAOYSA-N 0.000 description 1
- BDQNKCYCTYYMAA-UHFFFAOYSA-N 1-isocyanatonaphthalene Chemical compound C1=CC=C2C(N=C=O)=CC=CC2=C1 BDQNKCYCTYYMAA-UHFFFAOYSA-N 0.000 description 1
- BUZMJVBOGDBMGI-UHFFFAOYSA-N 1-phenylpropylbenzene Chemical compound C=1C=CC=CC=1C(CC)C1=CC=CC=C1 BUZMJVBOGDBMGI-UHFFFAOYSA-N 0.000 description 1
- POXWDTQUDZUOGP-UHFFFAOYSA-N 1h-1,4-diazepine Chemical compound N1C=CC=NC=C1 POXWDTQUDZUOGP-UHFFFAOYSA-N 0.000 description 1
- UXOXUHMFQZEAFR-UHFFFAOYSA-N 2,2',5,5'-Tetrachlorobenzidine Chemical group C1=C(Cl)C(N)=CC(Cl)=C1C1=CC(Cl)=C(N)C=C1Cl UXOXUHMFQZEAFR-UHFFFAOYSA-N 0.000 description 1
- IANXAXNUNBAWBA-UHFFFAOYSA-N 2,2,3-trimethylundecane Chemical compound CCCCCCCCC(C)C(C)(C)C IANXAXNUNBAWBA-UHFFFAOYSA-N 0.000 description 1
- LTMRRSWNXVJMBA-UHFFFAOYSA-L 2,2-diethylpropanedioate Chemical compound CCC(CC)(C([O-])=O)C([O-])=O LTMRRSWNXVJMBA-UHFFFAOYSA-L 0.000 description 1
- IVIDDMGBRCPGLJ-UHFFFAOYSA-N 2,3-bis(oxiran-2-ylmethoxy)propan-1-ol Chemical compound C1OC1COC(CO)COCC1CO1 IVIDDMGBRCPGLJ-UHFFFAOYSA-N 0.000 description 1
- BJINVQNEBGOMCR-UHFFFAOYSA-N 2-(2-methoxyethoxy)ethyl acetate Chemical compound COCCOCCOC(C)=O BJINVQNEBGOMCR-UHFFFAOYSA-N 0.000 description 1
- FALRKNHUBBKYCC-UHFFFAOYSA-N 2-(chloromethyl)pyridine-3-carbonitrile Chemical compound ClCC1=NC=CC=C1C#N FALRKNHUBBKYCC-UHFFFAOYSA-N 0.000 description 1
- PTTPXKJBFFKCEK-UHFFFAOYSA-N 2-Methyl-4-heptanone Chemical compound CC(C)CC(=O)CC(C)C PTTPXKJBFFKCEK-UHFFFAOYSA-N 0.000 description 1
- HDPLHDGYGLENEI-UHFFFAOYSA-N 2-[1-(oxiran-2-ylmethoxy)propan-2-yloxymethyl]oxirane Chemical compound C1OC1COC(C)COCC1CO1 HDPLHDGYGLENEI-UHFFFAOYSA-N 0.000 description 1
- FVCHRIQAIOHAIC-UHFFFAOYSA-N 2-[1-[1-[1-(oxiran-2-ylmethoxy)propan-2-yloxy]propan-2-yloxy]propan-2-yloxymethyl]oxirane Chemical compound C1OC1COC(C)COC(C)COC(C)COCC1CO1 FVCHRIQAIOHAIC-UHFFFAOYSA-N 0.000 description 1
- AOBIOSPNXBMOAT-UHFFFAOYSA-N 2-[2-(oxiran-2-ylmethoxy)ethoxymethyl]oxirane Chemical compound C1OC1COCCOCC1CO1 AOBIOSPNXBMOAT-UHFFFAOYSA-N 0.000 description 1
- WTYYGFLRBWMFRY-UHFFFAOYSA-N 2-[6-(oxiran-2-ylmethoxy)hexoxymethyl]oxirane Chemical compound C1OC1COCCCCCCOCC1CO1 WTYYGFLRBWMFRY-UHFFFAOYSA-N 0.000 description 1
- KUAUJXBLDYVELT-UHFFFAOYSA-N 2-[[2,2-dimethyl-3-(oxiran-2-ylmethoxy)propoxy]methyl]oxirane Chemical compound C1OC1COCC(C)(C)COCC1CO1 KUAUJXBLDYVELT-UHFFFAOYSA-N 0.000 description 1
- JTXMVXSTHSMVQF-UHFFFAOYSA-N 2-acetyloxyethyl acetate Chemical compound CC(=O)OCCOC(C)=O JTXMVXSTHSMVQF-UHFFFAOYSA-N 0.000 description 1
- ZMPNWMGCRIDTOD-UHFFFAOYSA-N 2-dodecoxybenzene-1,4-diamine Chemical compound CCCCCCCCCCCCOC1=CC(N)=CC=C1N ZMPNWMGCRIDTOD-UHFFFAOYSA-N 0.000 description 1
- PXMHXIKHKVXJLD-UHFFFAOYSA-N 2-methylbuta-1,3-dien-1-one Chemical compound C=CC(C)=C=O PXMHXIKHKVXJLD-UHFFFAOYSA-N 0.000 description 1
- FJNLCHNQVJVCPY-UHFFFAOYSA-N 2-n-methoxy-2-n-methyl-4-n,6-n-dipropyl-1,3,5-triazine-2,4,6-triamine Chemical compound CCCNC1=NC(NCCC)=NC(N(C)OC)=N1 FJNLCHNQVJVCPY-UHFFFAOYSA-N 0.000 description 1
- FMYGCJKGQDFOKJ-UHFFFAOYSA-N 2-pentadecoxybenzene-1,4-diamine Chemical compound CCCCCCCCCCCCCCCOC1=CC(N)=CC=C1N FMYGCJKGQDFOKJ-UHFFFAOYSA-N 0.000 description 1
- NUIURNJTPRWVAP-UHFFFAOYSA-N 3,3'-Dimethylbenzidine Chemical group C1=C(N)C(C)=CC(C=2C=C(C)C(N)=CC=2)=C1 NUIURNJTPRWVAP-UHFFFAOYSA-N 0.000 description 1
- JEAQJTYJUMGUCD-UHFFFAOYSA-N 3,4,5-triphenylphthalic acid Chemical compound C=1C=CC=CC=1C=1C(C=2C=CC=CC=2)=C(C(O)=O)C(C(=O)O)=CC=1C1=CC=CC=C1 JEAQJTYJUMGUCD-UHFFFAOYSA-N 0.000 description 1
- GWHLJVMSZRKEAQ-UHFFFAOYSA-N 3-(2,3-dicarboxyphenyl)phthalic acid Chemical compound OC(=O)C1=CC=CC(C=2C(=C(C(O)=O)C=CC=2)C(O)=O)=C1C(O)=O GWHLJVMSZRKEAQ-UHFFFAOYSA-N 0.000 description 1
- ZBMISJGHVWNWTE-UHFFFAOYSA-N 3-(4-aminophenoxy)aniline Chemical compound C1=CC(N)=CC=C1OC1=CC=CC(N)=C1 ZBMISJGHVWNWTE-UHFFFAOYSA-N 0.000 description 1
- GDGWSSXWLLHGGV-UHFFFAOYSA-N 3-(4-aminophenyl)-1,1,3-trimethyl-2h-inden-5-amine Chemical compound C12=CC(N)=CC=C2C(C)(C)CC1(C)C1=CC=C(N)C=C1 GDGWSSXWLLHGGV-UHFFFAOYSA-N 0.000 description 1
- RNLHGQLZWXBQNY-UHFFFAOYSA-N 3-(aminomethyl)-3,5,5-trimethylcyclohexan-1-amine Chemical compound CC1(C)CC(N)CC(C)(CN)C1 RNLHGQLZWXBQNY-UHFFFAOYSA-N 0.000 description 1
- IRESXNMNAGCVLK-UHFFFAOYSA-N 3-[3-(2,3-dicarboxy-4,5,6-triphenylphenyl)phenyl]-4,5,6-triphenylphthalic acid Chemical compound C=1C=CC=CC=1C=1C(C=2C=CC=CC=2)=C(C=2C=CC=CC=2)C(C(=O)O)=C(C(O)=O)C=1C(C=1)=CC=CC=1C(C(=C1C=2C=CC=CC=2)C=2C=CC=CC=2)=C(C(O)=O)C(C(O)=O)=C1C1=CC=CC=C1 IRESXNMNAGCVLK-UHFFFAOYSA-N 0.000 description 1
- TVOXGJNJYPSMNM-UHFFFAOYSA-N 3-[4-(2,3-dicarboxy-4,5,6-triphenylphenyl)phenyl]-4,5,6-triphenylphthalic acid Chemical compound C=1C=CC=CC=1C=1C(C=2C=CC=CC=2)=C(C=2C=CC=CC=2)C(C(=O)O)=C(C(O)=O)C=1C(C=C1)=CC=C1C(C(=C1C=2C=CC=CC=2)C=2C=CC=CC=2)=C(C(O)=O)C(C(O)=O)=C1C1=CC=CC=C1 TVOXGJNJYPSMNM-UHFFFAOYSA-N 0.000 description 1
- YOWKKGPNCDIFFB-UHFFFAOYSA-N 3-decyloxolane-2,5-dione Chemical compound CCCCCCCCCCC1CC(=O)OC1=O YOWKKGPNCDIFFB-UHFFFAOYSA-N 0.000 description 1
- YAXXOCZAXKLLCV-UHFFFAOYSA-N 3-dodecyloxolane-2,5-dione Chemical compound CCCCCCCCCCCCC1CC(=O)OC1=O YAXXOCZAXKLLCV-UHFFFAOYSA-N 0.000 description 1
- OFNISBHGPNMTMS-UHFFFAOYSA-N 3-methylideneoxolane-2,5-dione Chemical compound C=C1CC(=O)OC1=O OFNISBHGPNMTMS-UHFFFAOYSA-N 0.000 description 1
- UCSYVYFGMFODMY-UHFFFAOYSA-N 3-phenoxyaniline Chemical compound NC1=CC=CC(OC=2C=CC=CC=2)=C1 UCSYVYFGMFODMY-UHFFFAOYSA-N 0.000 description 1
- BZECBEKZECEQRI-UHFFFAOYSA-N 3-tetradecyloxolane-2,5-dione Chemical compound CCCCCCCCCCCCCCC1CC(=O)OC1=O BZECBEKZECEQRI-UHFFFAOYSA-N 0.000 description 1
- LJMPOXUWPWEILS-UHFFFAOYSA-N 3a,4,4a,7a,8,8a-hexahydrofuro[3,4-f][2]benzofuran-1,3,5,7-tetrone Chemical compound C1C2C(=O)OC(=O)C2CC2C(=O)OC(=O)C21 LJMPOXUWPWEILS-UHFFFAOYSA-N 0.000 description 1
- UHMARZNHEMRXQH-UHFFFAOYSA-N 3a,4,5,7a-tetrahydro-2-benzofuran-1,3-dione Chemical compound C1=CCCC2C(=O)OC(=O)C21 UHMARZNHEMRXQH-UHFFFAOYSA-N 0.000 description 1
- ICNFHJVPAJKPHW-UHFFFAOYSA-N 4,4'-Thiodianiline Chemical compound C1=CC(N)=CC=C1SC1=CC=C(N)C=C1 ICNFHJVPAJKPHW-UHFFFAOYSA-N 0.000 description 1
- YBRVSVVVWCFQMG-UHFFFAOYSA-N 4,4'-diaminodiphenylmethane Chemical compound C1=CC(N)=CC=C1CC1=CC=C(N)C=C1 YBRVSVVVWCFQMG-UHFFFAOYSA-N 0.000 description 1
- IBOFVQJTBBUKMU-UHFFFAOYSA-N 4,4'-methylene-bis-(2-chloroaniline) Chemical compound C1=C(Cl)C(N)=CC=C1CC1=CC=C(N)C(Cl)=C1 IBOFVQJTBBUKMU-UHFFFAOYSA-N 0.000 description 1
- CMSGUKVDXXTJDQ-UHFFFAOYSA-N 4-(2-naphthalen-1-ylethylamino)-4-oxobutanoic acid Chemical compound C1=CC=C2C(CCNC(=O)CCC(=O)O)=CC=CC2=C1 CMSGUKVDXXTJDQ-UHFFFAOYSA-N 0.000 description 1
- NRLUQVLHGAVXQB-UHFFFAOYSA-N 4-(4-amino-2-chloro-5-methoxyphenyl)-5-chloro-2-methoxyaniline Chemical group C1=C(N)C(OC)=CC(C=2C(=CC(N)=C(OC)C=2)Cl)=C1Cl NRLUQVLHGAVXQB-UHFFFAOYSA-N 0.000 description 1
- QYIMZXITLDTULQ-UHFFFAOYSA-N 4-(4-amino-2-methylphenyl)-3-methylaniline Chemical group CC1=CC(N)=CC=C1C1=CC=C(N)C=C1C QYIMZXITLDTULQ-UHFFFAOYSA-N 0.000 description 1
- IYRKKFOTDLQTCT-UHFFFAOYSA-N 4-(4-anthracen-1-ylphenoxy)aniline Chemical compound NC1=CC=C(OC2=CC=C(C=C2)C2=CC=CC3=CC4=CC=CC=C4C=C23)C=C1 IYRKKFOTDLQTCT-UHFFFAOYSA-N 0.000 description 1
- SXPGQGNWEWPWQZ-UHFFFAOYSA-N 4-(triethoxymethyl)dodecan-1-amine Chemical compound NCCCC(C(OCC)(OCC)OCC)CCCCCCCC SXPGQGNWEWPWQZ-UHFFFAOYSA-N 0.000 description 1
- DZIHTWJGPDVSGE-UHFFFAOYSA-N 4-[(4-aminocyclohexyl)methyl]cyclohexan-1-amine Chemical compound C1CC(N)CCC1CC1CCC(N)CC1 DZIHTWJGPDVSGE-UHFFFAOYSA-N 0.000 description 1
- HSBOCPVKJMBWTF-UHFFFAOYSA-N 4-[1-(4-aminophenyl)ethyl]aniline Chemical compound C=1C=C(N)C=CC=1C(C)C1=CC=C(N)C=C1 HSBOCPVKJMBWTF-UHFFFAOYSA-N 0.000 description 1
- WUPRYUDHUFLKFL-UHFFFAOYSA-N 4-[3-(4-aminophenoxy)phenoxy]aniline Chemical compound C1=CC(N)=CC=C1OC1=CC=CC(OC=2C=CC(N)=CC=2)=C1 WUPRYUDHUFLKFL-UHFFFAOYSA-N 0.000 description 1
- NHLGDELWVDRKBL-UHFFFAOYSA-N 4-[4-(1,1,1,3,3,3-hexafluoropropan-2-yl)phenoxy]-3-(trifluoromethyl)aniline Chemical compound NC1=CC(=C(OC2=CC=C(C=C2)C(C(F)(F)F)C(F)(F)F)C=C1)C(F)(F)F NHLGDELWVDRKBL-UHFFFAOYSA-N 0.000 description 1
- SSDBTLHMCVFQMS-UHFFFAOYSA-N 4-[4-(1,1,1,3,3,3-hexafluoropropan-2-yl)phenoxy]aniline Chemical compound C1=CC(N)=CC=C1OC1=CC=C(C(C(F)(F)F)C(F)(F)F)C=C1 SSDBTLHMCVFQMS-UHFFFAOYSA-N 0.000 description 1
- HHLMWQDRYZAENA-UHFFFAOYSA-N 4-[4-[2-[4-(4-aminophenoxy)phenyl]-1,1,1,3,3,3-hexafluoropropan-2-yl]phenoxy]aniline Chemical compound C1=CC(N)=CC=C1OC1=CC=C(C(C=2C=CC(OC=3C=CC(N)=CC=3)=CC=2)(C(F)(F)F)C(F)(F)F)C=C1 HHLMWQDRYZAENA-UHFFFAOYSA-N 0.000 description 1
- MRTAEHMRKDVKMS-UHFFFAOYSA-N 4-[4-[4-(3,4-dicarboxyphenoxy)phenyl]sulfanylphenoxy]phthalic acid Chemical compound C1=C(C(O)=O)C(C(=O)O)=CC=C1OC(C=C1)=CC=C1SC(C=C1)=CC=C1OC1=CC=C(C(O)=O)C(C(O)=O)=C1 MRTAEHMRKDVKMS-UHFFFAOYSA-N 0.000 description 1
- ZVFRMELZVKCNLO-UHFFFAOYSA-N 4-[4-[4-(4-pentylcyclohexyl)cyclohexyl]phenoxy]benzene-1,3-diamine Chemical compound C1CC(CCCCC)CCC1C1CCC(C=2C=CC(OC=3C(=CC(N)=CC=3)N)=CC=2)CC1 ZVFRMELZVKCNLO-UHFFFAOYSA-N 0.000 description 1
- PJWQLRKRVISYPL-UHFFFAOYSA-N 4-[4-amino-3-(trifluoromethyl)phenyl]-2-(trifluoromethyl)aniline Chemical group C1=C(C(F)(F)F)C(N)=CC=C1C1=CC=C(N)C(C(F)(F)F)=C1 PJWQLRKRVISYPL-UHFFFAOYSA-N 0.000 description 1
- WJMQNPAEXWNWMD-UHFFFAOYSA-N 4-[9-(4-aminophenyl)-10h-anthracen-9-yl]aniline Chemical compound C1=CC(N)=CC=C1C1(C=2C=CC(N)=CC=2)C2=CC=CC=C2CC2=CC=CC=C21 WJMQNPAEXWNWMD-UHFFFAOYSA-N 0.000 description 1
- HCCRFHKQDVMDKQ-UHFFFAOYSA-N 4-[9-(4-hydroxyphenyl)-10h-anthracen-9-yl]phenol Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2CC2=CC=CC=C21 HCCRFHKQDVMDKQ-UHFFFAOYSA-N 0.000 description 1
- YBNWBQXABYLBMR-UHFFFAOYSA-N 4-dodecoxybenzene-1,3-diamine Chemical compound CCCCCCCCCCCCOC1=CC=C(N)C=C1N YBNWBQXABYLBMR-UHFFFAOYSA-N 0.000 description 1
- 125000004203 4-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- YFBMJEBQWQBRQJ-UHFFFAOYSA-N 4-n-(4-aminophenyl)-4-n-phenylbenzene-1,4-diamine Chemical compound C1=CC(N)=CC=C1N(C=1C=CC(N)=CC=1)C1=CC=CC=C1 YFBMJEBQWQBRQJ-UHFFFAOYSA-N 0.000 description 1
- RHJVCIJERZCGKT-UHFFFAOYSA-N 4-octadecoxybenzene-1,3-diamine Chemical compound CCCCCCCCCCCCCCCCCCOC1=CC=C(N)C=C1N RHJVCIJERZCGKT-UHFFFAOYSA-N 0.000 description 1
- SZLOMZIVKBNFKQ-UHFFFAOYSA-N 4-pentadecoxybenzene-1,3-diamine Chemical compound CCCCCCCCCCCCCCCOC1=CC=C(N)C=C1N SZLOMZIVKBNFKQ-UHFFFAOYSA-N 0.000 description 1
- BGQNOPFTJROKJE-UHFFFAOYSA-N 5,6-diamino-1,3-dimethylpyrimidine-2,4-dione Chemical compound CN1C(N)=C(N)C(=O)N(C)C1=O BGQNOPFTJROKJE-UHFFFAOYSA-N 0.000 description 1
- BBTNLADSUVOPPN-UHFFFAOYSA-N 5,6-diaminouracil Chemical compound NC=1NC(=O)NC(=O)C=1N BBTNLADSUVOPPN-UHFFFAOYSA-N 0.000 description 1
- VQVIHDPBMFABCQ-UHFFFAOYSA-N 5-(1,3-dioxo-2-benzofuran-5-carbonyl)-2-benzofuran-1,3-dione Chemical compound C1=C2C(=O)OC(=O)C2=CC(C(C=2C=C3C(=O)OC(=O)C3=CC=2)=O)=C1 VQVIHDPBMFABCQ-UHFFFAOYSA-N 0.000 description 1
- IPEMCIBPDYCJLO-UHFFFAOYSA-N 5-[(3,5,5,8,8-pentamethyl-6,7-dihydronaphthalen-2-yl)methyl]-n-(2,4,6-trimethoxyphenyl)furan-2-carboxamide Chemical compound COC1=CC(OC)=CC(OC)=C1NC(=O)C(O1)=CC=C1CC1=CC(C(CCC2(C)C)(C)C)=C2C=C1C IPEMCIBPDYCJLO-UHFFFAOYSA-N 0.000 description 1
- VWRKHZDUJPWJKV-UHFFFAOYSA-N 6-(carboxymethyl)bicyclo[2.2.1]heptane-2,3,5-tricarboxylic acid Chemical compound C1C2C(C(O)=O)C(CC(=O)O)C1C(C(O)=O)C2C(O)=O VWRKHZDUJPWJKV-UHFFFAOYSA-N 0.000 description 1
- CPNAVTYCORRLMH-UHFFFAOYSA-N 6-phenylphenanthridine-3,8-diamine Chemical compound C=1C(N)=CC=C(C2=CC=C(N)C=C22)C=1N=C2C1=CC=CC=C1 CPNAVTYCORRLMH-UHFFFAOYSA-N 0.000 description 1
- KPIAHQAOODFLBZ-UHFFFAOYSA-N 9-methylcarbazole-3,6-diamine Chemical compound NC1=CC=C2N(C)C3=CC=C(N)C=C3C2=C1 KPIAHQAOODFLBZ-UHFFFAOYSA-N 0.000 description 1
- NKSQIEJTEVJKKB-UHFFFAOYSA-N 9-phenylcarbazole-3,6-diamine Chemical compound C12=CC=C(N)C=C2C2=CC(N)=CC=C2N1C1=CC=CC=C1 NKSQIEJTEVJKKB-UHFFFAOYSA-N 0.000 description 1
- MSSXOMSJDRHRMC-UHFFFAOYSA-N 9H-purine-2,6-diamine Chemical compound NC1=NC(N)=C2NC=NC2=N1 MSSXOMSJDRHRMC-UHFFFAOYSA-N 0.000 description 1
- YJKJAYFKPIUBAW-UHFFFAOYSA-N 9h-carbazol-1-amine Chemical compound N1C2=CC=CC=C2C2=C1C(N)=CC=C2 YJKJAYFKPIUBAW-UHFFFAOYSA-N 0.000 description 1
- 241000208140 Acer Species 0.000 description 1
- IYLLULUTZPKQBW-UHFFFAOYSA-N Acrinol Chemical compound CC(O)C(O)=O.C1=C(N)C=CC2=C(N)C3=CC(OCC)=CC=C3N=C21 IYLLULUTZPKQBW-UHFFFAOYSA-N 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- JGFGMVAAQJDHFG-UHFFFAOYSA-N C(C)(=O)OCCNCCNCCC(C)CCCCCCCCCC(OCC)(OCC)OCC Chemical compound C(C)(=O)OCCNCCNCCC(C)CCCCCCCCCC(OCC)(OCC)OCC JGFGMVAAQJDHFG-UHFFFAOYSA-N 0.000 description 1
- ICWNIKLKVHTFOW-UHFFFAOYSA-N C(C)OC(CCCCCCCCCCCCNCCNCCN)(OCC)OCC Chemical compound C(C)OC(CCCCCCCCCCCCNCCNCCN)(OCC)OCC ICWNIKLKVHTFOW-UHFFFAOYSA-N 0.000 description 1
- MOQRRJXBFAQMIU-UHFFFAOYSA-N C(C1CO1)OCC(C(OC)(OC)OC)CCCCCCCC Chemical compound C(C1CO1)OCC(C(OC)(OC)OC)CCCCCCCC MOQRRJXBFAQMIU-UHFFFAOYSA-N 0.000 description 1
- UGGZPAYEYLXUKI-UHFFFAOYSA-N C(C1CO1)OCC(C(OCC)(OCC)OCC)CCCCCCCC Chemical compound C(C1CO1)OCC(C(OCC)(OCC)OCC)CCCCCCCC UGGZPAYEYLXUKI-UHFFFAOYSA-N 0.000 description 1
- QMUVQASGACIPFI-UHFFFAOYSA-N C(C1CO1)OCCC(C(OCC)(OCC)OCC)CCCCCCCC Chemical compound C(C1CO1)OCCC(C(OCC)(OCC)OCC)CCCCCCCC QMUVQASGACIPFI-UHFFFAOYSA-N 0.000 description 1
- MTDLVDBRMBSPBJ-UHFFFAOYSA-N C(C1CO1)OCCCC(C(OCC)(OCC)OCC)CCCCCCCC Chemical compound C(C1CO1)OCCCC(C(OCC)(OCC)OCC)CCCCCCCC MTDLVDBRMBSPBJ-UHFFFAOYSA-N 0.000 description 1
- GZIMARRFAKWMKY-UHFFFAOYSA-N C1CCCC2C3CCCCC3CCC12.C1CCCC1 Chemical class C1CCCC2C3CCCCC3CCC12.C1CCCC1 GZIMARRFAKWMKY-UHFFFAOYSA-N 0.000 description 1
- JINPRYUMLMJPFE-UHFFFAOYSA-N CC1=C(C=NC=CN1)CCCCCCCCCC Chemical compound CC1=C(C=NC=CN1)CCCCCCCCCC JINPRYUMLMJPFE-UHFFFAOYSA-N 0.000 description 1
- SFHDLGQJNYBJBG-UHFFFAOYSA-N CCCCCC1CCC(CC1)C2CCC(CC2)C3=CC=C(C=C3)OC(=O)C4=CC(=CC(=C4)[N+](=O)[O-])[N+](=O)[O-] Chemical compound CCCCCC1CCC(CC1)C2CCC(CC2)C3=CC=C(C=C3)OC(=O)C4=CC(=CC(=C4)[N+](=O)[O-])[N+](=O)[O-] SFHDLGQJNYBJBG-UHFFFAOYSA-N 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 239000004986 Cholesteric liquid crystals (ChLC) Substances 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- AQZGPSLYZOOYQP-UHFFFAOYSA-N Diisoamyl ether Chemical compound CC(C)CCOCCC(C)C AQZGPSLYZOOYQP-UHFFFAOYSA-N 0.000 description 1
- VYZAHLCBVHPDDF-UHFFFAOYSA-N Dinitrochlorobenzene Chemical compound [O-][N+](=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 VYZAHLCBVHPDDF-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- KMTRUDSVKNLOMY-UHFFFAOYSA-N Ethylene carbonate Chemical compound O=C1OCCO1 KMTRUDSVKNLOMY-UHFFFAOYSA-N 0.000 description 1
- WJYIASZWHGOTOU-UHFFFAOYSA-N Heptylamine Chemical compound CCCCCCCN WJYIASZWHGOTOU-UHFFFAOYSA-N 0.000 description 1
- 239000005264 High molar mass liquid crystal Substances 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- DMBHHRLKUKUOEG-UHFFFAOYSA-N N-phenyl aniline Natural products C=1C=CC=CC=1NC1=CC=CC=C1 DMBHHRLKUKUOEG-UHFFFAOYSA-N 0.000 description 1
- MCEZDKVYAJYJKX-UHFFFAOYSA-N N1C(OC2=CC=CC=C12)=C1N=C2C=CC=CC2=C1 Chemical compound N1C(OC2=CC=CC=C12)=C1N=C2C=CC=CC2=C1 MCEZDKVYAJYJKX-UHFFFAOYSA-N 0.000 description 1
- HNJYHRSYMUUVEX-UHFFFAOYSA-N NC(CC(C(OC)(OC)OC)CCCCCCCC)C Chemical compound NC(CC(C(OC)(OC)OC)CCCCCCCC)C HNJYHRSYMUUVEX-UHFFFAOYSA-N 0.000 description 1
- KUXIUJAXHQHZAM-UHFFFAOYSA-N NC1=CC=C(C(C(=O)NC2=CC=CC=C2)(O)C2=CC=C(C=C2)N)C=C1 Chemical compound NC1=CC=C(C(C(=O)NC2=CC=CC=C2)(O)C2=CC=C(C=C2)N)C=C1 KUXIUJAXHQHZAM-UHFFFAOYSA-N 0.000 description 1
- XJDCHDFUMGSEHD-UHFFFAOYSA-N NCCCC(C(OC)(OC)OC)CCCCCCCC Chemical compound NCCCC(C(OC)(OC)OC)CCCCCCCC XJDCHDFUMGSEHD-UHFFFAOYSA-N 0.000 description 1
- QVVNSYWEOYEMQK-UHFFFAOYSA-N NCCCC1(OC(C(OC1C)C)C)C Chemical compound NCCCC1(OC(C(OC1C)C)C)C QVVNSYWEOYEMQK-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- KMCMODAVNVQVIE-UHFFFAOYSA-N O=[PH2]C1=CC=CC=C1.OC(=O)C1=CC=CC=C1C(O)=O.OC(=O)C1=CC=CC=C1C(O)=O Chemical compound O=[PH2]C1=CC=CC=C1.OC(=O)C1=CC=CC=C1C(O)=O.OC(=O)C1=CC=CC=C1C(O)=O KMCMODAVNVQVIE-UHFFFAOYSA-N 0.000 description 1
- REYJJPSVUYRZGE-UHFFFAOYSA-N Octadecylamine Chemical compound CCCCCCCCCCCCCCCCCCN REYJJPSVUYRZGE-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 229920000265 Polyparaphenylene Polymers 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- WDVSHHCDHLJJJR-UHFFFAOYSA-N Proflavine Chemical compound C1=CC(N)=CC2=NC3=CC(N)=CC=C3C=C21 WDVSHHCDHLJJJR-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- 239000002262 Schiff base Substances 0.000 description 1
- 150000004753 Schiff bases Chemical class 0.000 description 1
- PLZVEHJLHYMBBY-UHFFFAOYSA-N Tetradecylamine Chemical compound CCCCCCCCCCCCCCN PLZVEHJLHYMBBY-UHFFFAOYSA-N 0.000 description 1
- GTTSNKDQDACYLV-UHFFFAOYSA-N Trihydroxybutane Chemical compound CCCC(O)(O)O GTTSNKDQDACYLV-UHFFFAOYSA-N 0.000 description 1
- FAOMZVDZARKPFJ-UHFFFAOYSA-N WIN 18446 Chemical compound ClC(Cl)C(=O)NCCCCCCCCNC(=O)C(Cl)Cl FAOMZVDZARKPFJ-UHFFFAOYSA-N 0.000 description 1
- OXIKYYJDTWKERT-UHFFFAOYSA-N [4-(aminomethyl)cyclohexyl]methanamine Chemical compound NCC1CCC(CN)CC1 OXIKYYJDTWKERT-UHFFFAOYSA-N 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- TUVYSBJZBYRDHP-UHFFFAOYSA-N acetic acid;methoxymethane Chemical compound COC.CC(O)=O TUVYSBJZBYRDHP-UHFFFAOYSA-N 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 125000002723 alicyclic group Chemical group 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- UPOYFZYFGWBUKL-UHFFFAOYSA-N amiphenazole Chemical compound S1C(N)=NC(N)=C1C1=CC=CC=C1 UPOYFZYFGWBUKL-UHFFFAOYSA-N 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000006267 biphenyl group Chemical group 0.000 description 1
- TUQQUUXMCKXGDI-UHFFFAOYSA-N bis(3-aminophenyl)methanone Chemical compound NC1=CC=CC(C(=O)C=2C=C(N)C=CC=2)=C1 TUQQUUXMCKXGDI-UHFFFAOYSA-N 0.000 description 1
- ZLSMCQSGRWNEGX-UHFFFAOYSA-N bis(4-aminophenyl)methanone Chemical compound C1=CC(N)=CC=C1C(=O)C1=CC=C(N)C=C1 ZLSMCQSGRWNEGX-UHFFFAOYSA-N 0.000 description 1
- JWXLCQHWBFHMOI-NIQMUPOESA-N bis[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] carbonate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C(C1)[C@]2(C)CC[C@@H]1OC(=O)O[C@@H]1CC2=CC[C@H]3[C@@H]4CC[C@H]([C@H](C)CCCC(C)C)[C@@]4(C)CC[C@@H]3[C@@]2(C)CC1 JWXLCQHWBFHMOI-NIQMUPOESA-N 0.000 description 1
- 229910052797 bismuth Inorganic materials 0.000 description 1
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 1
- WKDNYTOXBCRNPV-UHFFFAOYSA-N bpda Chemical compound C1=C2C(=O)OC(=O)C2=CC(C=2C=C3C(=O)OC(C3=CC=2)=O)=C1 WKDNYTOXBCRNPV-UHFFFAOYSA-N 0.000 description 1
- HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 1
- 235000013844 butane Nutrition 0.000 description 1
- QVYARBLCAHCSFJ-UHFFFAOYSA-N butane-1,1-diamine Chemical compound CCCC(N)N QVYARBLCAHCSFJ-UHFFFAOYSA-N 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- CURBACXRQKTCKZ-UHFFFAOYSA-N cyclobutane-1,2,3,4-tetracarboxylic acid Chemical compound OC(=O)C1C(C(O)=O)C(C(O)=O)C1C(O)=O CURBACXRQKTCKZ-UHFFFAOYSA-N 0.000 description 1
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 1
- NLUNLVTVUDIHFE-UHFFFAOYSA-N cyclooctylcyclooctane Chemical compound C1CCCCCCC1C1CCCCCCC1 NLUNLVTVUDIHFE-UHFFFAOYSA-N 0.000 description 1
- WOSVXXBNNCUXMT-UHFFFAOYSA-N cyclopentane-1,2,3,4-tetracarboxylic acid Chemical compound OC(=O)C1CC(C(O)=O)C(C(O)=O)C1C(O)=O WOSVXXBNNCUXMT-UHFFFAOYSA-N 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- WYACBZDAHNBPPB-UHFFFAOYSA-N diethyl oxalate Chemical compound CCOC(=O)C(=O)OCC WYACBZDAHNBPPB-UHFFFAOYSA-N 0.000 description 1
- GYZLOYUZLJXAJU-UHFFFAOYSA-N diglycidyl ether Chemical compound C1OC1COCC1CO1 GYZLOYUZLJXAJU-UHFFFAOYSA-N 0.000 description 1
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 1
- 125000005594 diketone group Chemical group 0.000 description 1
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical class COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 1
- 150000005182 dinitrobenzenes Chemical class 0.000 description 1
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Natural products C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 239000012776 electronic material Substances 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- UHKJHMOIRYZSTH-UHFFFAOYSA-N ethyl 2-ethoxypropanoate Chemical compound CCOC(C)C(=O)OCC UHKJHMOIRYZSTH-UHFFFAOYSA-N 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000005329 float glass Substances 0.000 description 1
- RMBPEFMHABBEKP-UHFFFAOYSA-N fluorene Chemical compound C1=CC=C2C3=C[CH]C=CC3=CC2=C1 RMBPEFMHABBEKP-UHFFFAOYSA-N 0.000 description 1
- 125000001207 fluorophenyl group Chemical group 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- PKWIYNIDEDLDCJ-UHFFFAOYSA-N guanazole Chemical compound NC1=NNC(N)=N1 PKWIYNIDEDLDCJ-UHFFFAOYSA-N 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- KAJZYANLDWUIES-UHFFFAOYSA-N heptadecan-1-amine Chemical compound CCCCCCCCCCCCCCCCCN KAJZYANLDWUIES-UHFFFAOYSA-N 0.000 description 1
- IZKZIDXHCDIZKY-UHFFFAOYSA-N heptane-1,1-diamine Chemical compound CCCCCCC(N)N IZKZIDXHCDIZKY-UHFFFAOYSA-N 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- BUHXFUSLEBPCEB-UHFFFAOYSA-N icosan-1-amine Chemical compound CCCCCCCCCCCCCCCCCCCCN BUHXFUSLEBPCEB-UHFFFAOYSA-N 0.000 description 1
- AMGQUBHHOARCQH-UHFFFAOYSA-N indium;oxotin Chemical compound [In].[Sn]=O AMGQUBHHOARCQH-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000011810 insulating material Substances 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- VFTGLSWXJMRZNB-UHFFFAOYSA-N isoamyl isobutyrate Chemical compound CC(C)CCOC(=O)C(C)C VFTGLSWXJMRZNB-UHFFFAOYSA-N 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 238000010030 laminating Methods 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- BDJSOPWXYLFTNW-UHFFFAOYSA-N methyl 3-methoxypropanoate Chemical compound COCCC(=O)OC BDJSOPWXYLFTNW-UHFFFAOYSA-N 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- SJPFBRJHYRBAGV-UHFFFAOYSA-N n-[[3-[[bis(oxiran-2-ylmethyl)amino]methyl]phenyl]methyl]-1-(oxiran-2-yl)-n-(oxiran-2-ylmethyl)methanamine Chemical compound C1OC1CN(CC=1C=C(CN(CC2OC2)CC2OC2)C=CC=1)CC1CO1 SJPFBRJHYRBAGV-UHFFFAOYSA-N 0.000 description 1
- ICXMVMOJRRHROE-UHFFFAOYSA-N n-benzyl-1-(oxiran-2-yl)-n-(oxiran-2-ylmethyl)methanamine Chemical compound C1OC1CN(CC=1C=CC=CC=1)CC1CO1 ICXMVMOJRRHROE-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OLAPPGSPBNVTRF-UHFFFAOYSA-N naphthalene-1,4,5,8-tetracarboxylic acid Chemical compound C1=CC(C(O)=O)=C2C(C(=O)O)=CC=C(C(O)=O)C2=C1C(O)=O OLAPPGSPBNVTRF-UHFFFAOYSA-N 0.000 description 1
- DOBFTMLCEYUAQC-UHFFFAOYSA-N naphthalene-2,3,6,7-tetracarboxylic acid Chemical compound OC(=O)C1=C(C(O)=O)C=C2C=C(C(O)=O)C(C(=O)O)=CC2=C1 DOBFTMLCEYUAQC-UHFFFAOYSA-N 0.000 description 1
- YTVNOVQHSGMMOV-UHFFFAOYSA-N naphthalenetetracarboxylic dianhydride Chemical compound C1=CC(C(=O)OC2=O)=C3C2=CC=C2C(=O)OC(=O)C1=C32 YTVNOVQHSGMMOV-UHFFFAOYSA-N 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- NIHNNTQXNPWCJQ-UHFFFAOYSA-N o-biphenylenemethane Natural products C1=CC=C2CC3=CC=CC=C3C2=C1 NIHNNTQXNPWCJQ-UHFFFAOYSA-N 0.000 description 1
- IOQPZZOEVPZRBK-UHFFFAOYSA-N octan-1-amine Chemical compound CCCCCCCCN IOQPZZOEVPZRBK-UHFFFAOYSA-N 0.000 description 1
- UFOIOXZLTXNHQH-UHFFFAOYSA-N oxolane-2,3,4,5-tetracarboxylic acid Chemical compound OC(=O)C1OC(C(O)=O)C(C(O)=O)C1C(O)=O UFOIOXZLTXNHQH-UHFFFAOYSA-N 0.000 description 1
- KJOMYNHMBRNCNY-UHFFFAOYSA-N pentane-1,1-diamine Chemical compound CCCCC(N)N KJOMYNHMBRNCNY-UHFFFAOYSA-N 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
- DGTNSSLYPYDJGL-UHFFFAOYSA-N phenyl isocyanate Chemical compound O=C=NC1=CC=CC=C1 DGTNSSLYPYDJGL-UHFFFAOYSA-N 0.000 description 1
- 238000000206 photolithography Methods 0.000 description 1
- ZRXDBIJHYWJRMT-UHFFFAOYSA-N piperidine-1,4-diamine Chemical compound NC1CCN(N)CC1 ZRXDBIJHYWJRMT-UHFFFAOYSA-N 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920001707 polybutylene terephthalate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 108010040003 polyglutamine Proteins 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical class [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 150000003147 proline derivatives Chemical class 0.000 description 1
- WYVAMUWZEOHJOQ-UHFFFAOYSA-N propionic anhydride Chemical compound CCC(=O)OC(=O)CC WYVAMUWZEOHJOQ-UHFFFAOYSA-N 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- ZZYXNRREDYWPLN-UHFFFAOYSA-N pyridine-2,3-diamine Chemical compound NC1=CC=CN=C1N ZZYXNRREDYWPLN-UHFFFAOYSA-N 0.000 description 1
- YAAWASYJIRZXSZ-UHFFFAOYSA-N pyrimidine-2,4-diamine Chemical compound NC1=CC=NC(N)=N1 YAAWASYJIRZXSZ-UHFFFAOYSA-N 0.000 description 1
- 150000004060 quinone imines Chemical class 0.000 description 1
- 239000002964 rayon Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000012812 sealant material Substances 0.000 description 1
- 239000005361 soda-lime glass Substances 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 229940014800 succinic anhydride Drugs 0.000 description 1
- OAXARSVKYJPDPA-UHFFFAOYSA-N tert-butyl 4-prop-2-ynylpiperazine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCN(CC#C)CC1 OAXARSVKYJPDPA-UHFFFAOYSA-N 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 150000000000 tetracarboxylic acids Chemical class 0.000 description 1
- 229910001887 tin oxide Inorganic materials 0.000 description 1
- GKYPJLUHGAJKEM-UHFFFAOYSA-N tin;dihydrate Chemical compound O.O.[Sn] GKYPJLUHGAJKEM-UHFFFAOYSA-N 0.000 description 1
- 150000003609 titanium compounds Chemical class 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 239000002966 varnish Substances 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000009941 weaving Methods 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- 125000002256 xylenyl group Chemical class C1(C(C=CC=C1)C)(C)* 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/52—Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
- C09K19/54—Additives having no specific mesophase characterised by their chemical composition
- C09K19/56—Aligning agents
-
- G—PHYSICS
- G02—OPTICS
- G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
- G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
- G02F1/01—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour
- G02F1/13—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour based on liquid crystals, e.g. single liquid crystal display cells
- G02F1/133—Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
- G02F1/1333—Constructional arrangements; Manufacturing methods
- G02F1/1337—Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
Landscapes
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Nonlinear Science (AREA)
- General Physics & Mathematics (AREA)
- Mathematical Physics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Optics & Photonics (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Organic Chemistry (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Liquid Crystal (AREA)
Abstract
Description
.200946563 六、發明說明: · Λ 【發明所屬之技術領域】 本發明涉及液晶配向劑和液晶顯示元件。 【先前技術】 目前,作爲液晶顯示元件,已知具有所謂TN型(扭曲 向列)液晶胞的TN型液晶顯示元件,其在設置了透明導電 膜的基板表面上形成由聚醯亞胺等製成的液晶配向膜,作 爲液晶顯示元件用的基板,將其一對(兩塊)相對設置,在 ® 其間隙內塡充具有正介電各向異性的向列型液晶層,構成 夾層結構的胞,該液晶分子的長軸從一塊基板向另一塊基 板連續地扭轉90度。另外,最近還開發了比TN型液晶顯 示元件負荷比高的STN(超扭曲向列)型液晶顯示元件。這 種STN型液晶顯示元件將在向列型液晶中摻合了作爲光學 活性物質的手性劑的物質作爲液晶使用,其利用由該液晶 分子的長軸在基板間處於連續扭轉180度以上幅度的狀態 所產生的雙折射效應。這些TN型液晶顯示元件和STN型 ^ 液晶顯示元件中液晶的配向,通常由進行了打磨處理的液 晶配向膜產生。 此外,作爲與這些不同類型的液晶顯示元件,還已知 使具有負介電各向異性的液晶分子在基板上垂直配向的 VA(垂直配向)型液晶顯示元件。在VA型液晶顯示元件中, 在向基板間施加電壓使液晶分子朝向與基板平行的方向傾 斜時,必須使液晶分子自基板法線方向向基板面內的一個 方向傾斜。作爲爲此目的的手段,已提出了例如在ITO上 200946563 形成突起以控制液晶配向方向的MVA方式(專利文獻1和 非專利文獻1 )、設計電極結構以控制配向方向的EVA方式 (非專利文獻2)、通過光照射使配向膜改性而控制配向方向 的光配向方式(參見非專利文獻3)等方案。 而由四羧酸二酐與二胺縮聚製得的聚醯亞胺,已知其 耐熱性和耐化學試劑性優良。因而,聚醯亞胺被用於各種 用途,特別是在電學、電子材料領域,作爲保護材料、絕 緣材料等已被廣泛應用。特別是在液晶顯示元件的配向膜 0 用途中,從塗膜的耐久性角度考慮,迄今還主要是使用聚 醯亞胺。但是,爲了液晶顯示元件的高性能化、顯示的高 密度化等目的,聚醯亞胺的表面性能特受注重,對於以前 的聚醯亞胺配向膜,也提高對優良性能的要求。例如對於 液晶配向控制力、預傾角性能、殘像性能等,要求表現更 高的性能。 由聚醯亞胺製作的液晶配向膜,通常,可以通過將作 爲聚醯亞胺前體的聚醯胺酸或其脫水閉環而成的可溶性醯 〇 亞胺化聚合物的有機溶劑溶液的這種液晶配向劑塗敷於基 板上,經加熱使其醯亞胺化而製得。根據專利文獻2,通 過使用含有由下述式(III)或(IV).200946563 VI. Description of the Invention: Λ Technical Field of the Invention The present invention relates to a liquid crystal alignment agent and a liquid crystal display element. [Prior Art] As a liquid crystal display element, a TN type liquid crystal display element having a so-called TN type (twisted nematic) liquid crystal cell is known, which is formed of a polyimide film or the like on the surface of a substrate on which a transparent conductive film is provided. A liquid crystal alignment film is used as a substrate for a liquid crystal display element, and a pair of (two pieces) are disposed opposite each other, and a nematic liquid crystal layer having positive dielectric anisotropy is filled in the gap therebetween to form a sandwich structure. The long axis of the liquid crystal molecules is continuously twisted by 90 degrees from one substrate to the other. Further, recently, an STN (Super Twisted Nematic) type liquid crystal display element having a higher load ratio than a TN type liquid crystal display element has been developed. Such an STN type liquid crystal display device uses a substance which is a chiral agent which is an optically active substance in a nematic liquid crystal, and is used as a liquid crystal by a continuous twist of 180 degrees or more between substrates by the long axis of the liquid crystal molecule. The birefringence effect produced by the state. The alignment of the liquid crystals in these TN type liquid crystal display elements and STN type liquid crystal display elements is usually produced by a liquid crystal alignment film which has been subjected to a rubbing treatment. Further, as a liquid crystal display element of a different type from these, a VA (Vertical Alignment) type liquid crystal display element in which liquid crystal molecules having negative dielectric anisotropy are vertically aligned on a substrate is also known. In the VA liquid crystal display device, when a voltage is applied between the substrates to tilt the liquid crystal molecules in a direction parallel to the substrate, it is necessary to tilt the liquid crystal molecules from the substrate normal direction in one direction in the substrate surface. As a means for this purpose, for example, an MVA method in which protrusions are formed on ITO 200946563 to control the alignment direction of liquid crystals (Patent Document 1 and Non-Patent Document 1), and an EVA method in which an electrode structure is designed to control an alignment direction has been proposed (Non-Patent Literature) 2) A method of modifying the alignment film by light irradiation to control the alignment direction of the alignment direction (see Non-Patent Document 3). Further, polyimine which is obtained by polycondensation of tetracarboxylic dianhydride and diamine is known to have excellent heat resistance and chemical resistance. Therefore, polyimine has been used in various applications, particularly in the fields of electricity and electronic materials, and has been widely used as a protective material and an insulating material. In particular, in the use of the alignment film 0 of a liquid crystal display element, from the viewpoint of durability of a coating film, polyimine has been mainly used so far. However, in order to improve the performance of the liquid crystal display element and to increase the density of the display, the surface properties of the polyimide have been particularly emphasized, and the prior polyimine alignment film has also been required to have excellent performance. For example, liquid crystal alignment control force, pretilt performance, afterimage performance, etc., require higher performance. A liquid crystal alignment film made of polyimine, usually, an organic solvent solution of a soluble ruthenium-imiding polymer which is a polyaminic acid as a polyimine precursor or a dehydration ring-closing thereof The liquid crystal alignment agent is applied onto a substrate and heated to imidize the oxime. According to Patent Document 2, by using the formula (III) or (IV)
200946563 (式(III)和(IV)中,n2各自爲4或6) 表示的結構的二胺合成的聚醯胺酸或其醯亞胺化聚合物 的液晶配向劑’可形成能夠產生穩定的預傾角的液晶配向 膜。該技術是通過在液晶配向膜上導入來自於上述式(III) 或(IV)表示的二胺的液晶類似骨架而實現預傾角的穩定化 的。據說通過應用具有這種結構的聚合物,能夠形成垂直 配向性優良的VA型液晶顯示元件用液晶配向膜(以下也稱 爲“垂直配向型液晶配向膜”)。但是,在專利文獻2中, 〇 沒有改善電壓保持率和殘像性能。 另外’在專利文獻3中,報導了通過使用含有採用 3,5,6·三羧基-2-羧甲基降冰片烷-2 :3,5:6-二酐作爲四羧酸 二酐所合成的聚合物的液晶配向劑,能夠實現高溫領域的 高電壓保持率。但是,該技術仍然沒有實現殘像性能的改 善。 在此,若注目於液晶顯,示元件的製造步驟,近年來的 發展有著明顯的進展。例如,作爲向一對基板間的間隙內 〇 塡充液晶材料的方法,以前通過間隙將一對基板相對設置 後’採用向其間隙內收入液晶的方法。而近年來,作爲取 代匕的新方法,提出了液晶滴下(〇neDropFill=ODF)方式 (專利文獻4)。ODF方式是將液晶材料的液滴滴在基板的液 晶配向膜上,將該液晶滴用相對向的基板擠壓擴展,同時 在真空下將基板貼合的方法。若採用該方法,具有能夠大 幅縮短液晶塡充步驟所需要的時間的優點,但是,在液晶 滴下部分會產生滴痕,當將其製成液晶顯示元件時,可以 指出能夠目視到該滴痕產生液晶配向不均的問題。該液晶 200946563 配向不均’被認爲是由於向液晶配向膜滴下液晶材料時的 撞擊而局部地擾亂液晶配向膜的配向性緣故。爲了解決該 問題’進行了通過液晶配向膜材料來解決的嘗試(專利文獻 5),但是仍不夠理想,特別是當採用〇DF方式製造Va型 液晶顯示元件時,要求抑制上述液晶配向不均。 【專利文獻1】日本特開平11— 258605號公報 【專利文獻2】日本特開平09-278724號公報 【專利文獻3】日本特開平1丨一 843 91號公報 〇 【 專利文獻4】日本特開平6— 3635號公報 【專利文獻5】日本特開2007 - 183564號公報 【專利文獻6】曰本特開平6-222366號公報 【專利文獻7】日本特開平6-281937號公報 【專利文獻8】日本特開平5-107544號公報 【專利文獻9】日本特開平4— 281427號公報 【非專利文獻1】“液晶”,Vo 1 · 3,N 〇 . 2,1 1 7 ( 1 9 9 9 年) Φ 【非專利文獻2】“液晶”,Vo 1.3,No. 4,272(1999 年) 【非專利文獻 3】“Jpn J. Appl. phys.” Vol 36, L428(l997 年) 【發明内容】 本發明的第一目的是,提供能夠形成電壓保持率和殘 像性能優良的液晶配向膜的液晶配向劑。本發明的第二目 的是,提供即使在液晶塡充步驟中採用ODF方式的情況 下,也能形成不會因液晶滴下而發生液晶配向不均的液晶 200946563 配向膜的液晶配向劑。這種本發明的液晶配向劑,可特佳 用於垂直配向型液晶顯示元件的液晶配向膜的形成。 本發明的另一目的是’提供一種顯不品質優異的液晶 顯示元件。 本發明的其他目的和優點,可以由以下的說明看出。 本發明者們鑑於上述情況而進行了專心硏究,結果發 現,通過使用含有用具有特定結構的二胺合成的特定聚合 物的液晶配向劑,能夠形成電壓保持率和殘像性能優良的 G 液晶配向膜,從而達成了本發明。 即,本發明的上述目的和優點,第一,由一種液晶配 向劑達成,其包括選自聚醯胺酸及其醯亞胺化聚合物構成 的群組中的至少一種聚合物,該聚醯胺酸使四羧酸二酐與 含有選自下述式(I)和(II)各自表示的化合物中的至少一種 的二胺反應所製得,200946563 (In the formulae (III) and (IV), the diamine-synthesized polyamine or the quinone imidized polymer liquid crystal alignment agent of the structure represented by 4 or 6) can form a stable Pre-tilt liquid crystal alignment film. This technique achieves stabilization of the pretilt angle by introducing a liquid crystal-like skeleton derived from the diamine represented by the above formula (III) or (IV) onto the liquid crystal alignment film. It is said that a liquid crystal alignment film for a VA liquid crystal display element (hereinafter also referred to as "vertical alignment type liquid crystal alignment film") having excellent vertical alignment property can be formed by using a polymer having such a structure. However, in Patent Document 2, 电压 does not improve voltage holding ratio and afterimage performance. Further, in Patent Document 3, it is reported that it is synthesized by using a tricarboxylic dianhydride containing 3,5,6-tricarboxy-2-carboxymethylnorbornane-2:3,5:6-dianhydride as a tetracarboxylic dianhydride. The liquid crystal alignment agent of the polymer can achieve high voltage retention in the high temperature field. However, this technique still does not improve the afterimage performance. Here, if attention is paid to liquid crystal display, the manufacturing steps of the display elements have been significantly advanced in recent years. For example, as a method of filling a liquid crystal material into a gap between a pair of substrates, a pair of substrates are previously disposed to face each other through a gap, and a method of collecting liquid crystal into the gap is employed. In recent years, as a new method for replacing bismuth, a liquid crystal dropping (〇neDropFill=ODF) method has been proposed (Patent Document 4). The ODF method is a method in which droplets of a liquid crystal material are dropped on a liquid crystal alignment film of a substrate, and the liquid crystal droplets are pressed and expanded by opposing substrates, and the substrate is bonded under vacuum. According to this method, there is an advantage that the time required for the liquid crystal charging step can be greatly shortened, but dripping marks are generated in the liquid crystal dropping portion, and when it is made into a liquid crystal display element, it can be pointed out that the drop mark can be visually observed. The problem of uneven liquid crystal alignment. This liquid crystal 200946563 alignment unevenness is considered to be a partial disturbance of the alignment of the liquid crystal alignment film due to the impact when the liquid crystal material is dropped onto the liquid crystal alignment film. In order to solve this problem, an attempt has been made to solve the problem by the liquid crystal alignment film material (Patent Document 5), but it is still not satisfactory. In particular, when the Va type liquid crystal display element is manufactured by the 〇DF method, it is required to suppress the above-described liquid crystal alignment unevenness. [Patent Document 1] Japanese Laid-Open Patent Publication No. Hei 09-278724 (Patent Document 3) Japanese Patent Laid-Open Publication No. Hei No. Hei. Japanese Laid-Open Patent Publication No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. JP-A-5-107544 [Patent Document 9] Japanese Laid-Open Patent Publication No. Hei-4-281427 (Non-Patent Document 1) "Liquid Crystal", Vo 1 · 3, N 〇. 2, 1 1 7 (19.9) Φ [Non-Patent Document 2] "Liquid Crystal", Vo 1.3, No. 4, 272 (1999) [Non-Patent Document 3] "Jpn J. Appl. phys." Vol 36, L428 (1999) [Invention] A first object of the invention is to provide a liquid crystal alignment agent capable of forming a liquid crystal alignment film excellent in voltage holding ratio and afterimage performance. A second object of the present invention is to provide a liquid crystal alignment agent which can form a liquid crystal 200946563 alignment film which does not cause liquid crystal alignment unevenness due to liquid crystal dropping even when the ODF method is employed in the liquid crystal charging step. Such a liquid crystal alignment agent of the present invention can be preferably used for the formation of a liquid crystal alignment film of a vertical alignment type liquid crystal display element. Another object of the present invention is to provide a liquid crystal display element which is excellent in quality. Other objects and advantages of the invention will be apparent from the description which follows. The present inventors have conducted intensive studies in view of the above circumstances, and as a result, it has been found that by using a liquid crystal alignment agent containing a specific polymer synthesized using a diamine having a specific structure, it is possible to form a G liquid crystal excellent in voltage holding ratio and afterimage performance. The alignment film is achieved, thereby achieving the present invention. That is, the above objects and advantages of the present invention, first, achieved by a liquid crystal alignment agent comprising at least one polymer selected from the group consisting of polylysine and its quinone imidized polymer, the polyfluorene The amine acid is obtained by reacting a tetracarboxylic dianhydride with a diamine containing at least one selected from the group consisting of compounds represented by the following formulas (I) and (II),
(上述式中,nl各自獨立地爲1〜8的整數)。 本發明的上述目的和優點,第二,由一種液晶顯示元 件達成,其具有由上述液晶配向劑形成的液晶配向膜° 本發明的上述目的和優點,第三,由上述式(1)或(Π) 表示的化合物達成。 本發明的液晶配向劑能夠形成電壓保持率和殘像@倉巨 200946563 優良的液晶配向膜。並且,本發明的液晶配向劑,即使在 液晶塡充步驟中採用ODF方式的情況下,也能形成不會因 液晶滴下而發生液晶配向不均的液晶配向膜。本發明的液 晶配向劑可以用於TN型和STN型液晶顯示元件等,特別 是可特別適用於VA型液晶顯示元件。 本發明的液晶顯示元件可以有效地用於各種裝置,例 如可適用於計算器、手錶、臺鐘、計數顯示幕、文字處理 器、個人電腦、液晶電視機等的顯示裝置。 〇 【實施方式】 以下,對本發明進行具體說明。 本發明的液晶配向劑包括選自聚酸胺酸及其醯亞胺化 聚合物構成的群組中的至少一種聚合物,該聚醯胺酸使四 羧酸二酐與含有選自上述式(I)和(II)各自表示的化合物中 的至少一種的二胺反應所製得。 <四羧酸二酐> 作爲可用於合成本發明中所用的聚醯胺酸的四羧酸二 〇 酐,可以列舉例如丁烷四羧酸二酐、1,2,3,4-環丁烷四羧酸 二酐、1,2-二甲基-1,2,3,4-環丁烷四羧酸二酐、1,3-二甲基 -1,2,3,4-環丁烷四羧酸二酐、1,3-二氯-1,2,3,4·環丁烷四羧 酸二酐、1,2,3,4-四甲基-1,2,3,4-環丁烷四羧酸二酐、 1,2,3,4-環戊烷四羧酸二酐、1,2,4,5-環己烷四羧酸二酐、 3,3’,4,4’-二環己基四羧酸二酐、2,3,5-三羧基環戊基醋酸 二酐、2,3,4,5-四氫呋喃四羧酸二酐、1,3,33,4,5,91)-六氫 -5-(四氫-2,5-二氧代-3-呋喃基)-萘[1,2<]-呋喃-1,3-二 酮、l,3,3a,4,5,9b-六氫-5-甲基-5-(四氫-2,5-二氧代-3-呋喃 200946563 基)-萘[l,2-c]·呋喃-1,3·二 _、13,3&4,591)_六氡_5乙基 -5-(四氫_2’5-二氧代-3-呋喃基)_萘[u.cp呋喃_1 二 酮、1’3,3&,4,5,9卜六氫-7_甲基-5_(四氫_2,5_二氧代_^呋喃 基)-萘[1,2-C]-呋喃·U·二酮、以山^外六氦小乙基 -5-(四氫-2,5-二氧代_3_呋喃基卜萘呋喃1 二 酮、1,3’3&,4,5,915-六氫-8_甲基_5_(四氫_2,5_二氧代_3_’呋喃 基)-萘n,2-C]-呋喃-!,3·二酮、^,“,^外六氫+乙基 -5-(四氫-2,5-一氧代-3-呋喃基)_萘卜呋喃·ι %二 β 酮、1,3,3a,4,5,9b-六氫 _5,8-二甲基-5-(四氫-2,5_二氧代 _3_ 呋喃基)·萘[l,2-c]-肤喃·丨,3_二酮、5_(2,5_二氧代四氫呋喃 基)-3-甲基-3-環己烯_1,2_二羧酸酐、雙環[2 2 2]•辛_7烯 •2’3,5,6-四羧酸二酐、3_氧雜雙環[3 21]辛烷_2,4·二酮_6_ 螺-3’-(四氫呋喃-2,,5,_二酮)、5_(2,5_二氧代四氫·3咲喃 基)-3-甲基_3_環己烯_1,2_二羧酸酐、3,5,6_三羧基_2_羧甲 基降冰片烷-2:3,5:6-二酐、4,9_二氧雜三環[531〇26]十— 烷-3,5’8,10-四酮、下述式(了—^和^一⑴各自表示的化合 © 物等脂肪族或脂環式四羧酸二(In the above formula, nl is each independently an integer of 1 to 8). The above objects and advantages of the present invention, and secondly, achieved by a liquid crystal display element having the liquid crystal alignment film formed of the above liquid crystal alignment agent, and the above objects and advantages of the present invention, and third, by the above formula (1) or Π) The compound represented is achieved. The liquid crystal alignment agent of the present invention can form a liquid crystal alignment film excellent in voltage holding ratio and afterimages @仓巨200946563. Further, in the liquid crystal alignment agent of the present invention, even when the ODF method is employed in the liquid crystal charging step, a liquid crystal alignment film which does not cause liquid crystal alignment unevenness due to liquid crystal dropping can be formed. The liquid crystal alignment agent of the present invention can be used for a TN type and STN type liquid crystal display element, etc., and is particularly suitable for a VA type liquid crystal display element. The liquid crystal display element of the present invention can be effectively used for various devices, for example, display devices applicable to calculators, watches, desk clocks, counting display screens, word processors, personal computers, liquid crystal televisions, and the like. [Embodiment] Hereinafter, the present invention will be specifically described. The liquid crystal alignment agent of the present invention comprises at least one polymer selected from the group consisting of polyamic acid and a quinone imidized polymer thereof, the polyamic acid and the tetracarboxylic dianhydride are selected from the above formula ( The diamine reaction of at least one of the compounds represented by I) and (II) is carried out. <tetracarboxylic dianhydride> As the tetracarboxylic phthalic anhydride which can be used for the synthesis of the polyamic acid used in the present invention, for example, butane tetracarboxylic dianhydride and 1,2,3,4-ring are exemplified. Butane tetracarboxylic dianhydride, 1,2-dimethyl-1,2,3,4-cyclobutane tetracarboxylic dianhydride, 1,3-dimethyl-1,2,3,4-ring Butane tetracarboxylic dianhydride, 1,3-dichloro-1,2,3,4·cyclobutane tetracarboxylic dianhydride, 1,2,3,4-tetramethyl-1,2,3, 4-cyclobutane tetracarboxylic dianhydride, 1,2,3,4-cyclopentanetetracarboxylic dianhydride, 1,2,4,5-cyclohexanetetracarboxylic dianhydride, 3,3', 4,4'-dicyclohexyltetracarboxylic dianhydride, 2,3,5-tricarboxycyclopentyl acetic acid dianhydride, 2,3,4,5-tetrahydrofuran tetracarboxylic dianhydride, 1,3,33, 4,5,91)-hexahydro-5-(tetrahydro-2,5-dioxo-3-furanyl)-naphthalene [1,2<]-furan-1,3-dione, l,3 , 3a,4,5,9b-hexahydro-5-methyl-5-(tetrahydro-2,5-dioxo-3-furan 200946563)-naphthalene [l,2-c]·furan-1 ,3·二_,13,3&4,591)_六氡_5ethyl-5-(tetrahydro-2'5-dioxo-3-furanyl)-naphthalene [u.cpfuran-1dione , 1'3,3&,4,5,9-hexahydro-7-methyl-5_(tetrahydro-2,5-dioxo-furanyl)- [1,2-C]-furan·U·dione, hexamethylene-6-(tetrahydro-2,5-dioxo-3-furanylnaphthalene furanone, 1,3'3&,4,5,915-hexahydro-8-methyl_5_(tetrahydro-2,5-dioxo-3-'furanyl)-naphthalene n,2-C]-furan-!, 3·dione, ^, “, ^ hexahydro + ethyl-5-(tetrahydro-2,5-monooxy-3-furanyl)-naphthofuran·ι % diβ-ketone, 1,3 ,3a,4,5,9b-hexahydro-5,8-dimethyl-5-(tetrahydro-2,5-dioxo-3-furanyl)-naphthalene [l,2-c]-furan ·丨, 3_dione, 5-(2,5-dioxotetrahydrofuranyl)-3-methyl-3-cyclohexene-1,2-dicarboxylic anhydride, bicyclo[2 2 2]•xin_7 Alkene 2'3,5,6-tetracarboxylic dianhydride, 3_oxabicyclo[3 21]octane-2,4·dione_6_ spiro-3'-(tetrahydrofuran-2,,5,_ Diketone), 5-(2,5-dioxotetrahydro-3-ylpyranyl)-3-methyl_3_cyclohexene-1,2-dicarboxylic anhydride, 3,5,6-tricarboxyl 2-carboxymethyl norbornane-2:3,5:6-dianhydride, 4,9-dioxatricyclo[531〇26]deca--3,5'8,10-tetraketone, lower An aliphatic or alicyclic tetracarboxylic acid such as a compound such as -^ and ^1(1)
(Τ-Ι)(Τ-Ι)
(Τ-ΙΙ) (式中’R1和R3各自表示具有芳香環的2價有機基圑, R2和R4各自表示氫原子或者院基,存在的多個R2和R4 -10- 200946563 各自可以相同,也可以不同); 均苯四酸二酐、3,3’,4,4’-二苯酮四羧酸二酐、 3,3’,4,4’-二苯基碾四羧酸二酐、1,4,5,8-萘四羧酸二酐、 2,3,6,7-萘四羧酸二酐、3,3’,4,4’-二苯基醚四羧酸二酐、 3,3’,4,4’-二甲基二苯基矽烷四羧酸二酐、3,3’,4,4’-四苯基 矽烷四羧酸二酐、1,2,3,4-呋喃四羧酸二酐、4,4’-雙(3,4-二羧基苯氧基)二苯基硫醚二酐、4,4’-雙(3,4-二羧基苯氧基) 二苯基碾二酐、4,4’-雙(3,4-二羧基苯氧基)二苯基丙烷二 0 酐、3,3’,4,4’-全氟異亞丙基二鄰苯二甲酸二酐、3,3’,4,4’-聯苯四羧酸二酐、2,2’,3,3’-聯苯四羧酸二酐、雙(鄰苯二甲 酸)苯膦氧化物二酐、對亞苯基-雙(三苯基鄰苯二甲酸)二 酐、間亞苯基-雙(三苯基鄰苯二甲酸)二酐、雙(三苯基鄰苯 二甲酸)-4,4’-二苯醚二酐、雙(三苯基鄰苯二甲酸)-4,4’-二 苯基甲烷二酐、乙二醇-雙(脫水偏苯三酸酯)、丙二醇-雙(脫 水偏苯三酸酯)、1,4-丁二醇-雙(脫水偏苯三酸酯)、1,6-己 二醇-雙(脫水偏苯三酸酯)、1,8-辛二醇-雙(脫水偏苯三酸 〇 酯)、2,2-雙(4-羥苯基)丙烷-雙(脫水偏苯三酸酯)、下述式 (T — 1)〜(T- 4)各自表示的化合物等芳香族四羧酸二酐 等。它們可以一種單獨或兩種以上組合使用。 -11 - 200946563(Τ-ΙΙ) (wherein R1 and R3 each represent a divalent organic group fluorene having an aromatic ring, and R2 and R4 each represent a hydrogen atom or a yard group, and a plurality of R2 and R4-10-200946563 present may be the same, Also different); pyromellitic dianhydride, 3,3',4,4'-benzophenonetetracarboxylic dianhydride, 3,3',4,4'-diphenyltricarboxylic dianhydride 1,4,5,8-naphthalenetetracarboxylic dianhydride, 2,3,6,7-naphthalenetetracarboxylic dianhydride, 3,3',4,4'-diphenyl ether tetracarboxylic dianhydride , 3,3',4,4'-dimethyldiphenylnonanetetracarboxylic dianhydride, 3,3',4,4'-tetraphenylnonanetetracarboxylic dianhydride, 1,2,3, 4-furantetracarboxylic dianhydride, 4,4'-bis(3,4-dicarboxyphenoxy)diphenyl sulfide dianhydride, 4,4'-bis(3,4-dicarboxyphenoxy Diphenyl calcane, 4,4'-bis(3,4-dicarboxyphenoxy)diphenylpropane phthalic anhydride, 3,3',4,4'-perfluoroisopropylidene Phthalic phthalic anhydride, 3,3',4,4'-biphenyltetracarboxylic dianhydride, 2,2',3,3'-biphenyltetracarboxylic dianhydride, bis(phthalic acid) Phenylphosphine oxide dianhydride, p-phenylene-bis(triphenylphthalic acid) dianhydride , m-phenylene-bis(triphenylphthalic acid) dianhydride, bis(triphenylphthalic acid)-4,4'-diphenyl ether dianhydride, bis(triphenylphthalic acid) )-4,4'-diphenylmethane dianhydride, ethylene glycol-bis(hydroper trimellitate), propylene glycol-bis(hydroper trimellitate), 1,4-butanediol-double ( Dehydrated trimellitate), 1,6-hexanediol-bis(anhydrotrimellitic acid ester), 1,8-octanediol-bis(dehydrated trimellitate), 2,2-double (4-hydroxyphenyl)propane-bis(hydrogen trimellitate), an aromatic tetracarboxylic dianhydride such as a compound represented by the following formulas (T-1) to (T-4), and the like. They may be used alone or in combination of two or more. -11 - 200946563
φ 本發明中所用的聚醯胺酸的合成 酐,上述當中,從能夠使其表現良好& 出發,較佳含有選自丁烷四羧酸二酐、 酸二酐、1,3-二甲基-1,2,3,4-環丁烷四 環戊烷四羧酸二酐、2,3,5-三羧基環戊 三羧基-2-羧甲基降冰片烷-2:3,5 :6-二| 氫- 5-(四氫-2,5-二氧代-3-呋喃基)-萘 酮、1,3,3&,4,5,91)-六氫-8-甲基-5-(四氫 基)-萘[l,2-c]-呋喃-1,3-二酮、l,3,3a,4 中使用的四羧酸二 3液晶配向性的角度 1,2,3,4-環丁烷四羧 羧酸二酐、1,2,3,4-基醋酸二酐、3,5,6-干、l,3,3a,4,5,9b-六 [l,2-c]-呋喃-1,3-二 -2,5-二氧代-3-呋喃 ,5,9 b · /、氯-5,8 - 一 甲 -12- 200946563 基- 5-(四氫-2,5-二氧代-3-呋喃基)-萘[l,2-c]-呋喃-1,3-二 酮、雙環[2.2.2]-辛-7-烯-2,3,5,6-四羧酸二酐、3-氧雜雙瓌 [3.2.1]辛烷·2,4-二酮-6-螺-3’-(四氫呋喃-2’,5’-二酮)、 5-(2,5·二氧代四氫-3-呋喃基)-3-甲基-3-環己烯-1,2-二羧 酸酐、3,5,6-三羧基-2-羧甲基降冰片烷- 2:3,5:6-二酐、4,9-二氧雜三環[5.3.1.02’6]十一烷-3,5,8,10-四酮、均苯四酸二 酐、3,3’,4,4,-二苯酮四羧酸二酐、3,3’,4,4’-二苯基颯四羧 酸二酐、2,2’,3,3,-聯苯四羧酸二酐、1,4,5,8-萘四羧酸二 〇 酐、上述式(T— I)表示的化合物中的下述式(T 一 5)〜(T 一 7) 各自表示的化合物以及上述式(T- II)表示的化合物中的下 述式(T - 8)表示的化合物構成的群組中的至少一種(以下 稱爲“特定四羧酸二酐”)的四羧酸二酐。φ The synthetic anhydride of polyglycine used in the present invention is preferably selected from the group consisting of butane tetracarboxylic dianhydride, acid dianhydride, and 1,3-dimethyl hydride. 1,2-,3,4-cyclobutanetetracyclopentanetetracarboxylic dianhydride, 2,3,5-tricarboxycyclopentacarboxy-2-carboxymethylnorbornane-2:3,5 :6-di|hydrogen-5-(tetrahydro-2,5-dioxo-3-furanyl)-naphthalenone, 1,3,3&,4,5,91)-hexahydro-8-A Angle of orientation of the tetracarboxylic acid di 3 liquid crystal used in the group 5-(tetrahydro)-naphthalene [l,2-c]-furan-1,3-dione, 1,3,3a,4, 2,3,4-cyclobutane tetracarboxylic acid dianhydride, 1,2,3,4-based acetic acid dianhydride, 3,5,6-dry, l,3,3a,4,5,9b-six [l,2-c]-furan-1,3-di-2,5-dioxo-3-furan, 5,9 b · /, chloro-5,8 - monomethyl-12- 200946563 ke - 5 -(tetrahydro-2,5-dioxo-3-furanyl)-naphthalene [l,2-c]-furan-1,3-dione, bicyclo[2.2.2]-oct-7-ene- 2,3,5,6-tetracarboxylic dianhydride, 3-oxabiindole [3.2.1]octane·2,4-dione-6-spiro-3'-(tetrahydrofuran-2', 5' -dione), 5-(2,5-dioxotetrahydro-3-furanyl)-3-methyl-3-cyclohexene-1 ,2-dicarboxylic anhydride, 3,5,6-tricarboxy-2-carboxymethylnorbornane-2:3,5:6-dianhydride, 4,9-dioxatricyclo[5.3.1.02' 6] undecane-3,5,8,10-tetraketone, pyromellitic dianhydride, 3,3',4,4,-benzophenonetetracarboxylic dianhydride, 3,3',4, 4'-diphenylphosphonium tetracarboxylic dianhydride, 2,2',3,3,-biphenyltetracarboxylic dianhydride, 1,4,5,8-naphthalenetetracarboxylic acid diacetic anhydride, the above formula ( The compound represented by the following formula (T-5) to (T-7) in the compound represented by T-I) and the compound represented by the above formula (T-II) are represented by the following formula (T-8); A tetracarboxylic dianhydride of at least one of the group consisting of compounds (hereinafter referred to as "specific tetracarboxylic dianhydride").
作爲特定四羧酸二酐,較佳選自1,2,3,4-環丁烷四羧酸 -13- 200946563 二酐、2,3,5-三羧基環戊基醋酸二酐、1,3,3&,4,5,91)_六氮 -5-(四氫-2,5·二氧代-3-呋喃基)-萘[l,2-c]_咲喃_13_二 酮、1,3,3&,4,5,91>-六氫-8-甲基-5-(四氫-2,5-二氧代_3_咲喃 基)-萘[l,2-c]-呋喃-1,3-二酮、3-氧雜雙環[3.2·ι]辛院_2 4_ 二酮-6-螺- 3’·(四氫呋喃-2’,5’-二酮)、5-(2,5·二氧代四氯 -3-呋喃基)-3-甲基-3-環己烯-1,2-二羧酸酐、3,5,6_三殘基 -2-羧甲基降冰片烷-2:3,5:6-二酐、4,9-二氧雜三環 [5.3.1.02,0]十一烷·3,5,8,10·四酮、均苯四酸二酐以及上述 0 式(Τ— 1)表示的化合物構成的群組中的至少一種,特佳爲 3,5,6-三羧基-2-羧甲基降冰片烷-2:3,5:6-二酐。 本發明中所用的聚醯胺酸的合成中使用的四竣 酐,較佳相對於全部四羧酸二酐,含有80莫耳%以上如上 所述的特定四羧酸二酐,更佳爲含有90莫耳%以上,特佳 爲含有95莫耳%以上。 <二胺> 本發明中所用的聚醯胺酸的合成中使用的二胺,含有 〇 選自上述式(I)和(II)各自表示的化合物中的至少一種。 在上述式(I)和(II)中,nl較佳各自爲3〜6的整數。鍵 合在苯環上的兩個氨基,相對於其他的取代基,較佳位於 2,4位或者3,5位。 上述式(I)表示的化合物,可以通過例如使相應的 4-(4-(4-正烷基環己基)環己基)苯酚與鹵代二硝基苯進行 脫鹵化氫縮合後,將所得的二硝基化合物還原而合成。上 述式(II)表示的化合物,可以通過例如使相應的4-(4-(4-正 烷基環己基)環己基)苯酚與二硝基苯甲醯氯進行酯化反應 -14- 200946563 後,將所得的二硝基化合物還原而合成。 上述式(I)和(II)各自表示的化合物,其所具有的苯環 任選可被一個或兩個以上碳原子數爲1〜4的烷基(較佳甲 基)取代。 作爲本發明中所用的聚醯胺酸的合成中使用的二胺’ 可以僅使用選自上述式(I)和(II)各自表示的化合物中的至 少一種,或者也可以將選自上述式(I)和(II)各自表示的化 合物中的至少一種與其他二胺聯用。 〇 作爲可以在這裏聯用的其他二胺,可以列舉例如下述 式(D— I)表示的化合物,As the specific tetracarboxylic dianhydride, it is preferably selected from 1,2,3,4-cyclobutanetetracarboxylic acid-13-200946563 dianhydride, 2,3,5-tricarboxycyclopentyl acetic acid dianhydride, 1, 3,3&,4,5,91)_hexanitro-5-(tetrahydro-2,5-dioxo-3-furanyl)-naphthalene [l,2-c]-咲 __13_二Ketone, 1,3,3&,4,5,91>-hexahydro-8-methyl-5-(tetrahydro-2,5-dioxo-3-indolyl)-naphthalene [l,2 -c]-furan-1,3-dione, 3-oxabicyclo[3.2·ι]辛院_2 4_dione-6-spiro-3'·(tetrahydrofuran-2',5'-dione) , 5-(2,5·dioxotetrachloro-3-furanyl)-3-methyl-3-cyclohexene-1,2-dicarboxylic anhydride, 3,5,6-tris-2 -carboxymethylnorbornane-2:3,5:6-dianhydride, 4,9-dioxatricyclo[5.3.1.02,0]undecane·3,5,8,10·tetraketone, At least one of the group consisting of pyromellitic dianhydride and a compound represented by the above formula (Τ-1), particularly preferably 3,5,6-tricarboxy-2-carboxymethylnorbornane-2: 3,5:6-dianhydride. The tetraphthalic anhydride used in the synthesis of the polyamic acid used in the present invention preferably contains 80 mol% or more of the specific tetracarboxylic dianhydride as described above, and more preferably contains all of the tetracarboxylic dianhydride. 90% or more, particularly preferably 95% or more. <Diamine> The diamine used in the synthesis of the polyamic acid used in the present invention contains at least one selected from the group consisting of the compounds represented by the above formulas (I) and (II). In the above formulae (I) and (II), nl is preferably each an integer of from 3 to 6. The two amino groups bonded to the benzene ring are preferably at the 2, 4 or 3, 5 positions with respect to the other substituents. The compound represented by the above formula (I) can be obtained by, for example, dehydrohalogenating a corresponding 4-(4-(4-n-alkylcyclohexyl)cyclohexyl)phenol with a halogenated dinitrobenzene. The dinitro compound is reduced and synthesized. The compound represented by the above formula (II) can be obtained, for example, by esterification of the corresponding 4-(4-(4-n-alkylcyclohexyl)cyclohexyl)phenol with dinitrobenzoguanidine chloride -14-200946563 The obtained dinitro compound is reduced and synthesized. The compound represented by each of the above formulas (I) and (II) may have a benzene ring optionally substituted by one or two alkyl groups (preferably methyl groups) having 1 to 4 carbon atoms. The diamine used in the synthesis of the polyamic acid used in the present invention may be at least one selected from the compounds each represented by the above formulas (I) and (II), or may be selected from the above formula ( At least one of the compounds represented by each of I) and (II) is used in combination with other diamines. 〇 As the other diamine which can be used in combination here, for example, a compound represented by the following formula (D-I) can be cited.
(式(D-Ι)中,X1 表示選自-〇-、-COO-、-OCO-、-NHCO-、 -CONH-和- CO-的2價有機基團,R5表示具有甾體骨架的1 價有機基團,R6表示碳原子數爲1〜4的烷基,al表示0 〜3的整數)、下述式(D— II)表示的化合物,(In the formula (D-Ι), X1 represents a divalent organic group selected from the group consisting of -〇-, -COO-, -OCO-, -NHCO-, -CONH-, and -CO-, and R5 represents a steroid skeleton. a monovalent organic group, R6 represents an alkyl group having 1 to 4 carbon atoms, a1 represents an integer of 0 to 3, and a compound represented by the following formula (D-II),
(式(D — II)中,X2 各自表示選自-0-、-COO-、-OCO-、 -NHCO-、-CONH-和-CO-的2價有機基團,R7表示具有甾 體骨架的2價有機基團,R*各自表示碳原子數爲1〜4的 烷基,a2各自表示〇〜3的整數)等具有甾體骨架的二胺; -15- 200946563 對苯二胺、間苯二胺、4,4’-二氨基二苯基甲烷、4,4’-二氨基二苯基乙烷、4,4’-二氨基二苯基硫醚、4,4’-二氨基 二苯基楓、4,4’-二氨基苯甲醯苯胺、4,4’-二氨基二苯醚、 1,5-二氨基萘、2,2’-二甲基-4,4’-二氨基聯苯、3,3’-二甲基 -4,4’-二氨基聯苯、2,2’-雙(三氟甲基)-4,4’-二氨基聯苯、 3,3’-雙(三氟甲基)-4,4’-二氨基聯苯、5-氨基-1-(4’-氨基苯 基)-1,3,3-三甲基茚滿、6-氨基-1-(4’-氨基苯基)-1,3,3-三甲 基茚滿、3,4’-二氨基二苯基醚、3,3’-二氨基二苯酮、3,4’-0 二氨基二苯酮、4,4’-二氨基二苯酮、2,2-雙[4-(4-氨基苯氧 基)苯基]丙烷、2,2-雙[4-(4-氨基苯氧基)苯基]六氟丙烷、 2,2-雙(4-氨基苯基)六氟丙烷、雙[4-(4-氨基苯氧基)苯基] 颯、1,4-雙(4-氨基苯氧基)苯、1,3-雙(4-氨基苯氧基)苯、 1,3-雙(3-氨基苯氧基)苯、9,9-雙(4-氨基苯基)-10-氫蒽、 2,7-二氨基芴、9,9-二甲基-2,7-二氨基芴、9,9-雙(4-氨基苯 基)芴、4,4’-亞甲基-雙(2-氯苯胺)、2,2’,5,5’-四氯-4,4’-二 氨基聯苯、2,2’-二氯-4,4’-二氨基-5,5’-二甲氧基聯苯、 〇 3,3’-二甲氧基-4,4’-二氨基聯苯' 4,4’-(對亞苯基二異亞丙 基)雙苯胺、4,4’-(間亞苯基二異亞丙基)雙苯胺、2,2’-雙 [4-(4-氨基-2-三氟甲基苯氧基)苯基]六氟丙烷、4,4’-二氨 基-2,2’-雙(三氟甲基)聯苯、4,4’-雙[(4-氨基-2-三氟甲基) 苯氧基]-八氟聯苯、4,4’-雙(4-氨基苯氧基)聯苯等芳香族二 胺; 1,1-間苯二甲胺、1,3-丙二胺、丁二胺、戊二胺、己二 胺、庚二胺、辛二胺、壬二胺、1,4 -二氨基環己烷、異佛 爾酮二胺、四氫二環戊二烯二胺、六氫-4,7-甲撐茚二亞甲 -16 - 200946563 基二胺、三環[6.2.1.02,7]十一碳烯二甲二胺、4,4,-亞甲基 雙(環己胺)、1,3-雙(氨基甲基)環己烷' 1,4-雙(氨基甲基) 環己烷等脂肪族二胺和脂環式二胺; 2,3-二氨基吡啶、2,6-二氨基吡啶、3,4-二氨基吡啶、 2,4-二氨基嘧啶、5,6-二氨基·2,3·二氟基吡哄、5,6-二氨基 -2,4-二羥基嘧啶、2,4-二氨基-6-二甲氨基-1,3,5-三阱、1,4-雙(3-氨基丙基)哌畊、2,4-二氨基-6-異丙氧基-1,3,5-三畊、 2,4_二氨基-6-甲氧基·1,3,5-三畊、2,4-二氨基-6-苯基 φ -1,3,5-三哄、2,4-二氨基-6-甲基-s-三阱、2,4-二氨基-1,3,5-三畊、4,6-二氨基-2·乙烯基-s-三畊、2,4-二氨基-5·苯基噻 唑、2,6-二氨基嘌呤、5,6-二氨基-1,3-二甲基尿嘧啶、3,5-二氨基-1,2,4-三唑、6,9-二氨基-2-乙氧基吖啶乳酸酯、3,8-二氨基-6-苯基菲啶、1,4-二氨基哌畊、3,6-二氨基吖啶、 雙(4-氨基苯基)苯基胺、3,6-二氨基咔唑、Ν-甲基-3,6-二氨 基咔唑、Ν-乙基-3,6-二氨基咔唑、Ν-苯基-3,6-二氨基咔 唑、Ν,Ν’-雙(4-氨基苯基)聯苯胺、Ν,Ν’-雙(4-氨基苯 φ 基)-Ν,Ν’-二甲基聯苯胺、下述式(D — III)表示的化合物,(In the formula (D-II), X2 each represents a divalent organic group selected from the group consisting of -0, -COO-, -OCO-, -NHCO-, -CONH-, and -CO-, and R7 represents a steroid skeleton a divalent organic group, each of R* represents an alkyl group having 1 to 4 carbon atoms, and a2 each represents an integer of 〇~3), such as a diamine having a steroid skeleton; -15- 200946563 p-phenylenediamine, Phenylenediamine, 4,4'-diaminodiphenylmethane, 4,4'-diaminodiphenylethane, 4,4'-diaminodiphenyl sulfide, 4,4'-diamino Phenyl maple, 4,4'-diaminobenzilanilide, 4,4'-diaminodiphenyl ether, 1,5-diaminonaphthalene, 2,2'-dimethyl-4,4'-di Aminobiphenyl, 3,3'-dimethyl-4,4'-diaminobiphenyl, 2,2'-bis(trifluoromethyl)-4,4'-diaminobiphenyl, 3,3' -bis(trifluoromethyl)-4,4'-diaminobiphenyl, 5-amino-1-(4'-aminophenyl)-1,3,3-trimethylindan, 6-amino- 1-(4'-Aminophenyl)-1,3,3-trimethylindan, 3,4'-diaminodiphenyl ether, 3,3'-diaminobenzophenone, 3,4' -0 diaminobenzophenone, 4,4'-diaminobenzophenone, 2,2-bis[4-(4-amino Phenoxy)phenyl]propane, 2,2-bis[4-(4-aminophenoxy)phenyl]hexafluoropropane, 2,2-bis(4-aminophenyl)hexafluoropropane, double [ 4-(4-Aminophenoxy)phenyl]anthracene, 1,4-bis(4-aminophenoxy)benzene, 1,3-bis(4-aminophenoxy)benzene, 1,3-double (3-Aminophenoxy)benzene, 9,9-bis(4-aminophenyl)-10-hydroquinone, 2,7-diaminopurine, 9,9-dimethyl-2,7-diamino Ruthenium, 9,9-bis(4-aminophenyl)anthracene, 4,4'-methylene-bis(2-chloroaniline), 2,2',5,5'-tetrachloro-4,4' -diaminobiphenyl, 2,2'-dichloro-4,4'-diamino-5,5'-dimethoxybiphenyl, 〇3,3'-dimethoxy-4,4'- Diaminobiphenyl '4,4'-(p-phenylene diisopropylidene) bisaniline, 4,4'-(m-phenylene diisopropylidene) bisaniline, 2,2'-double [ 4-(4-Amino-2-trifluoromethylphenoxy)phenyl]hexafluoropropane, 4,4'-diamino-2,2'-bis(trifluoromethyl)biphenyl, 4,4 An aromatic diamine such as '-bis[(4-amino-2-trifluoromethyl)phenoxy]-octafluorobiphenyl or 4,4'-bis(4-aminophenoxy)biphenyl; 1-m-xylylenediamine, 1,3-propanediamine, Butanediamine, pentanediamine, hexamethylenediamine, heptanediamine, octanediamine, decanediamine, 1,4-diaminocyclohexane, isophoronediamine, tetrahydrodicyclopentadienediamine , hexahydro-4,7-methylene quinone dimethylene-16 - 200946563 bisdiamine, tricyclo[6.2.1.02,7]undecene dimethyldiamine, 4,4,-methylene bis ( Aliphatic diamines such as cyclohexylamine, 1,3-bis(aminomethyl)cyclohexane' 1,4-bis(aminomethyl)cyclohexane and alicyclic diamines; 2,3-diamino Pyridine, 2,6-diaminopyridine, 3,4-diaminopyridine, 2,4-diaminopyrimidine, 5,6-diamino-2,3·difluoropyridinium, 5,6-diamino- 2,4-dihydroxypyrimidine, 2,4-diamino-6-dimethylamino-1,3,5-tri-trap, 1,4-bis(3-aminopropyl)piped, 2,4-di Amino-6-isopropoxy-1,3,5-three tillage, 2,4-diamino-6-methoxy-1,3,5-three tillage, 2,4-diamino-6-benzene φ φ -1,3,5-triazine, 2,4-diamino-6-methyl-s-tripper, 2,4-diamino-1,3,5-three tillage, 4,6-di Amino-2·vinyl-s-triple, 2,4-diamino-5-phenylthiazole, 2,6-diaminopurine, 5,6-diamino-1,3-dimethyluracil, 3,5-diamino -1,2,4-triazole, 6,9-diamino-2-ethoxy acridine lactate, 3,8-diamino-6-phenylphenanthridine, 1,4-diaminopiperidin , 3,6-diaminoacridine, bis(4-aminophenyl)phenylamine, 3,6-diaminocarbazole, oxime-methyl-3,6-diaminocarbazole, oxime-ethyl- 3,6-diaminocarbazole, fluorenyl-phenyl-3,6-diaminocarbazole, anthracene, Ν'-bis(4-aminophenyl)benzidine, anthracene, Ν'-bis(4-aminobenzene φ base)-Ν, Ν'-dimethylbenzidine, a compound represented by the following formula (D-III),
(式(D — III)中,R9表示具有選自吡啶、嘧啶、三阱、哌啶 以及哌阱的含氮原子環狀結構的1價有機基團,X3表示2 價的有機基團,Rle表示碳原子數爲1〜4的烷基,a3表示 〇〜3的整數)、下述式(D— IV)表示的化合物’ -17- .200946563(In the formula (D-III), R9 represents a monovalent organic group having a nitrogen atom-containing cyclic structure selected from the group consisting of pyridine, pyrimidine, triple trap, piperidine, and pipe trap, and X3 represents a divalent organic group, Rle An alkyl group having 1 to 4 carbon atoms, a3 represents an integer of 〇3, and a compound represented by the following formula (D-IV) '-17-.200946563
(式(D— IV)中,R11表示具有選自吡啶、嘧啶、三阱、哌陡 以及哌哄的含氮原子環狀結構的2價有機基團,X4各自表 示2價的有機基團,存在的多個X4各自可以相同,也可以 不同,R12各自表示碳原子數爲1〜4的院基,a4各自表示 0〜3的整數)等分子內具有兩個一級氨基以及該一級氨基 ® 以外的氮原子的二胺; 下述式(D - V)表示的化合物等單取代苯二胺,(In the formula (D-IV), R11 represents a divalent organic group having a nitrogen atom-containing cyclic structure selected from the group consisting of pyridine, pyrimidine, triple trap, piperazine, and piperazine, and each of X4 represents a divalent organic group. Each of the plurality of X4 groups may be the same or different, each of R12 represents a group having 1 to 4 carbon atoms, and a4 each represents an integer of 0 to 3, and has two primary amino groups in the molecule and the primary amino group. a diamine of a nitrogen atom; a monosubstituted phenylenediamine such as a compound represented by the following formula (D - V),
(式(D — V)中,X5 表示選自 _〇_、_c〇〇-、_〇c〇_、-NHCO-、 -CONH-以及-CO-的2價有機基團,R13表示具有選自三氟 甲基苯基、三氟甲氧基苯基和氟代苯基中的基團的1價有 ® 機基團或者碳原子數爲6〜30的烷基,R14表示碳原子數爲 1〜4的院基,a5表不〇〜3的整數);下述式(d— νι)表示 的化合物等二氨基有機矽氧烷,(In the formula (D - V), X5 represents a divalent organic group selected from the group consisting of _〇_, _c〇〇-, _〇c〇_, -NHCO-, -CONH-, and -CO-, and R13 represents an optional a monovalent group having a group derived from a trifluoromethylphenyl group, a trifluoromethoxyphenyl group and a fluorophenyl group or an alkyl group having 6 to 30 carbon atoms, and R14 is a carbon atom a base of 1 to 4, a5 is not an integer of ~3; a diaminoorganooxane such as a compound represented by the following formula (d- νι),
(式(D — VI)中,R15各自表示碳原子數爲12的烴基存 在的多個R15各自可以相同,也可以不同,p各自爲丨〜] 的整數,q爲1〜20的整數);下述式(D— υ〜(Ε) — 2)各自 -18- 200946563 表示的化合物等, H2Nv4f=\ /=yNH2 \_^咖4一0 (D-1)(In the formula (D-VI), each of R15 in which R15 represents a hydrocarbon group having 12 carbon atoms may be the same or different, p is an integer of 丨~], and q is an integer of 1 to 20); The following formula (D - υ ~ (Ε) - 2) each of the compounds represented by -18-200946563, H2Nv4f = \ / = yNH2 \_^ coffee 4 - 0 (D-1)
(式(D—1)中的y爲2〜12的整數,式(d—2)中的z爲 Ο 1〜5的整數)。上述芳香族二胺以及上述式(D-1)和(D— 2) 各自表示的化合物的苯環任選可被一個或兩個以上碳原子 數爲1〜4的烷基(較佳爲甲基)取代。 這些二胺可以單獨或者兩種以上組合使用。 上述式(D— I)、(D— II)、(D-III)、(D-IV)和(D-V) 中的R6、R8、R10、R12和R14各自較佳爲甲基,al、a2、 a3、a4和a5各自較佳爲0或1,更佳爲0。 上述式(D-Ι)和(D — II)的R5和R6中的甾體骨架,是 〇 指由環戊烷一全氫菲核構成的骨架或其碳一碳鍵中的一個 或兩個以上改爲雙鍵的骨架。作爲具有這種甾體骨架的R5 的1價有機基團和R6的2價有機基團,各自較佳碳原子數 爲17〜40的基團,更佳碳原子數爲17〜30的基團。 作爲R5的具體例子,可以列舉例如膽甾烷-3-基、膽 甾-5-烯-3-基、膽甾-24-烯-3-基、膽甾-5,24-二烯-3-基、羊 毛甾烷-3-基、羊毛甾-5-烯-3-基、羊毛甾-24-烯-3-基 '羊 毛甾-5,24-二烯-3-基等;作爲R6的具體例子,可以列舉例 如膽甾烷-3,6-二基、膽甾-5-烯-3,6-二基、膽甾-24-烯-3,6- -19- 200946563 二基、膽甾烷-3,3-二基、羊毛甾烷-3,6-二基、羊毛甾烷-3,3-二基等。 作爲上述式(D - I)表示的化合物的具體例子,可以列 舉例如下述式(D— 3)〜(D— 7)各自表示的化合物,(y in the formula (D-1) is an integer of 2 to 12, and z in the formula (d-2) is an integer of Ο 1 to 5). The aromatic diamine and the benzene ring of the compound represented by each of the above formulas (D-1) and (D-2) may be optionally one or more alkyl groups having 1 to 4 carbon atoms (preferably A). Base) replaced. These diamines may be used alone or in combination of two or more. R6, R8, R10, R12 and R14 in the above formulae (D-I), (D-II), (D-III), (D-IV) and (DV) are each preferably a methyl group, al, a2. Each of a3, a4 and a5 is preferably 0 or 1, more preferably 0. The steroid skeleton in R5 and R6 of the above formulae (D-Ι) and (D-II) is a skeleton consisting of a cyclopentane-perhydrophenanthrene nucleus or one or two of its carbon-carbon bonds. The above is changed to the skeleton of the double bond. The monovalent organic group of R5 having such a steroid skeleton and the divalent organic group of R6 each preferably have a group having from 17 to 40 carbon atoms, more preferably a group having from 17 to 30 carbon atoms. . Specific examples of R5 include, for example, cholestyl-3-yl, cholest-5-en-3-yl, cholest-24-en-3-yl, cholest-5-24-diene-3 -yl, lanostan-3-yl, lanolin-5-en-3-yl, lanolin-24-en-3-yl'lanethin-5,24-dien-3-yl, etc.; as R6 Specific examples thereof include, for example, cholestane-3,6-diyl, cholest-5-ene-3,6-diyl, cholest-24-ene-3,6--19-200946563 diyl, Cholestane-3,3-diyl, lanostane-3,6-diyl, lanostane-3,3-diyl, and the like. Specific examples of the compound represented by the above formula (D - I) include compounds represented by the following formulas (D-3) to (D-7), respectively.
作爲上述式(D - II)表示的化合物的具體例子,可以列 舉例如下述式(D — 9)〜(D— 11)各自表示的化合物。 -20- 200946563Specific examples of the compound represented by the above formula (D - II) include compounds represented by the following formulas (D-9) to (D-11). -20- 200946563
上遽其他二胺中’作爲較佳的,可以列舉選自上述式 (D — I)表示的化合物和上述式(D— η)表示的化合物構成的 群組中的至少一種(以下稱爲“其他特定二胺(1)”)以及選 自對苯二胺、4,4,-二氨基二苯甲烷、4,4,_二氨基二苯硫 φ 醚、1,5-二氨基萘、2,2’-二甲基-4,4,-二氨基聯苯、2,2,-雙(三氟甲基)_4,4,_二氨基聯苯、2,7_二氨基芴、4,4,_二氨 基二苯基醚、2,2-雙[4-(4-氨基苯氧基)苯基]丙烷、9,9_雙(4_ 氣基苯基)荀、2,2-雙[4-(4_氨基苯氧基)苯基]六氟丙院、2,2-雙(4-氨基苯基)六氟丙烷、4,4’-(對亞苯基二異亞丙基)雙苯 胺、4,4’-(間亞苯基二異亞丙基)雙苯胺、1,4-雙(4-氨基苯 氧基)苯、4,4’-雙(4-氨基苯氧基)聯苯、1,4-環己烷二胺、 4,4’-亞甲基二(環己胺)、1,3·雙(氨基甲基)環己烷、2,6-二 氨基吡啶、3,4-二氨基吡啶、2,4-二氨基嘧啶、3,6-二氨基 -21- 200946563 吖啶、3,6-二氨基咔唑、N-甲基-3,6-二氨基咔唑、N-Ζ*基 -3,6-二氨基咔唑、N-苯基-3,6-二氨基咔唑、N,N,-雙(4_藝 基苯基)聯苯胺、上述式(D-III)表示的化合物中的下述式 (D — 12)表示的化合物、上述式(D — IV)表示的化合物中的 下述式(D- 13)表示的化合物、In the above-mentioned other diamine, at least one selected from the group consisting of a compound represented by the above formula (D-I) and a compound represented by the above formula (D-η) (hereinafter referred to as " Other specific diamines (1)") and selected from the group consisting of p-phenylenediamine, 4,4,-diaminodiphenylmethane, 4,4,diaminodiphenylthioxanthene, 1,5-diaminonaphthalene, 2 , 2'-dimethyl-4,4,-diaminobiphenyl, 2,2,-bis(trifluoromethyl)-4,4,diaminobiphenyl, 2,7-diaminopurine, 4, 4,_Diaminodiphenyl ether, 2,2-bis[4-(4-aminophenoxy)phenyl]propane, 9,9-bis(4-hydroxyphenyl)anthracene, 2,2-double [4-(4-Aminophenoxy)phenyl]hexafluoropropane, 2,2-bis(4-aminophenyl)hexafluoropropane, 4,4'-(p-phenylene diisopropylidene Diphenylamine, 4,4'-(m-phenylene diisopropylidene) bisaniline, 1,4-bis(4-aminophenoxy)benzene, 4,4'-bis(4-aminophenoxyl) Biphenyl, 1,4-cyclohexanediamine, 4,4'-methylenebis(cyclohexylamine), 1,3 bis(aminomethyl)cyclohexane, 2,6-diamino Pyridine, 3,4-diaminopyridine, 2,4-diamine Pyrimidine, 3,6-diamino-21- 200946563 acridine, 3,6-diaminocarbazole, N-methyl-3,6-diaminocarbazole, N-fluorenyl-3,6-di An aminocarbazole, N-phenyl-3,6-diaminocarbazole, N,N,-bis(4-aminophenyl)benzidine, a compound of the above formula (D-III) (D-12) a compound represented by the following formula (D-13) in the compound represented by the above formula (D-IV),
上述式(D- V)表示的化合物中的十二烷氧基-2,4_二氨 基苯、十五烷氧基-2,4-二氨基苯、十六烷氧基-2,4_二氨基 苯、十八烷氧基-2,4-二氨基苯、十二烷氧基·2,5_二氨基 苯、十五烷氧基-2,5-二氨基苯、十六烷氧基-2,5_二氨基 苯、十八烷氧基-2,5-二氨基苯、下述式(D_M)〜(D-i6) 各自表示的化合物和上述式(D_VI)表示的化合物中的 1’3-雙(3 _氨基丙基四甲基二矽氧烷構成的群組中的至少 —種(以下稱爲“其他特定二胺(2)”), -22- 200946563Dodecyloxy-2,4-diaminobenzene, pentadecyloxy-2,4-diaminobenzene, hexadecyloxy-2,4_ in the compound represented by the above formula (D-V) Diaminobenzene, octadecyloxy-2,4-diaminobenzene, dodecyloxy-2,5-diaminobenzene, pentadecyloxy-2,5-diaminobenzene, hexadecane a compound represented by the formula (D-VI) and a compound represented by the above formula (D-VI), wherein the compound represented by the formula (D_M) to (D-i6) is a compound represented by the above formula (D-VI). At least one of the groups consisting of 1'3-bis(3-aminopropyltetramethyldioxane) (hereinafter referred to as "other specific diamine (2)"), -22-200946563
Ο 本發明中所用的聚酿胺酸的合成中使用的二胺,較佳 相對於全部二胺,含有5莫耳%以上選自上述式(1)和(π) 各自表示的化合物中的至少一種,更佳爲含有1ί>〜9〇莫耳 %,進一步較佳爲含有20〜80莫耳%,特佳爲含有3〇〜5〇 莫耳%。The diamine used in the synthesis of the poly-aracine used in the present invention preferably contains at least 5 mol% or more of at least a compound selected from the above formulas (1) and (π) with respect to all diamines. More preferably, it contains 1 ί > 〜 9 〇 mol %, further preferably contains 20 to 80 mol %, and particularly preferably contains 3 〇 5 〇 mol %.
本發明中所用的聚醯胺酸的合成中使用的二胺,除了 選自上述式(I)和(II)各自表示的化合物中的至少一種以 外,較佳還含有選自如上所述的其他特定二胺(1)和特定二 胺(2)構成的群組中的至少一種,較佳相對於全部二胺,含 有10〜90莫耳%這些二胺,更佳含有20〜80莫耳%,進一 步較佳含有50〜70莫耳%。 本發明中所用的聚醯胺酸的合成中使用的二胺,特佳 爲以下(1)或(2)中的任意一者。 (1)以上述比率含有選自上述式(I)和(Π)各自表示的化 合物中的至少一種,並且相對於全部二胺,較佳含有10〜 90莫耳%其他特定二胺(2),更佳含有20〜80莫耳%,進一 -23- 200946563 步較佳含有50〜70莫耳。/。。 (2)以上述比率含有選自上述式(I)和(II)各自表示的化 合物中的至少一種,並且相對於全部二胺,較佳爲含有1 〜20莫耳%其他特定二胺(1),更佳爲含有5〜10莫耳%。 對於上述式(2)的情況,其中較佳含有選自上述式(I) 和(II)各自表示的化合物中的至少一種、其他特定二胺(1) 和其他特定二胺(2)的二胺。作爲它們的含量比率,對於選 自上述式(I)和(II)各自表示的化合物中的至少一種以及其 © 他特定二胺(1),各自爲上述的比率,對於特定二胺(2),相 對於全部二胺,較佳爲10〜80莫耳%,更佳爲20〜70莫 耳%。 <聚醯胺酸的合成> 本發明中所用的聚醯胺酸,可以通過使如上所述的四 羧酸二酐與二胺反應而合成。 供給聚醯胺酸合成反應的四羧酸二酐與二胺的使用比 率,較佳相對於二胺中所含的1當量氨基,使四羧酸二酐 〇 的酸酐基爲0.5〜2當量的比率,更佳使其爲0.7〜1.2當量 的比率。 聚醯胺酸的合成反應,較佳在有機溶劑中,較佳於-2 0 〜150 °C、更佳於0〜100 °C的溫度條件下進行,較佳以0.5 〜1 20小時,更佳以2〜1 0小時的反應時間進行。 這裏,作爲有機溶劑,只要是能夠溶解合成的聚醯胺 酸的溶劑,則對其沒有特別的限制,可以列舉例如N-甲基 _2_吡咯烷酮、N,N-二甲基乙醯胺、N,N-二甲基甲醯胺、二 甲基亞楓、7-丁內酯、四甲基脲、六甲基磷醯三胺等非質 -24- 200946563 子類極性溶劑;間甲基酚、二甲苯酚、苯酚、鹵代苯酚等 酚類溶劑。有機溶劑的用量(a),較佳爲使四羧酸二酐和二 胺化合物的總量(b)相對於反應溶液的總量(a+ b)爲〇」〜 30重量%的量。另外,當有機溶劑與下述不良溶劑聯用時, 該有機溶劑的用量應理解爲有機溶劑與不良溶劑的合計用 量的含義。 上述有機溶劑中,在不使生成的聚醯胺酸析出的範圍 內,還可以聯用聚醯胺酸的不良溶劑醇類、酮類、酯類、 0 醚類、鹵代烴類、烴類等。作爲這種不良溶劑的具體例子, 可以列舉例如甲醇、乙醇、異丙醇 '環己醇、乙二醇、丙 二醇、1,4-丁二醇、三甘醇、乙二醇單甲醚、乳酸乙酯、 乳酸丁酯、丙酮、甲基乙基酮、甲基異丁基酮、環己酮、 醋酸甲酯、醋酸乙酯、醋酸丁酯、甲氧基丙酸甲酯、乙氧 基丙酸乙酯、草酸二乙酯、丙二酸二乙酯、乙醚、乙二醇 甲醚、乙二醇乙醚、乙二醇正丙醚、乙二醇異丙醚、乙二 醇正丁醚、乙二醇二甲基醚、乙二醇乙酸乙酸酯、二甘醇 〇 二甲醚、二甘醇二乙醚、二甘醇單甲醚、二甘醇單乙醚、 二甘醇單甲醚乙酸酯、二甘醇單乙醚乙酸酯、四氫呋喃、 二氯甲烷、1,2-二氯乙烷、1,4-二氯丁烷、三氯乙烷、氯苯、 鄰二氯苯、己烷、庚烷、辛烷、苯、甲苯、二甲苯、丙酸 異戊酯、異丁酸異戊酯、異戊醚等。 在聚醯胺酸的合成時,當將有機溶劑與不良溶劑聯用 時,不良溶劑的使用比率’相對於有機溶劑和不良溶劑的 合計量,較佳爲20重量%以下’更佳爲1〇重量%以下。 如上所述,得到溶解了聚醯胺酸的反應溶液。該反應 -25- .200946563 溶液可以直接供給液晶配向劑的配製,也可以將 中所含的聚醯胺酸分離出來後供給液晶配向劑的 者也可以將分離出的聚醯胺酸精製後再供給液晶 配製。聚醯胺酸的分離,可以通過將上述反應溶 大量的不良溶劑中,得到析出物,再減壓乾燥該 方法’或者將反應溶液用蒸發器減壓蒸餾的方法 另外’通過進行一次或者幾次使該聚醯胺酸再次 機溶劑中,然後用不良溶劑使其析出的方法,或 ❹ 減壓蒸餾的步驟-可以精製聚醯胺酸。 <醯亞胺化聚合物> 本發明中使用的醯亞胺化聚合物,可以通過 述的聚醯胺酸的醯胺酸結構脫水閉環以醯亞胺化 在此,可以是聚醯胺酸所具有的醯胺酸結構全部 的完全醯亞胺化物,也可以是醯胺酸結構與醯亞 的醯亞胺化聚合物。本發明中使用的醯亞胺化聚 亞胺化率較佳爲50%以上,更佳爲55〜95%,特 〇 90%。這裏,所謂“醯亞胺化率”,是指相對於 聚合物中的醯胺酸結構數量與醯亞胺環數量的合 醯亞胺環數量的比率用百分率表示的値。此時, 的一部分也可以是異醯亞胺環。 聚醯胺酸的脫水閉環,可以(i)通過加熱聚醯 法,或者(ii)通過將聚醯胺酸溶解於有機溶劑中, 中加入脫水劑和脫水閉環催化劑並根據需要加熱 行。 上述(i)的加熱聚醯胺酸的方法中的反應溫度 反應溶液 配製,或 配向劑的 液投入到 析出物的 而進行。 溶解於有 用蒸發器 將如上所 而製得。 脫水閉環 胺環並存 合物的醯 隹爲60〜 醯亞胺化 計數量, 醯亞胺環 胺酸的方 向該溶液 的方法進 ’較佳爲 -26- 200946563 50〜200 °C,更佳爲60〜170 °C«當反應溫度不足50 °C時, 則脫水閉環反應不能進行充分,若反應溫度超過200 t, 則會出現所得醃亞胺化聚合物的分子量下降的情況。反應 時間較佳爲1〜120小時,更佳爲2〜3〇小時。 在上述(ii)的在聚醯胺酸溶液中添加脫水劑和脫水閉 環催化劑的方法中,作爲脫水劑,可以使用例如醋酸酐、 丙酸酐、三氟乙酸酐等酸酐》脫水劑的用量,較佳相對於 聚醯胺酸的1莫耳重複單元爲0.01〜20莫耳。另外,作爲 φ 脫水閉環催化劑,可以使用例如吡啶、三甲吡啶、二甲吡 啶、三乙胺等三級胺。但是,並不局限於這些。脫水閉環 催化劑的用量,相對於1莫耳所用脫水劑,較佳爲0.01〜 10莫耳。另外,作爲脫水閉環反應中使用的有機溶劑,可 以列舉作爲聚醯胺酸合成中所用溶劑而例示的有機溶劑。 脫水閉環反應的反應溫度,較佳爲0〜180 °C,更佳爲10 〜150 °C,反應時間較佳爲0.5〜30小時,更佳爲2〜10小 時》 〇 上述方法⑴中製得的醯亞胺化聚合物,可以將其直接 供給液晶配向劑的配製,或者也可以將製得的醯亞胺化聚 合物精製後再供給液晶配向劑的配製。另外,在上述方法 (ii)中,得到含醯亞胺化聚合物的反應溶液。該反應溶液, 可以將其直接供給液晶配向劑的配製,也可以從反應溶液 中除去脫水劑和脫水閉環催化劑之後供給液晶配向劑的配 製,還可以將醢亞胺化聚合物分離出來後供給液晶配向劑 的配製,或者也可以將分離的醯亞胺化聚合物精製後再供 給液晶配向劑的配製。從反應溶液中除去脫水劑和脫水閉 -27- 200946563 環催化劑,可以採用例如溶劑置換等方法。醯亞胺化聚合 物的分離、精製,可以採取與以上作爲聚醯胺酸的分離、 精製方法所描述的同樣的操作而進行。 <末端修飾型的聚合物> 上述聚醯胺酸和醯亞胺化聚合物,各自還可以是進行 了分子量調節的末端修飾型聚合物》這種末端修飾型聚合 物可以通過在聚醯胺酸的合成時,向反應體系中加入單 酐、單胺化合物、單異氣酸酯化合物等合適的分子量調節 Φ 劑而合成。這裏,作爲單酐,可以列舉例如馬來酸酐、鄰 苯二甲酸酐、衣康酸酐、正癸基琥珀酸酐、正十二烷基琥 珀酸酐、正十四烷基琥珀酸酐、正十六烷基琥珀酸酐等。 作爲單胺化合物,可以列舉例如苯胺、環己胺、正丁胺、 正戊胺、正己胺、正庚胺、正辛胺、正壬胺、正癸胺、正 十一院胺、正十二院胺、正十三院胺、正十四院胺、正十 五烷胺、正十六烷胺、正十七烷胺、正十八烷胺、正二十 烷胺等。作爲單異氰酸酯化合物,可以列舉例如異氰酸苯 Q 酯、異氰酸萘基酯等。 分子量調節劑的使用比率,相對於100重量份聚醯胺 酸合成時所使用的四羧酸二酐和二胺的合計量,較佳爲20 重量份以下,更佳爲10重量份以下。 <聚合物的溶液黏度> 如上製得的聚醯胺酸或醯亞胺化聚合物,當分別配成 濃度爲10重量%的溶液時,較佳具有20〜800 mPa.s的溶 液黏度,更佳具有30〜500 mPa.s的溶液黏度。 上述聚合物的溶液黏度(mP a. s),是對採用該聚合物的 -28- 200946563 良溶劑(例如N -甲基-2-U比略院嗣、7 •丁內醋等)配成的濃 度10重量%的聚合物溶液’用E型旋轉黏度計在25 °C下測 定的値。 <其他成分> 本發明液晶配向劑,含有選自如上所述的聚醯胺酸及 其醯亞胺化聚合物構成的群組中的至少一種聚合物作爲必 需成分’除此以外,在不損害本發明效果和優點的前題下, 還可以進一步含有其他成分。作爲這種其他成分,可以列 〇 舉例如其他聚合物、分子內具有至少一個環氧基的化合物 (以下稱爲“環氧基化合物”)、官能性矽烷化合物。 作爲上述其他聚合物,可以列舉例如聚有機矽氧.院、 四羧酸二酐與不含上述式(I)和(II)各自表示的化合物中的 任何化合物的二胺反應所製得的聚醯胺酸(以下稱爲“其 他聚醯胺酸”)及其醯亞胺化聚合物(以下稱爲“其他醯亞 胺化聚合物”)、聚醯胺酸酯、聚酯、聚醯胺、織維素衍生 物、聚縮醒、聚苯乙嫌衍生物、聚(苯乙嫌-苯基馬來醯亞 〇 胺)衍生物、聚(甲基)丙烯酸酯等。其中,從清漆性狀和電 學性能優良的方面考慮,較佳爲其他聚醯胺酸或其他酸亞 胺化聚合物。 合成其他聚醯胺酸和其他醯亞胺化聚合物所使用的四 羧酸二酐,與作爲上述聚醯胺酸的合成中使用的四羧酸二 酐而例示的相同。合成其他聚醯胺酸和其他醯亞胺化聚合 物所使用的二胺,與作爲上述聚醯胺酸的合成中可以使用 的其他二胺而例示的相同。此時,相對於全部二胺,較佳 含有70莫耳%以上選自其他特定二胺(1)和(2)中的至少一 -29- 200946563 種的二胺’特佳含有90莫耳%以上的二胺。其他聚醯胺酸 和其他醯亞胺化聚合物’作爲二胺,除了使用不含上述式 (I)和(II)各自表示的化合物中的任何化合物的二胺以外, 可以分別按照以上作爲聚醯胺酸和醯亞胺化聚合物的合成 方法所描述的方法同樣地合成。其他聚醯胺酸和其他醯亞 胺化聚合物中,較佳其他聚醯胺酸。 本發明液晶配向劑中的其他聚合物的使用比率,相對 於聚合物的合計量(是指四羧酸二酐與含有上述式⑴或(11) ❹ 表示的化合物的二胺反應製得的聚醯胺酸及其醯亞胺化聚 合物以及任選使用的其他聚合物的合計量。下同),較佳爲 80重量%以下,更佳爲60重量%以下,進一步較佳爲40 重量%以下。 上述環氧基化合物,可以是從進一步提高由本發明液 晶配向劑形成的液晶配向膜對基板表面的黏附性的角度出 發而使用,較佳的可以列舉例如乙二醇二縮水甘油醚、聚 乙二醇二縮水甘油醚、丙二醇二縮水甘油醚、三丙二醇二 〇 縮水甘油醚、聚丙二醇二縮水甘油醚、新戊二醇二縮水甘 油醚、1,6-己二醇二縮水甘油醚、三羥甲基丙烷三縮水甘 油基醚、甘油二縮水甘油醚、2,2-二溴新戊二醇二縮水甘 油醚、N,N,N’,N’-四縮水甘油基-間苯二甲胺、1,3-雙(N,N-二縮水甘油基氨基甲基)環己烷、Ν,Ν,Ν’,Ν’-四縮水甘油基 -4,4’-二氨基二苯基甲烷、N,N-二縮水甘油基-苄胺、N,N-二縮水甘油基-氨基甲基環己烷等。這些環氧基化合物的混 合比率,相對於100重量份聚合物的合計量,較佳爲40重 量份以下,更佳爲0.1〜30重量份。 -30- 200946563 作爲上述官能性矽烷化合物,可以列舉例如3-氨基丙 基三甲氧基矽烷、3-氨基丙基三乙氧基矽烷、2-氨基丙基 三甲氧基矽烷、2-氨基丙基三乙氧基矽烷、ν·(2-氨基乙 基)-3-氨基丙基三甲氧基矽烷、Ν-(2-氨基乙基)-3-氨基丙基 甲基二甲氧基矽烷、3-脲基丙基三甲氧基矽烷、3·脲基丙 基二乙氧基砂院、Ν -乙氧鑛基-3·氨基丙基二甲氧基砍院、 Ν-乙氧羰基-3-氨基丙基三乙氧基矽烷、Ν-三乙氧基矽烷基 丙基三亞乙基三胺、Ν-三甲氧基矽烷基丙基三亞乙基三 φ 胺、10-三甲氧基矽烷-1,4,7-三氮雜癸烷、10-三乙氧基矽 烷基-1,4,7-三氮雜癸烷、9-三甲氧基矽烷基-3,6-二氮雜壬 基乙酸酯、9-三乙氧基矽烷基-3,6-二氮雜壬基乙酸酯、9-三甲氧基矽烷基·3,6-二氮雜壬酸甲酯、9-三乙氧基矽烷基 -3,6-二氮雜壬酸甲酯、Ν-苄基-3-氨基丙基三甲氧基矽烷、 Ν-苄基-3-氨基丙基三乙氧基矽烷、Ν-苯基-3-氨基丙基三甲 氧基矽烷、Ν-苯基-3-氨基丙基三乙氧基矽烷、環氧丙氧基 甲基三甲氧基矽烷、環氧丙氧基甲基三乙氧基矽烷、2-環 〇 氧丙氧基乙基三甲氧基矽烷、2-環氧丙氧基乙基三乙氧基 矽烷、3-環氧丙氧基丙基三甲氧基矽烷、3-環氧丙氧基丙 基三乙氧基矽烷等。 這些官能性矽烷化合物的混合比率,相對於100重量 份聚合物合計量,較佳爲2重量份以下,更佳爲0.2重量 份以下。 <液晶配向劑> 本發明的液晶配向劑是將選自如上所述的聚醯胺酸及 其醯亞胺化聚合物構成的群組中的至少一種聚合物以及根 -31- 200946563 據需要任選添加的其他成分,較佳爲溶解含 而構成的。 作爲上述聚合物,可以僅使用聚醯胺酸 用醯亞胺化聚合物,或者也可以聚醯胺酸和 物兩者一起使用。本發明液晶配向劑中所含 佳爲醯亞胺化聚合物或者聚醯胺酸與醯亞胺 合。這裏,相對於液晶配向劑中所含的聚醯 醯胺酸結構數量以及醯亞胺化聚合物所具有 0 數量和醯亞胺環數量的合計數量,醯亞胺化 的醯亞胺環的數量比率(以下稱爲“平均醯s 本發明液晶配向劑含有其他聚醯胺酸和其他 物時,平均醯亞胺化率應當理解爲也包括它 數値)較佳爲40%以上,更佳爲45〜90%,特名 作爲本發明液晶配向劑中可以使用的有 列舉以上作爲聚醯胺酸的合成反應中所用的 溶劑。並且,還可以適當地選擇聯用作爲聚 Q 反應時可以聯用的不良溶劑而例示的溶劑。 作爲本發明液晶配向劑中可以含有的 劑,可以列舉例如N-甲基-2-吡咯烷酮、r _ 內醯胺、N,N-二甲基甲醯胺、N,N-二甲基乙 -4-甲基-2-戊酮、乙二醇單甲醚、乳酸丁酯、 氧基丙酸甲酯、乙氧基丙酸乙酯、乙二醇甲 醚、乙二醇正丙醚、乙二醇異丙醚、乙二醇 纖劑)、乙二醇二甲基醚、乙二醇乙醚乙酸_ 醚、二甘醇二乙醚、二甘醇單甲醚、二甘醇 於有機溶劑中 ,也可以僅使 醯亞胺化聚合 的聚合物,較 化聚合物的組 胺酸所具有的 的醯胺酸結構 聚合物所具有 ί胺化率”。當 醯亞胺化聚合 們而計算得的 !爲 5 0 〜8 0 %。 機溶劑,可以 溶劑而例示的 醯胺酸的合成 特佳的有機溶 丁內酯、r -丁 ,醯胺、4-羥基 乙酸丁酯、甲 醚、乙二醇乙 正丁醚(丁基溶 i、二甘醇二甲 單乙醚、二甘 -32- 200946563 醇單甲醚乙酸酯、二甘醇單乙醚乙酸酯、丙酸異戊酯 丁酸異戊酯、二異丁基酮、異戊醚、碳酸乙二酯、碳 二酯等。它們可以單獨使用,或者也可以兩種以上混 用。特佳的溶劑組成,是使上述溶劑組合所得的組成 聚合物不會從配向劑中析出,且使配向劑的表面張力 25〜40 mN/m範圍的組成。 本發明液晶配向劑的固體含量濃度(液晶配向劑 含溶劑以外的成分的總重量占液晶配向劑總重量的tl φ 考慮黏性、揮發性等而進行選擇,較佳爲1〜10重量 也就是說,本發明的液晶配向劑,通過塗敷於基板表 除去溶劑而形成作爲液晶配向膜的塗膜,當固體含量 不足1重量%時,將會出現該塗膜的厚度過小而難以 良好的液晶配向膜的情況,當固體含量濃度超過10重 時,將導致塗膜的厚度過厚而同樣難以獲得良好的液 向膜,並且,液晶配向劑的黏性增大,導致塗敷性能變 特佳的固體含量濃度範圍,根據將液晶配向劑塗 〇 基板時所採用的方法而不同。例如,當採用旋塗法時 佳1.5〜4.5重量%的範圍。當採用印刷法時,特佳使 含量濃度爲3〜9重量%的範圍,這樣,可以使溶液黏 在12〜50mPa>s的範圍。當採用噴墨法時,特佳使固 量濃度爲1〜5重量%的範圍,這樣》可以使溶液黏度 3〜15 mPa*s的範圍。 配製本發明液晶配向劑時的溫度,較佳爲〇°c-°C,更佳爲2 0 °C〜6 (TC。 <液晶顯示元件> 、異 酸丙 合使 ,是 落在 中所 :率) %。 面並 濃度 獲得 .量% 晶配 差。 敷於 ,特 固體 度落 體含 落在 -33- -200 200946563 本發明的液晶顯示元件具有由如上所述的本發明液晶 配向劑形成的液晶配向膜。本發明液晶配向劑形成的液晶 配向膜’特別是當作爲垂直配向型液晶配向膜使用時,可 以最大限度地表現出高的電壓保持率和良好的殘像性能。 本發明的液晶顯示元件可以通過例如以下的方法製 造。 (1)採用例如輥塗法、旋塗法、印刷法、噴墨法等適當 的塗敷方法,將本發明的液晶配向劑塗敷於設有形成圖案 〇 的透明導電膜的基板一面上,接著,通過加熱塗敷面形成 塗膜。這裏,作爲基板,可以使用例如浮法玻璃、鈉鈣玻 璃等玻璃;聚對苯二甲酸乙二醇酯、聚對苯二甲酸丁二醇 酯、聚醚碾、聚碳酸酯、脂環式聚烯烴等塑膠製透明基板 等。作爲基板一面上設置的透明導電膜,可以使用例如氧 化錫(Sn02)製的NESA膜(美國PPG公司注冊商標)、氧化 銦一氧化錫(Ιη203 — Sn02)製的ITO膜等。這些透明導電膜 圖案的形成,可採用光刻蝕法,或者在形成透明導電膜時 〇 預先使用光罩的方法。在液晶配向劑的塗敷時,爲了進一 步改善基板表面和透明導電膜與塗膜的黏附性,還可以在 基板的該表面上,預先塗敷官能性矽烷化合物、官能性鈦 化合物等。液晶配向劑塗敷後,爲了防止塗敷的配向劑液 體下垂等的目的,較佳先進行預加熱(預烘焙)。預烘焙溫 度較佳爲30〜200 °c,更佳爲40〜150 °C,特佳40〜100 °C。 預烘焙時間較佳爲0.25〜10分鐘,更佳爲0.5〜5分鐘。然 後完全除去溶劑後,較佳進一步進行加熱(後烘焙)步驟。 該後烘焙溫度較佳爲80〜300 °C,更佳爲120〜250 °C。後 -34- .200946563 烘焙時間較佳爲5〜200分鐘,更佳爲10〜100分鐘。本發 明的液晶配向劑通過如上所述塗敷後除去有機溶劑而形成 作爲配向膜的塗膜,而當本發明的液晶配向劑中所含的聚 合物爲聚醯胺酸或者同時存在醯亞胺環結構和醯胺酸結構 的醯亞胺化聚合物時,還可以在形成塗膜後通過進一步加 熱使其進行脫水閉環反應,以形成進一步醯亞胺化的塗膜。 這裏形成的塗膜的厚度,較佳爲0.001〜Ιμιη,更佳爲 0.005〜0.5μιη 〇 Ο (2)如上形成的塗膜,可以將其直接作爲垂直配向型液 晶配向膜使用,也可以任選地採用纏有例如尼龍、人造纖 維、棉花等適當的纖維製的布的輥對塗膜面進行以一定方 向摩擦的打磨處理後再作爲液晶配向膜使用。並且,通過 對打磨處理後的塗膜,進行例如專利文獻6(日本特開平6 —2223 66號公報)或專利文獻7(日本特開平6 — 28 1 937號 公報)中所示的、對液晶配向膜的一部分照射紫外線而使液 晶配向膜一部分區域預傾角改變的處理,或者進行專利文 © 獻8(日本特開平5 - 1 07544號公報)中所示的、在液晶配向 膜的部分表面上形成保護膜後,以與先前打磨處理不同的 方向進行打磨處理後除去保護膜的處理,使液晶配向膜每 一區域具有不同的液晶配向能’能夠改善所得液晶顯示元 件的視場性能。在對塗膜面進行打磨處理時,也可根據需 要進行清洗。 (3)預製兩塊如上形成了液晶配向膜的基板,通過在該 兩塊基板間佈置液晶’製造液晶胞。液晶胞的製造,可以 列舉例如以下的兩種方法。 -35- 200946563 第一種方法,是以前已知的方法。首先,將兩塊基板 通過間隙(胞間隙)相對設置,使各自的液晶配向膜相對 向,將兩塊基板的周邊部位用密封劑貼合,向由基板表面 和密封劑圍成的胞間隙內注充液晶後,封閉注入孔,即可 製得液晶胞。 第二種方法,是被稱作爲〇DF(〇ne Drop Fill)方式的 方法。在形成液晶配向膜的兩塊基板中的一塊基板上的規 定部位,塗敷例如紫外線固化性密封劑材料,再在液晶配 〇 向膜面上滴下液晶後,貼合另一塊基板,使液晶配向膜向 對向,然後對基板整面照射紫外線,使密封劑固化,即可 製得液晶胞。本發明的液晶配向劑,具有即使採用ODF方 法製造VA型液晶顯示元件時,也能夠製得不會產生由液 晶滴痕導致的液晶配向不均的液晶顯示元件的優點。當本 發明的液晶配向劑包括採用除上述式(I)和(II)各自表示的 化合物中的至少一種以外還含有特定二胺(1)的二胺合成 的聚合物時,這種優點特別顯著。 〇 在採用上述第一和第二中的任一方法的情況下,均需 要接著將液晶胞加熱至所用液晶呈各向同性相的溫度後, 緩慢冷卻至室溫,來除去液晶塡充時的流動配向。 然後,通過在液晶胞的外側表面上貼合偏光板,即可 製得本發明的液晶顯示元件。 這裏,作爲密封劑,可以使用例如含作爲固化劑和間 隔物的氧化鋁球的環氧樹脂等。作爲液晶,可以列舉向列 型液晶和碟狀型液晶,其中較佳向列型液晶,可以使用例 如希夫氏鹼類液晶、氧化偶氮基類液晶、聯苯類液晶、苯 -36- 200946563 基環己烷類液晶、酯類液晶、三聯苯類液晶、聯苯基環己 烷類液晶、嘧啶類液晶、二氧六環類液晶、雙環辛烷類液 晶、立方烷類液晶等。並且,這些液晶中還可以進一步添 加例如氯化膽甾醇、膽甾醇壬酸酯、膽甾醇碳酸酯等膽甾 型液晶;以商品名“C-15” 、 “CB-15” (MERCK公司製) 銷售的手性劑而進行使用。 作爲液晶胞外表面上貼合的偏光板,可以列舉將聚乙 烯醇延伸配向同時吸收碘所得的稱作爲“ Η膜”的偏光膜 © 夾在醋酸纖維保護膜中而製成的偏光板,或者Η膜自身製 成的偏光板。 [實施例] 以下,通過實施例對本發明進行更具體的說明,但是 本發明並不局限於這些實施例。以下的合成例中聚合物的 溶液黏度和醯亞胺化聚合物的醯亞胺化率,分別採用以下 的方法評價。 [聚合物的溶液黏度] 〇 聚合物的溶液黏度是對各合成例中指出的聚合物溶液 採用Ε型黏度計在2 5 °C下測定的値。 [醯亞胺化聚合物的醯亞胺率] 將醯亞胺化聚合物在室溫下減壓乾燥後,使其溶於氘 代二甲亞碾中,以四甲基矽烷爲基準物,在室溫下測定 iH-NMR,由下述式(i)所示的公式求出。 醯亞胺化率(%) = (1 — Al/A2x a )xl 〇〇 (i) A1 : 10 ppm附近出現的源於NH基質子的峰面積 A2:源於其他質子的峰面積 -37- 200946563 α :相對於聚合物前體(聚醯胺酸)中的1個NH基質 子,其他質子的個數比率。 <上述式(I)或(II)表示的二胺的合成> 以下的各合成例,通過根據需要重複下述合成規模, 以確保之後合成例中必需量的產物。 合成例1 (1-(2,4-二氨基苯氧基)-4-(4-(4-正戊基環己基)環 己基)苯的合成) 按照下述合成路線 1合成 1-(2,4-二氨基苯氧 Ο 基)-4-(4-(4-正戊基環己基)環己基)苯(以下,也稱爲“二胺 Α” )。The diamine used in the synthesis of the polylysine used in the present invention preferably contains at least one selected from the group consisting of the compounds represented by the above formulas (I) and (II), and preferably further selected from the others described above. At least one of the group consisting of the specific diamine (1) and the specific diamine (2) preferably contains 10 to 90 mol% of these diamines, more preferably 20 to 80 mol%, based on the entire diamine. Further preferably, it contains 50 to 70 mol%. The diamine used in the synthesis of the polyamic acid used in the present invention is particularly preferably any one of the following (1) or (2). (1) at least one selected from the group consisting of the compounds represented by the above formulas (I) and (Π) in the above ratio, and preferably contains 10 to 90 mol% of other specific diamines relative to all diamines (2) More preferably contains 20~80 mol%, and the step of -23-200946563 preferably contains 50~70 mo. /. . (2) at least one selected from the group consisting of the compounds represented by the above formulas (I) and (II) in the above ratio, and preferably contains 1 to 20 mol% of other specific diamines relative to all diamines (1) ), more preferably contains 5 to 10 mol%. In the case of the above formula (2), it is preferred to contain at least one selected from the group consisting of the compounds represented by the above formulas (I) and (II), and other specific diamines (1) and other specific diamines (2). amine. As a content ratio thereof, at least one selected from the group consisting of the compounds represented by the above formulas (I) and (II) and the other specific diamine (1) thereof are each in the above ratio, for a specific diamine (2) It is preferably 10 to 80 mol%, more preferably 20 to 70 mol%, based on the entire diamine. <Synthesis of Polylysine> The polylysine used in the present invention can be synthesized by reacting the above-described tetracarboxylic dianhydride with a diamine. The use ratio of the tetracarboxylic dianhydride to the diamine supplied to the polyaminic acid synthesis reaction is preferably 0.5 to 2 equivalents based on 1 equivalent of the amino group contained in the diamine. The ratio is more preferably such that it is a ratio of 0.7 to 1.2 equivalents. The synthesis reaction of polylysine is preferably carried out in an organic solvent, preferably at a temperature of from -2 to 150 ° C, more preferably from 0 to 100 ° C, preferably from 0.5 to 1 20 hours, more preferably It is carried out with a reaction time of 2 to 10 hours. Here, the organic solvent is not particularly limited as long as it is a solvent capable of dissolving the synthesized polyamic acid, and examples thereof include N-methyl-2-pyrrolidone and N,N-dimethylacetamide. Non-quality-24- 200946563 sub-polar solvent such as N,N-dimethylformamide, dimethyl sulfoxide, 7-butyrolactone, tetramethylurea, hexamethylphosphonium triamine; A phenolic solvent such as phenol, xylenol, phenol or halogenated phenol. The amount (a) of the organic solvent is preferably such that the total amount (b) of the tetracarboxylic dianhydride and the diamine compound is from 〜 to 30% by weight based on the total amount (a + b) of the reaction solution. Further, when an organic solvent is used in combination with the following poor solvent, the amount of the organic solvent is understood to mean the total amount of the organic solvent and the poor solvent. In the organic solvent, a solvent alcohol, a ketone, an ester, an ether, a halogenated hydrocarbon, or a hydrocarbon may be used in combination with a polyglycine in a range in which the produced polyamine is not precipitated. Wait. Specific examples of such a poor solvent include methanol, ethanol, isopropanol 'cyclohexanol, ethylene glycol, propylene glycol, 1,4-butanediol, triethylene glycol, ethylene glycol monomethyl ether, and lactic acid. Ethyl ester, butyl lactate, acetone, methyl ethyl ketone, methyl isobutyl ketone, cyclohexanone, methyl acetate, ethyl acetate, butyl acetate, methyl methoxypropionate, ethoxy propyl Ethyl acetate, diethyl oxalate, diethyl malonate, diethyl ether, ethylene glycol methyl ether, ethylene glycol ether, ethylene glycol n-propyl ether, ethylene glycol isopropyl ether, ethylene glycol n-butyl ether, ethylene Alcohol dimethyl ether, ethylene glycol acetate acetate, diethylene glycol dimethyl ether, diethylene glycol diethyl ether, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monomethyl ether acetate , diethylene glycol monoethyl ether acetate, tetrahydrofuran, dichloromethane, 1,2-dichloroethane, 1,4-dichlorobutane, trichloroethane, chlorobenzene, o-dichlorobenzene, hexane, Heptane, octane, benzene, toluene, xylene, isoamyl propionate, isoamyl isobutyrate, isoamyl ether, and the like. In the synthesis of poly-proline, when the organic solvent is used in combination with a poor solvent, the use ratio of the poor solvent is preferably 20% by weight or less based on the total amount of the organic solvent and the poor solvent, and more preferably 1%. Below weight%. As described above, a reaction solution in which polylysine was dissolved was obtained. The reaction -25-.200946563 solution can be directly supplied to the preparation of the liquid crystal alignment agent, or the poly-proline acid contained in the solution can be separated and supplied to the liquid crystal alignment agent, and the separated polyamic acid can be refined. Supply liquid crystal preparation. The separation of the polyamic acid can be carried out by dissolving a large amount of the poor solvent in the above reaction to obtain a precipitate, and drying the method under reduced pressure or by subjecting the reaction solution to distillation under reduced pressure in an evaporator. The polyaminic acid can be purified by re-solving the poly-proline in a solvent and then precipitating it with a poor solvent or by subjecting to a vacuum distillation. <醯i-Iminylated Polymer> The ruthenium-imidized polymer used in the present invention may be deuterated by the guanidine structure of the poly-proline acid, and may be a polyamine. The acid has a complete ruthenium imide structure of a proline structure, and may also be a ruthenium-based polymer of a guanidine structure. The ruthenium imidization ratio used in the present invention is preferably 50% or more, more preferably 55 to 95%, particularly 90%. Here, the "yttrium imidization ratio" means the ratio of the ratio of the number of the proline structure in the polymer to the number of the ruthenium ring of the number of the quinone ring, expressed as a percentage. At this time, a part of it may also be an isoindole ring. The dehydration ring closure of the polyamic acid can be carried out by (i) heating the polyfluorene method, or (ii) by dissolving the polyphthalic acid in an organic solvent, adding a dehydrating agent and a dehydration ring-closing catalyst, and heating as needed. The reaction temperature in the method for heating poly-proline in (i) above is carried out, or the liquid of the alignment agent is introduced into the precipitate. Dissolved in a useful evaporator and prepared as above. The dehydrated ring-locked amine ring and the enthalpy of the compound are 60~ 醯 imidization count, and the method of the solution is preferably -26-200946563 50~200 °C, more preferably 60 to 170 °C «When the reaction temperature is less than 50 °C, the dehydration ring-closure reaction cannot be sufficiently carried out. If the reaction temperature exceeds 200 t, the molecular weight of the resulting marinated imidized polymer may decrease. The reaction time is preferably from 1 to 120 hours, more preferably from 2 to 3 hours. In the method of adding a dehydrating agent and a dehydration ring-closure catalyst to the polyaminic acid solution of the above (ii), as the dehydrating agent, for example, an amount of an acid anhydride such as acetic anhydride, propionic anhydride or trifluoroacetic anhydride can be used. Preferably, the 1 molar repeating unit relative to the polyamic acid is 0.01 to 20 moles. Further, as the φ dehydration ring-closing catalyst, a tertiary amine such as pyridine, trimethylpyridine, dimethylpyridine or triethylamine can be used. However, it is not limited to these. The amount of the dehydration ring-closing catalyst is preferably 0.01 to 10 moles per 1 mol of the dehydrating agent. In addition, as the organic solvent used in the dehydration ring-closure reaction, an organic solvent exemplified as a solvent used in the synthesis of polyglycolic acid can be mentioned. The reaction temperature of the dehydration ring closure reaction is preferably from 0 to 180 ° C, more preferably from 10 to 150 ° C, and the reaction time is preferably from 0.5 to 30 hours, more preferably from 2 to 10 hours. 〇 Prepared in the above method (1) The quinone imidized polymer may be directly supplied to the liquid crystal alignment agent, or the obtained quinone imidized polymer may be purified and then supplied to the liquid crystal alignment agent. Further, in the above method (ii), a reaction solution containing a ruthenium iodide polymer is obtained. The reaction solution may be directly supplied to the liquid crystal alignment agent, or may be supplied from the reaction solution to remove the dehydrating agent and the dehydration ring-closing catalyst, and then supplied to the liquid crystal alignment agent. The ruthenium iodide polymer may be separated and supplied to the liquid crystal. The formulation of the alignment agent or the separation of the separated ruthenium-imiding polymer may be supplied to the liquid crystal alignment agent. The dehydrating agent and the dehydrated -27-200946563 ring catalyst are removed from the reaction solution, and a method such as solvent replacement can be employed. The separation and purification of the ruthenium iodide polymer can be carried out in the same manner as described above for the separation and purification method of polyglycine. <Terminal-modified polymer> Each of the above-mentioned poly-proline and ruthenium-based polymers may be a terminal-modified polymer having a molecular weight adjusted. In the synthesis of an amine acid, a suitable molecular weight adjusting Φ agent such as a monoanhydride, a monoamine compound or a monoisophthalate compound is added to the reaction system to synthesize it. Here, examples of the monoanhydride include maleic anhydride, phthalic anhydride, itaconic anhydride, n-decyl succinic anhydride, n-dodecyl succinic anhydride, n-tetradecyl succinic anhydride, n-hexadecyl group. Succinic anhydride and the like. The monoamine compound may, for example, be aniline, cyclohexylamine, n-butylamine, n-pentylamine, n-hexylamine, n-heptylamine, n-octylamine, n-decylamine, n-decylamine, n-indolamine, ortho- 12 Amine, Zhengtiya, amine, tetradecylamine, n-pentadecylamine, n-hexadecaneamine, n-heptadecaneamine, n-octadecylamine, n-icosylamine, and the like. The monoisocyanate compound may, for example, be phenyl isocyanate or naphthyl isocyanate. The use ratio of the molecular weight modifier is preferably 20 parts by weight or less, more preferably 10 parts by weight or less based on the total amount of the tetracarboxylic dianhydride and the diamine used in the synthesis of the polyglycolic acid. <Solid viscosity of polymer> Polylysine or quinone imidized polymer prepared as above, when formulated into a solution having a concentration of 10% by weight, preferably has a solution viscosity of 20 to 800 mPa·s. More preferably, it has a solution viscosity of 30 to 500 mPa.s. The solution viscosity (mP a. s) of the above polymer is formulated into a good solvent of -28-200946563 (for example, N-methyl-2-U bis, • vinegar, etc.) using the polymer. The concentration of 10% by weight of the polymer solution was measured by an E-type rotary viscometer at 25 °C. <Other components> The liquid crystal alignment agent of the present invention contains at least one polymer selected from the group consisting of polylysine as described above and its quinone imidized polymer as an essential component. Further components may be further contained without prejudice to the effects and advantages of the present invention. As such other components, for example, other polymers, compounds having at least one epoxy group in the molecule (hereinafter referred to as "epoxy compounds"), and functional decane compounds can be listed. The other polymer may, for example, be a polyorganooxime, a tetracarboxylic dianhydride, and a polyamine obtained by reacting a diamine of any of the compounds represented by the above formulas (I) and (II). Proline (hereinafter referred to as "other poly-proline") and its quinone imidized polymer (hereinafter referred to as "other quinone imidized polymer"), polyglycolate, polyester, polyamine , weaving vitamin derivatives, polycondensation, polystyrene derivatives, poly(phenylethylidene-phenylmaleimide) derivatives, poly(meth)acrylates, and the like. Among them, other polyaminic acid or other acid imidized polymers are preferred from the viewpoint of excellent varnish properties and electrical properties. The tetracarboxylic dianhydride used in the synthesis of other polyaminic acid and other quinone imidized polymers is the same as exemplified as the tetracarboxylic dianhydride used in the synthesis of the above polyamic acid. The diamine used in the synthesis of other polyaminic acid and other quinone imidized polymers is the same as exemplified as the other diamine which can be used in the synthesis of the above polyamic acid. In this case, it is preferred to contain 70 mol% or more of at least one of -29 to 200946563 selected from other specific diamines (1) and (2) with respect to all diamines, and particularly preferably contain 90 mol%. The above diamine. Other polylysines and other quinone-imidized polymers 'as a diamine, except for using a diamine which does not contain any of the compounds represented by the above formulas (I) and (II), may be used as a poly The method described for the synthesis of proline and ruthenium iodide polymers is synthesized in the same manner. Among other polyaminic acids and other quinone aminated polymers, other polylysines are preferred. The use ratio of the other polymer in the liquid crystal alignment agent of the present invention is a total amount of the polymer (refers to a polymerization of a tetracarboxylic dianhydride and a diamine containing the compound represented by the above formula (1) or (11) ❹. The total amount of the proline acid and its quinone imidized polymer and optionally other polymers is the same, preferably 80% by weight or less, more preferably 60% by weight or less, still more preferably 40% by weight. the following. The epoxy group compound may be used from the viewpoint of further improving the adhesion of the liquid crystal alignment film formed of the liquid crystal alignment agent of the present invention to the surface of the substrate, and examples thereof include ethylene glycol diglycidyl ether and polyethylene glycol. Alcohol diglycidyl ether, propylene glycol diglycidyl ether, tripropylene glycol diglycidyl ether, polypropylene glycol diglycidyl ether, neopentyl glycol diglycidyl ether, 1,6-hexanediol diglycidyl ether, trihydroxyl Methylpropane triglycidyl ether, glycerol diglycidyl ether, 2,2-dibromoneopentyl glycol diglycidyl ether, N,N,N',N'-tetraglycidyl-m-xylylenediamine , 1,3-bis(N,N-diglycidylaminomethyl)cyclohexane, hydrazine, hydrazine, hydrazine, Ν'-tetraglycidyl-4,4'-diaminodiphenylmethane, N,N-diglycidyl-benzylamine, N,N-diglycidyl-aminomethylcyclohexane, and the like. The mixing ratio of these epoxy compounds is preferably 40 parts by weight or less, more preferably 0.1 to 30 parts by weight, based on 100 parts by total of the total amount of the polymer. -30-200946563 The functional decane compound may, for example, be 3-aminopropyltrimethoxydecane, 3-aminopropyltriethoxydecane, 2-aminopropyltrimethoxydecane or 2-aminopropyl. Triethoxy decane, ν·(2-aminoethyl)-3-aminopropyltrimethoxydecane, Ν-(2-aminoethyl)-3-aminopropylmethyldimethoxydecane, 3 -ureidopropyltrimethoxydecane,3·ureidopropyldiethoxylate, Ν-ethoxylated 3-(aminopropyldimethoxy), Ν-ethoxycarbonyl-3- Aminopropyltriethoxydecane, Ν-triethoxydecylpropyltriethylenetriamine, Ν-trimethoxydecylpropyltriethylenetriamine, 10-trimethoxydecane-1, 4,7-triazadecane, 10-triethoxydecyl-1,4,7-triazadecane, 9-trimethoxydecyl-3,6-diazepineacetic acid Ester, 9-triethoxydecyl-3,6-diazadecyl acetate, 9-trimethoxydecylmethyl 3,6-diazepine, 9-triethoxy Methyl decyl-3,6-diazepine, Ν-benzyl-3-aminopropyltrimethoxydecane, Ν-benzyl-3-amino Triethoxy decane, fluorenyl-phenyl-3-aminopropyltrimethoxy decane, fluorenyl-phenyl-3-aminopropyltriethoxy decane, glycidoxymethyltrimethoxy decane, Glycidoxymethyltriethoxydecane, 2-cyclopropoxypropoxyethyltrimethoxydecane, 2-glycidoxyethyltriethoxydecane, 3-epoxypropoxy Propyltrimethoxydecane, 3-glycidoxypropyltriethoxydecane, and the like. The mixing ratio of these functional decane compounds is preferably 2 parts by weight or less, more preferably 0.2 parts by weight or less based on 100 parts by total of the total amount of the polymer. <Liquid crystal alignment agent> The liquid crystal alignment agent of the present invention is at least one polymer selected from the group consisting of polylysine as described above and its ruthenium iodide polymer, and root-31-200946563 Other ingredients which are optionally added are preferably formed by dissolving the content. As the above polymer, it is possible to use only the ruthenium iodide polymer or the polyglycolic acid. The liquid crystal alignment agent of the present invention preferably contains a ruthenium iodide polymer or a polyamic acid and a ruthenium imine. Here, the amount of the ruthenium iodide ring of the ruthenium imine ring is compared with the number of the polyphthalic acid structures contained in the liquid crystal alignment agent and the total amount of the ruthenium iodide polymer and the number of the quinone ring. The ratio (hereinafter referred to as "average 醯s when the liquid crystal alignment agent of the present invention contains other polyamic acid and other substances, the average oxime imidization rate should be understood to include the number thereof" is preferably 40% or more, more preferably 45 to 90%, the specific name of the liquid crystal alignment agent of the present invention may be used as a solvent used in the synthesis reaction of polylysine as described above, and may be appropriately selected and used in combination as a polyQ reaction. A solvent which is exemplified as a poor solvent. Examples of the agent which may be contained in the liquid crystal alignment agent of the present invention include N-methyl-2-pyrrolidone, r _ decylamine, N,N-dimethylformamide, and N. , N-dimethylethyl-4-methyl-2-pentanone, ethylene glycol monomethyl ether, butyl lactate, methyl oxypropionate, ethyl ethoxypropionate, ethylene glycol methyl ether, Ethylene glycol n-propyl ether, ethylene glycol isopropyl ether, ethylene glycol fiber), ethylene glycol dimethyl ether Ethylene glycol ethyl ether acetic acid _ ether, diethylene glycol diethyl ether, diethylene glycol monomethyl ether, diethylene glycol in an organic solvent, can also be only ruthenium iodide polymerized polymer, compared to polymer histidine The proline acid structural polymer has a amide amination rate. When the yttrium imidization polymerization is calculated, it is 50 to 80%. Machine solvent, which can be exemplified by the synthesis of lysine which is exemplified by solvent, especially organic butyrolactone, r-butyl, decylamine, butyl 4-hydroxyacetate, methyl ether, ethylene glycol n-butyl ether (butyl hydride i, Diethylene glycol monoethyl ether, digan-32- 200946563 alcohol monomethyl ether acetate, diethylene glycol monoethyl ether acetate, isoamyl propionate isoamyl butyrate, diisobutyl ketone, isoprene Ether, ethylene carbonate, carbon diester, etc. These may be used singly or in combination of two or more. Particularly preferred solvent composition is such that the constituent polymer obtained by combining the above solvents does not precipitate from the alignment agent, and The composition of the surface tension of the alignment agent is in the range of 25 to 40 mN/m. The solid content concentration of the liquid crystal alignment agent of the present invention (the total weight of the liquid crystal alignment agent other than the solvent is tl φ of the total weight of the liquid crystal alignment agent, considering viscosity, The liquid crystal alignment agent of the present invention is formed by removing the solvent from the substrate to form a coating film as a liquid crystal alignment film when the solid content is less than 1% by weight. When the film will appear In the case where the liquid crystal alignment film is too small to be good, when the solid content concentration exceeds 10, the thickness of the coating film is too thick, and it is also difficult to obtain a good liquid film, and the viscosity of the liquid crystal alignment agent increases. The solid content concentration range which causes the coating performance to be excellent is different depending on the method used when the liquid crystal alignment agent is applied to the substrate. For example, when the spin coating method is used, the range of 1.5 to 4.5% by weight is preferably used. When the content concentration is in the range of 3 to 9 wt%, the solution can be adhered to the range of 12 to 50 mPa > s. When the ink jet method is used, the solid concentration is preferably 1 to 5 wt%. The range can be such that the viscosity of the solution is in the range of 3 to 15 mPa*s. The temperature at which the liquid crystal alignment agent of the present invention is formulated is preferably 〇°c-°C, more preferably 20 °C to 6 (TC. <Liquid crystal display element>, isocyanate, is in the middle: rate) %. The surface concentration is obtained. The amount % crystal matching. Apply to, the solidity falls in the -33- -200 200946563 The liquid crystal display element of the present invention has the above The liquid crystal alignment film formed by the liquid crystal alignment agent of the present invention. The liquid crystal alignment film formed by the liquid crystal alignment agent of the present invention can exhibit a high voltage holding ratio and a good performance when used as a vertical alignment type liquid crystal alignment film. Residual image performance The liquid crystal display element of the present invention can be produced, for example, by the following method: (1) The liquid crystal alignment of the present invention is applied by an appropriate coating method such as a roll coating method, a spin coating method, a printing method, or an inkjet method. The agent is applied to one surface of the substrate on which the transparent conductive film forming the pattern is provided, and then the coating film is formed by heating the coated surface. Here, as the substrate, for example, glass such as float glass or soda lime glass; polyparaphenylene can be used; A transparent substrate made of plastic such as ethylene glycol dicarboxylate, polybutylene terephthalate, polyether mill, polycarbonate, or alicyclic polyolefin. As the transparent conductive film provided on one surface of the substrate, for example, a NESA film made of tin oxide (Sn02) (registered trademark of PPG, USA), an ITO film made of indium tin oxide (Mn 203-Sn02), or the like can be used. These transparent conductive film patterns can be formed by photolithography or a method of using a photomask in advance when forming a transparent conductive film. In the application of the liquid crystal alignment agent, in order to further improve the adhesion between the surface of the substrate and the transparent conductive film and the coating film, a functional decane compound, a functional titanium compound or the like may be applied to the surface of the substrate in advance. After the application of the liquid crystal alignment agent, it is preferred to perform preheating (prebaking) for the purpose of preventing the liquid of the applied alignment agent from sagging. The prebaking temperature is preferably from 30 to 200 ° C, more preferably from 40 to 150 ° C, and particularly preferably from 40 to 100 ° C. The prebaking time is preferably from 0.25 to 10 minutes, more preferably from 0.5 to 5 minutes. After the solvent is completely removed, it is preferred to further carry out the heating (post-baking) step. The post-baking temperature is preferably from 80 to 300 ° C, more preferably from 120 to 250 ° C. After -34-.200946563, the baking time is preferably 5 to 200 minutes, more preferably 10 to 100 minutes. The liquid crystal alignment agent of the present invention forms a coating film as an alignment film by coating after removing the organic solvent as described above, and when the polymer contained in the liquid crystal alignment agent of the present invention is a polyamic acid or a quinone imine In the case of a quinone imidized polymer having a ring structure and a proline structure, it is also possible to carry out a dehydration ring-closure reaction by further heating after forming a coating film to form a further yttrium-imided coating film. The thickness of the coating film formed here is preferably 0.001 to Ιμηη, more preferably 0.005 to 0.5 μm 〇Ο (2) The coating film formed as described above may be used as a vertical alignment type liquid crystal alignment film as it is, or may be optionally used. The coating film surface is rubbed in a certain direction by a roll wrapped with a cloth made of a suitable fiber such as nylon, rayon, cotton or the like, and then used as a liquid crystal alignment film. In addition, the liquid crystal shown in the patent document 6 (Japanese Patent Laid-Open No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. A process in which a part of the alignment film is irradiated with ultraviolet rays to change a pretilt angle of a portion of the liquid crystal alignment film, or a part of the surface of the liquid crystal alignment film is shown in Patent Document No. 8 (Japanese Laid-Open Patent Publication No. Hei No. Hei No. Hei No. Hei No. Hei No. Hei No. Hei No. Hei No. Hei No. Hei No. Hei No. Hei No. Hei. After the protective film is formed, the treatment for removing the protective film after the rubbing treatment is performed in a direction different from the previous rubbing treatment, so that each liquid crystal alignment film has a different liquid crystal alignment energy can improve the field of view performance of the obtained liquid crystal display element. When the surface of the coating film is polished, it can be cleaned as needed. (3) Two substrates on which the liquid crystal alignment film was formed as described above were prefabricated, and liquid crystal cells were fabricated by arranging liquid crystals between the two substrates. For the production of the liquid crystal cell, for example, the following two methods can be cited. -35- 200946563 The first method is a previously known method. First, the two substrates are opposed to each other through a gap (cell gap), and the respective liquid crystal alignment films are opposed to each other, and the peripheral portions of the two substrates are bonded together with a sealant to the interstitial space surrounded by the substrate surface and the sealant. After filling the liquid crystal, the liquid crystal cell can be obtained by closing the injection hole. The second method is called the 〇DF (〇ne Drop Fill) method. Applying, for example, an ultraviolet curable sealant material to a predetermined portion of one of the two substrates forming the liquid crystal alignment film, and then dropping the liquid crystal onto the film surface after the liquid crystal alignment film is bonded to the film surface, and bonding the other substrate to match the liquid crystal The film is oriented oppositely, and then the entire surface of the substrate is irradiated with ultraviolet rays to cure the sealant, thereby obtaining a liquid crystal cell. The liquid crystal alignment agent of the present invention has an advantage that a liquid crystal display element which does not cause liquid crystal alignment unevenness due to liquid crystal droplets can be obtained even when a VA liquid crystal display element is produced by an ODF method. This advantage is particularly remarkable when the liquid crystal alignment agent of the present invention comprises a diamine-synthesized polymer containing a specific diamine (1) in addition to at least one of the compounds represented by the above formulas (I) and (II). . In the case of using any of the above first and second methods, it is necessary to subsequently heat the liquid crystal cell to a temperature at which the liquid crystal used is in an isotropic phase, and then slowly cool to room temperature to remove the liquid crystal charge. Flow alignment. Then, the liquid crystal display element of the present invention can be obtained by laminating a polarizing plate on the outer surface of the liquid crystal cell. Here, as the sealant, for example, an epoxy resin containing an alumina ball as a curing agent and a spacer can be used. Examples of the liquid crystal include nematic liquid crystal and dish-shaped liquid crystal. Among them, a nematic liquid crystal is preferable, and for example, a Schiff base liquid crystal, an azo-based liquid crystal, a biphenyl liquid crystal, or a benzene-36-200946563 can be used. A cyclohexane liquid crystal, an ester liquid crystal, a terphenyl liquid crystal, a biphenyl cyclohexane liquid crystal, a pyrimidine liquid crystal, a dioxane liquid crystal, a bicyclooctane liquid crystal, a cuba liquid crystal or the like. Further, in the liquid crystal, cholesteric liquid crystal such as cholesteryl cholesteryl, cholesteryl phthalate or cholesteryl carbonate may be further added; and the trade names "C-15" and "CB-15" (manufactured by MERCK Co., Ltd.) may be further added. Used as a chiral agent for sale. The polarizing plate to be bonded to the outer surface of the liquid crystal may be a polarizing plate made by sandwiching a polyvinyl alcohol and absorbing iodine, and a polarizing film, which is called a "ruthenium film", is sandwiched between the cellulose acetate protective film, or A polarizing plate made of the enamel film itself. [Examples] Hereinafter, the present invention will be more specifically described by examples, but the present invention is not limited to the examples. The solution viscosity of the polymer and the ruthenium iodide ratio of the ruthenium iodide polymer in the following synthesis examples were evaluated by the following methods. [Solid viscosity of the polymer] 溶液 The solution viscosity of the polymer is determined by measuring the polymer solution indicated in each synthesis example using a Ε-type viscometer at 25 °C. [The ruthenium imine ratio of the ruthenium iodide polymer] The ruthenium iodide polymer is dried under reduced pressure at room temperature, and then dissolved in a deuterated dimethyl sulphate, using tetramethyl decane as a reference. The iH-NMR was measured at room temperature and determined by the formula shown by the following formula (i). Ruthenium amination rate (%) = (1 - Al/A2x a )xl 〇〇(i) A1 : peak area A2 originating from the NH matrix near 10 ppm: peak area from other protons -37- 200946563 α : ratio of the number of other protons relative to one NH proton in the polymer precursor (polyglycolic acid). <Synthesis of diamine represented by the above formula (I) or (II)> The following synthesis examples are repeated as necessary to ensure the necessary amount of the product in the subsequent synthesis example. Synthesis Example 1 (Synthesis of 1-(2,4-diaminophenoxy)-4-(4-(4-n-pentylcyclohexyl)cyclohexyl)benzene) 1-(2) was synthesized according to the following Scheme 1 4-Diaminophenoxypurinyl-4-(4-(4-n-pentylcyclohexyl)cyclohexyl)benzene (hereinafter also referred to as "diamine oxime").
NOsNOs
合成路線1 在氮氣環境下,將1-氯-2,4-二硝基苯 20.3g(0.1莫 耳)、4-(4-(4-正戊基環己基)環己基)苯酚32.9g(0.1莫耳) 和碳酸鉀41.4g(0.3莫耳)溶於500m丨二甲基甲醯胺中,在 室溫下進行6小時反應。向反應溶液中加入500ml蒸餾水 並充分攪拌後,用5 00 ml氯仿萃取,將所得的有機層用蒸 餾水萃取洗滌》將洗滌後的有機層用硫酸鎂脫水後,採用 旋轉蒸發器除去溶劑,得到47.0g 1-(2,4-二硝基苯氧 -38- 200946563 基)-4-(4-(4-正戊基環己基)環己基)苯。 然後,在氮氣環境下,向上述1-(2,4-二硝基苯氧 基)·4-(4-(4-正戊基環己基)環己基)苯24.8g(0.05莫耳)中, 加入鈀/碳(Pd/C)18.2g和四氫呋喃300 ml,在70°C下攪拌 1小時。向該混合物中加入肼一水合物30ml,在氮氣下於 8 0°C攪拌3小時進行反應。反應結束後,濾出催化劑,濃 縮濾液,再加入3 00 ml氯仿使其全部溶解後,將有機溶劑 層用蒸餾水萃取洗滌。將有機溶劑層用硫酸鎂脫水後,用 〇 旋轉蒸發器濃縮,得到二胺A的粗製品。將該粗製品通過 柱層析進行精製,再除去溶劑,製得18.lg二胺A。 合成例2(3,5-二氨基苯甲酸4-(4-(4-正戊基環己基)環己基) 苯基酯的合成) 按照下述合成路線2合成3,5-二氨基苯甲酸4-(4-(4-正戊基環己基)環己基)苯基酯(以下,也稱爲“二胺B”)。Synthetic Route 1 20.3 g (0.1 mol) of 1-chloro-2,4-dinitrobenzene and 32.9 g of 4-(4-(4-n-pentylcyclohexyl)cyclohexyl)phenol (under nitrogen) 0.1 mol (mole) and potassium carbonate 41.4 g (0.3 mol) were dissolved in 500 m of dimethylformamide and allowed to react at room temperature for 6 hours. 500 ml of distilled water was added to the reaction solution and stirred well, and then extracted with 500 ml of chloroform, and the obtained organic layer was extracted and washed with distilled water. The organic layer after washing was dehydrated with magnesium sulfate, and the solvent was removed by a rotary evaporator to obtain 47.0. g 1-(2,4-Dinitrophenoxy-38- 200946563 yl)-4-(4-(4-n-pentylcyclohexyl)cyclohexyl)benzene. Then, under a nitrogen atmosphere, to the above 1-(2,4-dinitrophenoxy)·4-(4-(4-n-pentylcyclohexyl)cyclohexyl)benzene 24.8 g (0.05 mol) Palladium/carbon (Pd/C) 18.2 g and 300 ml of tetrahydrofuran were added, and the mixture was stirred at 70 ° C for 1 hour. To the mixture was added 30 ml of hydrazine monohydrate, and the mixture was stirred at 80 ° C for 3 hours under nitrogen to carry out a reaction. After completion of the reaction, the catalyst was filtered off, the filtrate was concentrated, and then further dissolved in 300 ml of chloroform, and the organic solvent layer was extracted and washed with distilled water. The organic solvent layer was dried over magnesium sulfate and concentrated on a rotary evaporator to give a crude product of diamine A. The crude product was purified by column chromatography, and then solvent was evaporated to yield 18. Synthesis Example 2 (Synthesis of 4-(4-(4-n-pentylcyclohexyl)cyclohexyl)phenyl ester of 3,5-diaminobenzoic acid) Synthesis of 3,5-diaminobenzoic acid according to the following Scheme 2 4-(4-(4-n-pentylcyclohexyl)cyclohexyl)phenyl ester (hereinafter also referred to as "diamine B").
合成路線2 在氮氣環境下,將4-(4-(4-正戊基環己基)環己基)苯酚 32’9g(0.1旲耳)、三乙胺l〇.6g(0105莫耳)和四氫呋喃3〇〇 ml進行混合’在下攪拌溶解。向該溶液中經3〇分鐘滴 -39- 200946563 加3,5-二硝基苯甲醯氯21.8g(0.105莫耳)與四氫呋喃100 ml的混合溶液,再在室溫下攪拌3小時進行反應。濾出析 出的鹽後,濃縮濾液,再加入300 ml氯仿使其全部溶解, 用蒸餾水萃取洗滌。將有機層用硫酸鎂脫水後,用旋轉蒸 發器濃縮。將製得的粗產物通過柱層析進行精製,再除去 溶劑,得到51.2g3,5-二硝基苯甲酸4-(4-(4-正戊基環己基) 環己基)苯基酯。 然後,在氮氣環境下,向上述 3,5 -二硝基苯甲酸 © 4-(4-(4-正戊基環己基)環己基)苯基酯26.1g(0.05莫耳)中 加入氯化錫二水合物112_8g(0.5莫耳)和乙酸乙酯400 nU, 加熱回流3小時進行反應。反應結束後,將反應溶液與400 ml飽和氟化鉀水溶液混合’充分攪拌後分液,將得到有機 層用蒸餾水萃取洗滌。然後將有機層用硫酸鎂脫水後,用 旋轉蒸發器濃縮’再通過柱層析進行精製,然後除去溶劑, 得到1 7.4 g二胺B。 合成例3 ® 按照專利文獻2(日本特開平〇9— 278724號公報)中記 載的方法,合成下述式表示的二胺C。 (CH2)4-CH3 nh2 二胺c 合成例4 按照專利文獻9(日本特開平4 — 28 1427號公報)中記載 的方法,合成上述式(D- 5)表示的化合物(以下稱爲“化合 物(D — 5 ) ”) -40- 200946563 <酿亞胺化聚合物的合成> 合成例5 將作爲四羧酸二酐的3,5,6-三羧基-2-羧甲基降冰片烷 -2:3,5··6-二酐12.5g(0.05莫耳)以及作爲二胺的對苯二胺 3_2g(0.03莫耳)和上述合成例1中合成的二胺a 8.7g(0.02 莫耳)溶於98g N-甲基-2-吡咯烷酮(NMP)中,在60°C下反 應6小時。取少量所得聚醯胺酸溶液,加入NMP配成聚醯 胺酸濃度爲10重量%的溶液,測定的溶液黏度爲51 mPa.s。 © 然後,向所得聚醯胺酸溶液中追加120gNMP,再加入 20g吡啶和20g醋酸酐,在litre下進行4小時脫水閉環反 應。脫水閉環反應後,通過將體系內的溶劑用新的γ-丁內 酯進行溶劑置換(通過該溶劑置換操作,將脫水閉環反應中 使用的吡啶和醋酸酐除去至體系外。下同),得到約170g 含有醯亞胺化率約爲90 %的醯亞胺化聚合物(A - 1)的溶 液。對該溶液,配成聚合物濃度爲10重量%的γ -丁內酯溶 液,測定的溶液黏度爲62 mP a· s。 © 合成例6 將作爲四羧酸二酐的3,5,6-三羧基-2-羧甲基降冰片烷 -2:3,5:6-二酐12.5g(0.05莫耳)以及作爲二胺的對苯二胺 3.2g(0.03 莫耳)和二胺 B9.2g(0.02 莫耳)溶於 98gNMP 中, 在6(TC下反應6小時。取少量所得聚醯胺酸溶液,加入NMP 配成聚醯胺酸濃度爲10重量%的溶液,測定的溶液黏度爲 6 1 mPa.s 〇 然後,向所得聚醯胺酸溶液中追加120g NMP,再加入 2〇g吡啶和20g醋酸酐,在U〇°C下進行4小時脫水閉環反 -41 - 200946563 應。脫水閉環反應後,通過將體系內的溶劑用新的γ_ 丁內 酯進行溶劑置換’得到約160g含有醯亞胺化率約爲90%的 醯亞胺化聚合物(A - 2)的溶液。對該溶液,配成聚合物濃度 爲10重量%的γ-丁內酯溶液,測定的溶液黏度爲71 mpa.s。 合成例7 將作爲四羧酸二酐的2,3,5 -三羧基環戊基醋酸二酐 llg(0.05莫耳)以及作爲二胺的對苯二胺3.2g(0.03莫耳)和 二胺A8.7g(0.02莫耳)溶於93gNMP中,在60。(:下反應6 © 小時。取少量所得聚醯胺酸溶液,加入NMP配成聚醯胺酸 濃度爲10重量%的溶液,測定的溶液黏度爲48 mPa.s。 然後,向所得聚醯胺酸溶液中追加120g N -甲基-2 -吡 略烷酮,再加入20g吡啶和20g醋酸酐,在ll〇°C下進行4 小時脫水閉環反應。脫水閉環反應後,通過將體系內的溶 劑用新的γ -丁內酯進行溶劑置換,得到約160g含有醯亞胺 化率約爲90%的醯亞胺化聚合物(A- 3)的溶液。對該溶 液’配成聚合物濃度爲10重量%的γ -丁內酯溶液,測定的 © 溶液黏度爲58 mPa-s。 合成例8 將作爲四羧酸二酐的3,5,6-三羧基-2-羧甲基降冰片烷 -2:3,5:6-二酐12.5 g(0.05莫耳),以及作爲二胺的對苯二胺 3.2g(0.03莫耳)、二胺A 6.5g(0.015莫耳)和化合物(D — 5)2.6g(0_005莫耳)溶於l〇〇g NMP中,在60°C下反應6小 時。取少量所得聚醯胺酸溶液,加入NMP配成聚醯胺酸濃 度爲10重量%的溶液,測定的溶液黏度爲47 mP a. s" 然後,向所,得聚醯胺酸溶液中追加124gNMP,再加入 -42- 200946563 2〇g吡啶和20g醋酸酐,在110°C下進行4小時脫水閉環反 應。脫水閉環反應後,通過將體系內的溶劑用新的丁內 酯進行溶劑置換,得到約180g含有醯亞胺化率約爲90%的 醯亞胺化聚合物(A- 4)的溶液。對該溶液,配成聚合物濃度 爲10重量%的γ-丁內酯溶液,測定的溶液黏度爲57 mPa·s» 合成例9 將作爲四羧酸二酐的3,5,6-三羧基-2-羧甲基降冰片烷 -2··3,5:6-二酐12.5g(0.05莫耳),作爲二胺的對苯二胺 〇 3.2g(0.03 莫耳)、二胺 B 6.9g(0.015 莫耳)和化合物(D-5)2.6g(0.005 莫耳)溶於101gNMP中,在60°C下反應6小 時。取少量所得聚醯胺酸溶液,加入NMP配成聚醯胺酸濃 度爲10重量%的溶液,測定的溶液黏度爲46 mPa.s。 然後,向所得聚醯胺酸溶液中追加126g NMP,再加入 20g吡啶和20g醋酸酐,在ll〇°C下進行4小時脫水閉環反 應。脫水閉環反應後,通過將體系內的溶劑用新的γ-丁內 酯進行溶劑置換,得到約185g含有醯亞胺化率約爲90%的 © 醯亞胺化聚合物(A - 5)的溶液。對該溶液,配成聚合物濃度 爲10重量%的γ-丁內酯溶液,測定的溶液黏度爲56 mpa.s。 合成例1 〇 將作爲四羧酸二酐的2,3,5-三羧基環戊基醋酸二酐 11.2g(0.05莫耳),作爲二胺的對苯二胺3.2g(0.03莫耳)、 二胺 A 6.5g(0.015 莫耳)和化合物(d — 5)2.6g(0.005 莫耳) 溶於94gNMP中’在60°C下反應6小時。取少量所得聚醯 胺酸溶液’加入NMP配成聚醯胺酸濃度爲1〇重量%的溶 液,測定的溶液黏度爲45 mPa.s。 -43- 200946563 然後’向所得聚醯胺酸溶液中追加l18gNMP,再加入 2〇g吡啶和20g醋酸酐,在n〇°C下進行4小時脫水閉環反 應。脫水閉環反應後,通過將體系內的溶劑用新的γ_ 丁內 酯進行溶劑置換’得到約180g含有醯亞胺化率約爲90%的 醯亞胺化聚合物(A_ 6)的溶液。對該溶液,配成聚合物濃 度爲10重量%的丁內酯溶液,測定的溶液黏度爲58 mPa. S 0 合成例11 © 將作爲四羧酸二酐的3,5,6 -三羧基-2-羧甲基降冰片烷 -2:3,5:6-二酐12.5§(0_05莫耳),以及作爲二胺的對苯二胺 3.2g(0.03莫耳)、二胺A 6.5g(0.015莫耳)和化合物(D-5)2.6g(0.005 莫耳)溶於100gNMP中,在60°C下反應6小 時。取少量所得聚醯胺酸溶液,加入NMP配成聚醯胺酸濃 度爲10重量%的溶液,測定的溶液黏度爲47 mP a· s。 然後,向所得聚醯胺酸溶液中追加1 243 g NMP,再加 入4g吡啶和5 · 1 g醋酸酐,在1 1 0°C下進行4小時脫水閉環 © 反應。脫水閉環反應後,通過將體系內的溶劑用新的γ· 丁 內酯進行溶劑置換,得到約17〇g含有醯亞胺化率約爲45% 的醯亞胺化聚合物(A- 7)的溶液。對該溶液,配成聚合物 濃度爲10重量%的γ-丁內酯溶液,測定的溶液黏度爲63 m P a· s 〇 <其他聚合物的合成> (其他醯亞胺化聚合物的合成) 合成例1 2 將作爲四羧酸二酐的3,5,6-三羧基-2-羧甲基降冰片烷 -44- 200946563 -2:3,5:6-二酐125g(0.5莫耳),作爲二胺的對苯二胺32g(0.3 莫耳)和二胺C70g(0.2莫耳)溶於9i〇gNMP中,在60°C下 反應6小時。取少量所得聚醯胺酸溶液,加入NMP配成聚 醯胺酸濃度爲10重量%的溶液,測定的溶液黏度爲55 mPa. S ° 然後,向所得聚醯胺酸溶液中追加ll〇〇g NMP,再加 入200g吡啶和200g醋酸酐,在ii〇°c下進行4小時脫水 閉環反應。脫水閉環反應後,通過將體系內的溶劑用新的 © γ -丁內酯進行溶劑置換,得到約1600g含有醯亞胺化率約 爲9 0%的醯亞胺化聚合物(A- 8)的溶液。對該溶液,配成 聚合物濃度爲10重量%的γ-丁內酯溶液,測定的溶液黏度 爲 6 5 mP a· s。 合成例1 3 將作爲四羧酸二酐的3,5,6-三羧基-2-羧甲基降冰片烷 -2:3,5:6-二酸酐12.5g(0.05莫耳),以及作爲二胺的對苯二 胺4.3g(0.04莫耳)和化合物(D-5)5.2g(0.01莫耳)溶於88g © NMP中,在60°C下反應6小時。取少量所得聚醯胺酸溶液, 加入NMP配成聚醯胺酸濃度爲10重量%的溶液,測定的溶 液黏度爲45 mPa-s。 然後,向所得聚醯胺酸溶液中追加U〇g NMP,再加入 20g吡啶和20g醋酸酐,在110°C下進行4小時脫水閉環反 應。脫水閉環反應後,通過將體系內的溶劑用新的γ-丁內 酯進行溶劑置換,得到約170g含有醯亞胺化率約爲90%的 醯亞胺化聚合物(A — 9)的溶液。對該溶液,配成聚合物濃 度爲10重量%的γ-丁內酯溶液,測定的溶液黏度爲55 mP a· -45- 200946563 (其他聚醯胺酸的合成) 合成例1 4 將作爲四羧酸二酐的均苯四酸二酐55g(0.25莫耳)和 1,2,3,4-環丁烷四羧酸二酐49g(0.25莫耳),作爲二胺的對 苯二胺54g(0.5莫耳)溶於630g NMP中,在60°C下反應6 小時。得到約1200g含有20重量%聚醯胺酸(B-1)的溶液。 取少量該聚醯胺酸溶液,加入NMP配成聚醯胺酸濃度爲 〇 10重量%的溶液,測定的溶液黏度爲70 mPa‘s。 實施例1 <液晶配向劑的配製> 將上述合成例5中製得的含醯亞胺化聚合物(A- 1)的 溶液和上述實施例14中製得的含聚醯胺酸(B - 1)的溶液, 以各溶液中所含的聚合物的重量比爲(A — 1):(B—1)=80 : 20進行混合,向其中加入r-丁內酯、NMP和丁基溶纖劑, 配成溶劑組成爲r -丁內酯:NMP : 丁基溶纖劑= 71: 17 : Ο 12(重量比)、固體含量濃度爲2.5重量%的溶液。將該溶液 用孔徑爲Ιμιη的濾器過濾,配製出液晶配向劑(S- 1)。該 液晶配向劑中所含的聚合物的平均醯亞胺化率列於表1。 <垂直配向型液晶胞的製造> 採用旋塗法將上述液晶配向劑(s-ι)塗敷在帶有ΙΤΟ 膜製透明電極的玻璃基板的透明電極面上,在80°c的加熱 板上預烘焙1分鐘後,再在200°c的加熱板上後烘焙10分 鐘,形成平均厚度爲60ηιη的塗膜(液晶配向膜)。重複該操 作,製作一對(兩塊)在透明電極面上具有液晶配向膜的基 -46 - .200946563 板。 在上述一對帶有液晶配向膜的基板的具有液晶配向膜 的各外緣上,塗敷加入了直徑爲5.5μιη的氧化鋁球的環氧 樹脂黏合劑後,使液晶配向膜面相對地重合並壓合,再使 黏合劑固化。接著,通過液晶注入口向一對基板間塡充負 型液晶(MERCK公司製,MLC-6608)後,用丙烯酸類光固化 黏合劑將液晶注入口封閉,製造出垂直配向型液晶胞。對 該液晶胞,如下進行電壓保持率和殘像性能的評價。評價 〇 結果列於表1。 <電壓保持率的評價> 在65 °C下,在167毫秒的時間跨度內,對上述垂直配 向型液晶胞施加1 V的電壓,施加時間爲60微秒,然後測 定從電壓解除至167毫秒後的電壓保持率。測定裝置採用 TOYO Corporation 製的 VHR-1。 <殘像性能的評價> 除了基板採用具有圖1所示圖案的兩個ITO製透明電 © 極的玻璃基板以外,與上述<垂直配向型液晶胞的製造>同 樣地製造垂直配向型液晶胞。 在40〜5 0°c的環境下,一邊對該液晶胞照射背光’— 邊同時向電極A施加6.0V、向電極B施加0.5V 168小時 的直流電壓。釋放應力後,向電極A、B以0.IV的梯度施 加0.1〜5.0V直流電壓,在各電壓下根據電極A、B的亮度 差判斷殘像性能。當沒有鑑定出亮度差的時,殘像性能判 定爲“優”,當亮度差很小時,殘像性能判定爲“良”, 當亮度差較大時,殘像性能判定爲“不良”。 -47- .200946563 實施例2〜1 2和比較例1〜3 除了按照表1中所列的聚合物組成以外,分別與實施 例1同樣地配製液晶配向劑(S-2)〜(S — 12)和(R—1)〜(R 一 3),製造液晶胞,並進行評價。評價結果列於表1。 另外,表1中聚合物種類名稱之後括弧中的數値,是 所用聚合物溶液中所含的聚合物的量(重量份),實施例9 〜11和比較例3中沒有使用聚醯胺酸溶液。 表1 液晶配向劑 液晶胞 名稱 聚合物 平均醯亞 胺化率 顧 保持率 殘像 性能 醯亞胺化聚合物翻 (重量份) 聚謙酸麵 (重量份) 實施例1 S-1 A-l(80) B-l(20) 66% 99% 優 實施例2 S-2 A-2(80) B-l(20) 66% 99% 良 實施例3 S—3 A-1(60) B-l(40) 46% 98% 優 實施例4 S-4 A-2(60) B-l(40) 45% 97% 良 實施例5 S-5 A-3(80) B-l(20) 67% 99% 優 實施例ό S-6 A-4(80) B—1(20) 66% 99% 優 實施例7 S-7 A-5(80) B—1(20) 66% 99% 良 實施例8 S-8 A-6(80) B-l(20) 67% 99% 優 實施例9 S-9 A-4(100) jfrrf. J\\\ 90% 99% 優 實施例1〇 S-10 A-5(100) AttC. ~IWIT 90% 99% 良 實施例π S-11 A-6(100) te j\y\ 90% 99% 優 實施例12 S-12 A-7(80) B—1(20) 36% 98% 優 比較例1 R-1 A-8(80) B-1(20) 68% 96% 不良 比較例2 R-2 A-9(80) B-l(20) 68% 98% 良 比較例3 R-3 A—9(100) 4nC m 90% 99% 優 -48- 200946563 實施例1 3 <液晶配向不均性能的評價> 採用旋塗法將上述實施例6中配製的液晶配向劑(S -6)塗敷在帶有ITO膜製透明電極的玻璃基板的透明電極面 上,在80°C的加熱板上預烘焙1分鐘後,再在2 0 0°C的加 熱板上後烘焙10分鐘,形成平均厚度爲6〇nm的塗膜(液晶 配向膜)。重複該操作,製作一對(兩塊)在透明電極面上具 有液晶配向膜的基板。 〇 在上述製造的具有液晶配向膜的基板中的一塊的液晶 配向膜面上,用微吸移管從高5mm的位置滴下5μ1超純水 的水滴,將其原樣地在室溫下自然乾燥。 除了使用包括如上所述通過液滴滴落對液晶配向膜面 產生過撞擊的基板的一對基板以外,與上述實施例1同樣 地製造垂直配向型液晶胞。 在室溫下對該液晶胞施加交流6.0V(峰-峰)、30Hz的 矩形波,同時在正交尼科耳棱鏡下進行觀察時,當沒有觀 〇 察到作爲液晶配向不均的超純水滴痕時,液晶配向不均性 能評價爲“優”,當觀察到細微的滴痕時,液晶配向不均 性能評價爲“良”,當明顯地觀察到滴痕時,液晶配向不 均性能評價爲“不良”。結果列於表2。 其中,上述超純水水滴的滴下,是用於調査在ODF步 驟中液晶滴下產生的撞擊影響的替代評價。 實施例1 4〜1 9以及比較例4和5 除了液晶配向劑分別使用表2中所列的以外,與上述 實施例13同樣地採用包括通過超純水滴落對液晶配向膜 -49- .200946563 面產生過撞擊的基板的一對基板製造垂直配向型液晶胞, 並進行液晶配向不均性能的評價。結果列於表2。 表2 液晶配向劑名稱 液晶配向不均性能 實施例13 S-6 優 實施例14 S-7 優 實施例15 S-8 優 實施例16 S-9 優 實施例17 S— 10 優 實施例18 S- 11 優 實施例19 S- 12 良 比較例4 R-2 不良 比較例5 R-3 不良 【圖式簡單說明】 第1圖爲殘像性能評價用的透明電極構造的示意圖。 【主要元件符號說明】 4K 〇Synthetic Route 2 4-(4-(4-n-pentylcyclohexyl)cyclohexyl)phenol 32'9g (0.1 旲), triethylamine 〇.6g (0105 mol) and tetrahydrofuran under nitrogen atmosphere 3 〇〇 ml was mixed and dissolved under stirring. To the solution, a mixture of 21.8 g (0.105 mol) of 3,5-dinitrobenzimid chloride and 100 ml of tetrahydrofuran was added dropwise to the solution for 3 minutes, and the mixture was stirred at room temperature for 3 hours. . After the precipitated salt was filtered off, the filtrate was concentrated, and then dissolved in 300 ml of chloroform, and extracted with distilled water. The organic layer was dried over magnesium sulfate and concentrated using a rotary evaporator. The crude product thus obtained was purified by column chromatography, and then solvent was removed to give 51.2 g of 4-(4-(4-n-pentylcyclohexyl)cyclohexyl)phenyl 3,5-dinitrobenzoate. Then, chlorination was carried out to the above-mentioned 3,5-dinitrobenzoic acid-4- 4-(4-(4-n-pentylcyclohexyl)cyclohexyl)phenyl ester 26.1 g (0.05 mol) under a nitrogen atmosphere. Tin dihydrate 112_8 g (0.5 mol) and ethyl acetate 400 nU were heated under reflux for 3 hours to carry out a reaction. After completion of the reaction, the reaction solution was mixed with 400 ml of a saturated potassium fluoride aqueous solution. After thorough stirring, the mixture was separated, and the obtained organic layer was extracted and washed with distilled water. Then, the organic layer was dehydrated with magnesium sulfate, concentrated by a rotary evaporator, and then purified by column chromatography, and then solvent was removed to obtain 1 7.4 g of diamine B. Synthesis Example 3 ® The diamine C represented by the following formula was synthesized by the method described in Patent Document 2 (JP-A No. 9-278724). (CH2)4-CH3 nh2 diamine c Synthesis Example 4 The compound represented by the above formula (D-5) is synthesized by the method described in Patent Document 9 (JP-A No. 4-281427) (hereinafter referred to as "compound" (D — 5 ) ”) -40- 200946563 <Synthesis of a brewed imidized polymer> Synthesis Example 5 3,5,6-tricarboxy-2-carboxymethylnorbornane as tetracarboxylic dianhydride 12.5 g (0.05 mol) of alkane-2:3,5·6-dianhydride, and 3-2 g (0.03 mol) of p-phenylenediamine as a diamine and 8.7 g (0.02 g of a diamine synthesized in the above Synthesis Example 1) Mohr) was dissolved in 98 g of N-methyl-2-pyrrolidone (NMP) and reacted at 60 ° C for 6 hours. A small amount of the obtained polyaminic acid solution was taken, and NMP was added to prepare a solution having a polyaminic acid concentration of 10% by weight, and the viscosity of the solution was determined to be 51 mPa·s. Then, 120 g of NMP was added to the obtained polyamic acid solution, and 20 g of pyridine and 20 g of acetic anhydride were further added, and a dehydration ring-closing reaction was carried out for 4 hours under litre. After the dehydration ring closure reaction, the solvent in the system is replaced with a new γ-butyrolactone solvent (by the solvent replacement operation, the pyridine and acetic anhydride used in the dehydration ring closure reaction are removed to the outside of the system. The same applies hereinafter). About 170 g of a solution containing a ruthenium iodide polymer (A-1) having a ruthenium iodide ratio of about 90%. This solution was prepared into a γ-butyrolactone solution having a polymer concentration of 10% by weight, and the measured solution viscosity was 62 mP a·s. © Synthesis Example 6 3,5,6-tricarboxy-2-carboxymethylnorbornane-2:3,5:6-dianhydride as tetracarboxylic dianhydride 12.5 g (0.05 mol) and as two The amine p-phenylenediamine 3.2g (0.03 mole) and the diamine B9.2g (0.02 mole) are dissolved in 98g NMP, and reacted at 6 (TC for 6 hours). A small amount of the obtained polyaminic acid solution is added to the NMP. A solution having a polyglycolic acid concentration of 10% by weight was measured, and the measured solution viscosity was 6 1 mPa·s. Then, 120 g of NMP was added to the obtained polyamic acid solution, and then 2 μg of pyridine and 20 g of acetic anhydride were added. 4 hours of dehydration ring closure at U 〇 ° C. Anti-41 - 200946563. After the dehydration ring closure reaction, the solvent in the system was replaced with a new γ-butyrolactone solvent to obtain about 160 g of yttrium imidization rate. 90% solution of ruthenium iodide polymer (A-2). The solution was formulated into a γ-butyrolactone solution having a polymer concentration of 10% by weight, and the measured solution viscosity was 71 mpa.s. 7 llg (0.05 mol) of 2,3,5-tricarboxycyclopentylacetic acid dianhydride as tetracarboxylic dianhydride and 3.2 g (0.03 mol) and diamine A8 of p-phenylenediamine as diamine. 7g (0.02 The ear is dissolved in 93g of NMP at 60% (6: hour). A small amount of the obtained polyaminic acid solution is added, and NMP is added to form a solution having a concentration of polyglycine of 10% by weight, and the viscosity of the solution is determined to be 48 mPa. Then, 120 g of N-methyl-2-pyrrolidone was added to the obtained polyamic acid solution, and 20 g of pyridine and 20 g of acetic anhydride were further added, and a dehydration ring-closure reaction was carried out for 4 hours at ll ° C. After the ring closure reaction, a solvent of the system was replaced with a new γ-butyrolactone to obtain about 160 g of a solution containing a ruthenium iodide polymer (A-3) having a ruthenium iodide ratio of about 90%. The solution was formulated into a γ-butyrolactone solution having a polymer concentration of 10% by weight, and the measured solution viscosity was 58 mPa-s. Synthesis Example 8 3,5,6-three as tetracarboxylic dianhydride Carboxy-2-carboxymethylnorbornane-2:3,5:6-dianhydride 12.5 g (0.05 mol), and p-phenylenediamine as diamine 3.2 g (0.03 mol), diamine A 6.5 g (0.015 mol) and compound (D-5) 2.6 g (0_005 mol) were dissolved in l〇〇g NMP and reacted at 60 ° C for 6 hours. A small amount of the obtained polyaminic acid solution was added and NMP was added. to make A solution having a lysine concentration of 10% by weight, the measured solution viscosity is 47 mP a. s" Then, 124 g of NMP is added to the polylysine solution, and then -42-200946563 2〇g pyridine and 20 g of acetic acid are added. The anhydride was subjected to a dehydration ring-closure reaction at 110 ° C for 4 hours. After the dehydration ring closure reaction, a solvent of the system was replaced with a new butyrolactone to obtain a solution of about 180 g of a ruthenium iodide polymer (A-4) having a ruthenium iodide ratio of about 90%. This solution was formulated into a γ-butyrolactone solution having a polymer concentration of 10% by weight, and the measured solution viscosity was 57 mPa·s. » Synthesis Example 9 3,5,6-tricarboxyl group as tetracarboxylic dianhydride 2-carboxymethyl norbornane-2··3,5:6-dianhydride 12.5 g (0.05 mol), p-phenylenediamine oxime 3.2 g (0.03 mol) as diamine, diamine B 6.9 g (0.015 mol) and compound (D-5) 2.6 g (0.005 mol) were dissolved in 101 g of NMP and reacted at 60 ° C for 6 hours. A small amount of the obtained polyaminic acid solution was taken, and NMP was added to prepare a solution having a polyglycine concentration of 10% by weight, and the solution viscosity was determined to be 46 mPa·s. Then, 126 g of NMP was added to the obtained polyaminic acid solution, and 20 g of pyridine and 20 g of acetic anhydride were further added, and a dehydration ring-closing reaction was carried out for 4 hours at ll °C. After the dehydration ring closure reaction, the solvent in the system was replaced with a new γ-butyrolactone to obtain about 185 g of a ruthenium iodide polymer (A-5) having a ruthenium iodide ratio of about 90%. Solution. To the solution, a γ-butyrolactone solution having a polymer concentration of 10% by weight was prepared, and the measured solution viscosity was 56 mPa·s. Synthesis Example 1 As a tetracarboxylic dianhydride, 11.2 g (0.05 mol) of 2,3,5-tricarboxycyclopentyl acetic acid dianhydride, 3.2 g (0.03 mol) of p-phenylenediamine as a diamine, Diamine A 6.5 g (0.015 mol) and compound (d-5) 2.6 g (0.005 mol) dissolved in 94 g of NMP 'reacted at 60 ° C for 6 hours. A small amount of the obtained polyamic acid solution was added to NMP to prepare a solution having a polyglycine concentration of 1% by weight, and the solution viscosity was determined to be 45 mPa·s. -43- 200946563 Then, l18 g of NMP was added to the obtained polyamic acid solution, and 2 g of pyridine and 20 g of acetic anhydride were further added, and a dehydration ring-closing reaction was carried out for 4 hours at n °C. After the dehydration ring closure reaction, a solvent of the system was replaced with a new γ-butyrolactone to obtain about 180 g of a solution containing a ruthenium iodide polymer (A-6) having a ruthenium iodide ratio of about 90%. The solution was formulated into a butyrolactone solution having a polymer concentration of 10% by weight, and the measured solution viscosity was 58 mPa. S 0 Synthesis Example 11 © 3,5,6-tricarboxyl group as tetracarboxylic dianhydride 2-carboxymethylnorbornane-2:3,5:6-dianhydride 12.5 § (0_05 mol), and as a diamine, p-phenylenediamine 3.2 g (0.03 mol), diamine A 6.5 g ( 0.015 moles and compound (D-5) 2.6 g (0.005 mol) were dissolved in 100 g of NMP and reacted at 60 ° C for 6 hours. A small amount of the obtained polyaminic acid solution was taken, and NMP was added to prepare a solution having a polyglycine concentration of 10% by weight, and the viscosity of the solution was determined to be 47 mP a·s. Then, 1 243 g of NMP was added to the obtained polyaminic acid solution, and 4 g of pyridine and 5 · 1 g of acetic anhydride were further added thereto, and dehydration ring-closure reaction was carried out at 110 ° C for 4 hours. After the dehydration ring closure reaction, the solvent in the system was replaced with a new γ-butyrolactone to obtain about 17 〇g of a ruthenium iodide polymer having a ruthenium iodide ratio of about 45% (A-7). The solution. This solution was formulated into a γ-butyrolactone solution having a polymer concentration of 10% by weight, and the measured solution viscosity was 63 m P a·s 〇 合成; Synthesis of other polymers > (Other yttrium-imidized polymers) Synthesis of Synthesis Example 1 2 3,5,6-Tricarboxy-2-carboxymethylnorbornane-44-200946563-2:3,5:6-dianhydride as a tetracarboxylic dianhydride 125 g (0.5 Mohr), 32 g (0.3 mol) of p-phenylenediamine as diamine and C70 g (0.2 mol) of diamine were dissolved in 9 μg of NMP and reacted at 60 ° C for 6 hours. Take a small amount of the obtained polyaminic acid solution, add NMP to form a solution having a concentration of polyglycine of 10% by weight, and determine the viscosity of the solution to be 55 mPa. S °, then add ll〇〇g to the obtained poly-proline solution. NMP was further added with 200 g of pyridine and 200 g of acetic anhydride, and a dehydration ring-closure reaction was carried out for 4 hours at 〇 ° °c. After the dehydration ring closure reaction, the solvent in the system was replaced with a new solvent of γ-butyrolactone to obtain about 1600 g of a ruthenium iodide polymer having a ruthenium iodide ratio of about 90% (A-8). The solution. To the solution, a γ-butyrolactone solution having a polymer concentration of 10% by weight was prepared, and the measured solution viscosity was 6 5 mP a·s. Synthesis Example 1 3 3,5,6-tricarboxy-2-carboxymethylnorbornane-2:3,5:6-dianhydride as tetracarboxylic dianhydride 12.5 g (0.05 mol), and as Diamine p-phenylenediamine 4.3 g (0.04 mol) and compound (D-5) 5.2 g (0.01 mol) were dissolved in 88 g of NMP and reacted at 60 ° C for 6 hours. A small amount of the obtained polyaminic acid solution was taken, and NMP was added to prepare a solution having a polyglycine concentration of 10% by weight, and the solution viscosity was determined to be 45 mPa-s. Then, U〇g NMP was added to the obtained polyamic acid solution, and 20 g of pyridine and 20 g of acetic anhydride were further added, and a dehydration ring-closing reaction was carried out at 110 ° C for 4 hours. After the dehydration ring closure reaction, a solvent of the system is replaced with a new γ-butyrolactone to obtain about 170 g of a solution containing a ruthenium iodide polymer (A-9) having a ruthenium iodide ratio of about 90%. . The solution was formulated into a γ-butyrolactone solution having a polymer concentration of 10% by weight, and the measured solution viscosity was 55 mP a· -45- 200946563 (synthesis of other polylysine) Synthesis Example 1 4 Pyromellitic dianhydride 55 g (0.25 mol) of carboxylic acid dianhydride and 49 g (0.25 mol) of 1,2,3,4-cyclobutane tetracarboxylic dianhydride, p-phenylenediamine 54 g as diamine (0.5 mol) was dissolved in 630 g of NMP and reacted at 60 ° C for 6 hours. About 1200 g of a solution containing 20% by weight of polyamic acid (B-1) was obtained. A small amount of the polyaminic acid solution was taken, and NMP was added to prepare a solution having a polyglycine concentration of 10% by weight, and the measured solution viscosity was 70 mPa's. Example 1 <Preparation of Liquid Crystal Aligning Agent> The solution containing the quinone imidized polymer (A-1) prepared in the above Synthesis Example 5 and the polyglycine containing product obtained in the above Example 14 ( The solution of B-1) is mixed with (A-1):(B-1)=80:20 by weight ratio of the polymer contained in each solution, and r-butyrolactone, NMP and butyl are added thereto. The fiber preparation is formulated into a solution of r-butyrolactone: NMP: butyl cellosolve = 71: 17 : Ο 12 (by weight), and a solid content concentration of 2.5% by weight. This solution was filtered through a filter having a pore size of Ιμηη to prepare a liquid crystal alignment agent (S-1). The average oxime imidization ratio of the polymer contained in the liquid crystal alignment agent is shown in Table 1. <Production of Vertical Alignment Type Liquid Crystal Cell> The liquid crystal alignment agent (s-ι) was applied onto a transparent electrode surface of a glass substrate having a transparent electrode made of a ruthenium film by spin coating, and heated at 80 ° C. After prebaking for 1 minute on the plate, it was post-baked on a hot plate at 200 ° C for 10 minutes to form a coating film (liquid crystal alignment film) having an average thickness of 60 ηηη. This operation was repeated to fabricate a pair of (two) base-46 - .200946563 plates having a liquid crystal alignment film on the transparent electrode surface. On each of the outer edges of the pair of liquid crystal alignment films having the liquid crystal alignment film, an epoxy resin adhesive having a diameter of 5.5 μm is applied, and the liquid crystal alignment film faces are relatively overlapped. And press, and then the adhesive is cured. Then, a negative liquid crystal (MLC-6608, manufactured by MERCK Co., Ltd.) was deposited between the pair of substrates through the liquid crystal injection port, and then the liquid crystal injection port was sealed with an acrylic photocurable adhesive to produce a vertical alignment type liquid crystal cell. For the liquid crystal cell, evaluation of voltage holding ratio and afterimage performance was performed as follows. Evaluation 〇 The results are shown in Table 1. <Evaluation of voltage holding ratio> A voltage of 1 V was applied to the above-mentioned vertical alignment type liquid crystal cell at 65 ° C for a time span of 167 msec, and the application time was 60 μsec, and then the voltage was released to 167. The voltage holding ratio after milliseconds. The measuring device was a VHR-1 manufactured by TOYO Corporation. <Evaluation of afterimage performance> A vertical alignment was produced in the same manner as in the above-mentioned <Production of Vertically Oriented Liquid Crystal Cell, except that a glass substrate having two ITO transparent electrodes having the pattern shown in Fig. 1 was used as the substrate. Liquid crystal cell. In the environment of 40 to 50 ° C, while the backlight was irradiated to the liquid crystal cell, 6.0 V was applied to the electrode A, and a DC voltage of 0.5 V for 168 hours was applied to the electrode B. After the stress was released, a DC voltage of 0.1 to 5.0 V was applied to the electrodes A and B at a gradient of 0. IV, and the afterimage performance was judged based on the difference in luminance between the electrodes A and B at each voltage. When the luminance difference was not identified, the afterimage performance was judged as "excellent", and when the luminance difference was small, the afterimage performance was judged as "good", and when the luminance difference was large, the afterimage performance was judged as "poor". -47-.200946563 Examples 2 to 1 2 and Comparative Examples 1 to 3 Liquid crystal alignment agents (S-2) to (S - were prepared in the same manner as in Example 1 except that the polymer compositions listed in Table 1 were used. 12) and (R-1)~(R-3), liquid crystal cells were produced and evaluated. The evaluation results are shown in Table 1. Further, the number in the parentheses after the name of the polymer species in Table 1 is the amount (parts by weight) of the polymer contained in the polymer solution used, and the polyamines were not used in Examples 9 to 11 and Comparative Example 3. Solution. Table 1 Liquid crystal alignment agent Liquid crystal cell name Polymer Average 醯 imidization rate Gu retention rate afterimage performance 醯 imidized polymer turning (parts by weight) Polyzinc acid surface (parts by weight) Example 1 S-1 Al (80 Bl(20) 66% 99% Excellent Example 2 S-2 A-2(80) Bl(20) 66% 99% Good Example 3 S-3 A-1(60) Bl(40) 46% 98 % Excellent Example 4 S-4 A-2(60) Bl(40) 45% 97% Good Example 5 S-5 A-3(80) Bl(20) 67% 99% Excellent Example ό S-6 A-4(80) B-1 (20) 66% 99% Excellent Example 7 S-7 A-5(80) B-1 (20) 66% 99% Good Example 8 S-8 A-6 ( 80) Bl(20) 67% 99% Excellent Example 9 S-9 A-4(100) jfrrf. J\\\ 90% 99% Excellent Example 1〇S-10 A-5(100) AttC. IWIT 90% 99% Good example π S-11 A-6(100) te j\y\ 90% 99% Excellent Example 12 S-12 A-7(80) B-1 (20) 36% 98% Excellent Comparative Example 1 R-1 A-8(80) B-1(20) 68% 96% Bad Comparative Example 2 R-2 A-9(80) Bl(20) 68% 98% Good Comparative Example 3 R- 3 A—9 (100) 4 nC m 90% 99% Excellent-48-200946563 Example 1 3 <Evaluation of liquid crystal alignment unevenness performance> The liquid crystal alignment agent prepared in the above Example 6 was spin-coated. -6) After being pre-baked on a transparent electrode surface of a glass substrate having a transparent electrode made of an ITO film, it was prebaked on a hot plate at 80 ° C for 1 minute, and then baked on a hot plate at 200 ° C for 10 minutes to form an average. A coating film (liquid crystal alignment film) having a thickness of 6 〇 nm. This operation was repeated to fabricate a pair of (two) substrates having a liquid crystal alignment film on the surface of the transparent electrode. 〇 On the liquid crystal alignment film surface of one of the substrates having the liquid crystal alignment film produced above, water droplets of 5 μl of ultrapure water were dropped from a position of 5 mm high by a micropipette, and naturally dried at room temperature. A vertical alignment type liquid crystal cell was produced in the same manner as in the above-described Example 1, except that a pair of substrates including a substrate having an impact on the liquid crystal alignment film surface by droplet dropping as described above was used. A rectangular wave of 6.0 V (peak-to-peak) and 30 Hz was applied to the liquid crystal cell at room temperature, and when observed under a crossed Nicol prism, ultrapure as a liquid crystal misalignment was observed without observation. When the water droplets were traced, the liquid crystal alignment unevenness performance was evaluated as "excellent". When fine droplet marks were observed, the liquid crystal alignment unevenness performance was evaluated as "good", and when the droplet marks were clearly observed, the liquid crystal alignment unevenness performance evaluation was performed. It is "bad". The results are shown in Table 2. Among them, the dropping of the above-mentioned ultrapure water droplets is an alternative evaluation for investigating the impact of the impact of liquid crystal dropping in the ODF step. Example 1 4 to 19 and Comparative Examples 4 and 5 In the same manner as in the above-described Example 13, except that the liquid crystal alignment agent was used as listed in Table 2, respectively, the liquid crystal alignment film was deposited by ultrapure water drop-49-.200946563 A pair of substrates having a surface on which the impact occurred were used to fabricate a vertical alignment type liquid crystal cell, and evaluation of the liquid crystal alignment unevenness performance was performed. The results are shown in Table 2. Table 2 Liquid crystal alignment agent name Liquid crystal alignment unevenness performance Example 13 S-6 Preferred embodiment 14 S-7 Excellent embodiment 15 S-8 Excellent embodiment 16 S-9 Excellent embodiment 17 S-10 Excellent example 18 S - 11 Preferred Embodiment 19 S- 12 Good Comparative Example 4 R-2 Poor Comparative Example 5 R-3 Poor [Simplified description of the drawings] Fig. 1 is a schematic view showing the structure of a transparent electrode for evaluation of afterimage performance. [Main component symbol description] 4K 〇
-50--50-
Claims (1)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008069302 | 2008-03-18 | ||
| JP2008135447 | 2008-05-23 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW200946563A true TW200946563A (en) | 2009-11-16 |
| TWI433870B TWI433870B (en) | 2014-04-11 |
Family
ID=41358606
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW098108523A TWI433870B (en) | 2008-03-18 | 2009-03-17 | Liquid crystal aligning agent and liquid crystal display element |
Country Status (4)
| Country | Link |
|---|---|
| JP (1) | JP5365780B2 (en) |
| KR (1) | KR101520970B1 (en) |
| CN (1) | CN101539687B (en) |
| TW (1) | TWI433870B (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103080190B (en) * | 2010-07-05 | 2015-04-01 | 日产化学工业株式会社 | Liquid crystal aligning agent, and liquid crystal display element using same |
| KR101878522B1 (en) * | 2011-03-07 | 2018-07-13 | 닛산 가가쿠 고교 가부시키 가이샤 | Composition, liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element |
| WO2012121257A1 (en) * | 2011-03-07 | 2012-09-13 | 日産化学工業株式会社 | Composition, liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element |
| WO2015050133A1 (en) * | 2013-10-01 | 2015-04-09 | 日産化学工業株式会社 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element using same |
| KR102124924B1 (en) * | 2013-12-10 | 2020-06-22 | 삼성디스플레이 주식회사 | Liquid crystal display and method of manufacturing the same |
| CN109196410B (en) * | 2016-03-29 | 2022-05-31 | 日产化学株式会社 | Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element |
| CN108070388B (en) * | 2017-12-05 | 2021-04-23 | 中节能万润股份有限公司 | Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element |
| CN111592891B (en) * | 2020-06-12 | 2022-03-01 | 江苏三月科技股份有限公司 | Liquid crystal aligning agent, liquid crystal alignment film prepared from same and liquid crystal display element |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59142526A (en) * | 1983-02-03 | 1984-08-15 | Sharp Corp | liquid crystal display element |
| JP2621347B2 (en) * | 1988-05-23 | 1997-06-18 | 日本合成ゴム株式会社 | Alignment material for liquid crystal display devices |
| US5969055A (en) * | 1996-05-16 | 1999-10-19 | Jsr Corporation | Liquid crystal alignment agent |
| JP2002040437A (en) * | 2000-07-19 | 2002-02-06 | Matsushita Electric Ind Co Ltd | LCD panel |
| JP5245187B2 (en) * | 2001-09-04 | 2013-07-24 | Jnc株式会社 | Polyamideimide, liquid crystal aligning agent varnish, and liquid crystal display element |
| JP4228614B2 (en) * | 2002-08-06 | 2009-02-25 | チッソ株式会社 | Phenylenediamine with ester bond |
| WO2006070819A1 (en) * | 2004-12-28 | 2006-07-06 | Nissan Chemical Industries, Ltd. | Liquid-crystal alignment material for vertical alignment, liquid-crystal alignment film, and liquid-crystal display element employing the same |
| JP4775796B2 (en) * | 2006-03-14 | 2011-09-21 | 独立行政法人物質・材料研究機構 | Liquid crystal alignment film, liquid crystal alignment agent, and liquid crystal display element |
| CN101135813B (en) * | 2006-08-29 | 2011-03-16 | Jsr株式会社 | Liquid crystal tropism agent, liquid crystal tropism film and liquid crystal display element |
| WO2008117759A1 (en) * | 2007-03-23 | 2008-10-02 | Nissan Chemical Industries, Ltd. | Diamine compound, polyamic acid, polyimide and liquid crystal aligning agent |
| KR101492656B1 (en) * | 2007-03-23 | 2015-02-12 | 닛산 가가쿠 고교 가부시키 가이샤 | Diamine compound, polyamic acid, polyimide and liquid crystal aligning agent |
| KR101518092B1 (en) * | 2007-12-28 | 2015-05-06 | 닛산 가가쿠 고교 가부시키 가이샤 | Liquid crystal aligning agent and liquid crystal display device using the same |
-
2009
- 2009-02-09 JP JP2009026835A patent/JP5365780B2/en active Active
- 2009-03-13 CN CN2009101270473A patent/CN101539687B/en active Active
- 2009-03-17 KR KR1020090022469A patent/KR101520970B1/en not_active Expired - Fee Related
- 2009-03-17 TW TW098108523A patent/TWI433870B/en active
Also Published As
| Publication number | Publication date |
|---|---|
| TWI433870B (en) | 2014-04-11 |
| KR101520970B1 (en) | 2015-05-15 |
| CN101539687B (en) | 2013-03-13 |
| KR20090100274A (en) | 2009-09-23 |
| CN101539687A (en) | 2009-09-23 |
| JP5365780B2 (en) | 2013-12-11 |
| JP2010002880A (en) | 2010-01-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI468435B (en) | Liquid crystal aligning agent, liquid crystal display element and compound | |
| TWI434111B (en) | Liquid crystal aligning agent and liquid crystal display element | |
| TWI499641B (en) | Liquid crystal alignment agent, liquid crystal display element, polyamic acid, polyimide and compound | |
| TW201006869A (en) | Liquid crystal alignment agent and liquid crystal display element | |
| TWI445736B (en) | Liquid crystal aligning agent, liquid crystal aligning film and liquid crystal display element | |
| TW201005005A (en) | Liquid crystal alignment agent and liquid crystal display element | |
| TWI433870B (en) | Liquid crystal aligning agent and liquid crystal display element | |
| TWI454805B (en) | Liquid crystal aligning agent and liquid crystal aligning element | |
| TWI475047B (en) | Liquid crystal alignment agent and liquid crystal display element | |
| TW200832019A (en) | Liguid crystal alignment agent and liquid crystal display element | |
| TWI637028B (en) | Liquid crystal alignment agent, liquid crystal alignment film, liquid crystal display element, polyamic acid and imidized polymer thereof and diamine compound | |
| TWI454806B (en) | Liquid crystal alignment agent, liquid crystal display element, polyamic acid, imidized polymer and compound | |
| TWI444727B (en) | Liquid crystal alignment agent and liquid crystal display element | |
| TWI427103B (en) | Liquid crystal aligning agent and liquid crystal display element | |
| TWI501011B (en) | Liquid crystal aligning agent and liquid crystal display element | |
| TWI399596B (en) | Liquid crystal orientation agent and liquid crystal display element | |
| TWI439770B (en) | Liquid crystal alignment agent and liquid crystal alignment film | |
| TW200819510A (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element | |
| TWI467290B (en) | Liquid crystal aligning agent, liquid crystal display element, polyamic acid, polyimide and compound | |
| TWI386434B (en) | Liquid crystal alignment agent and liquid crystal display element | |
| TWI461460B (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
| TWI444726B (en) | Vertical alignment type liquid crystal alignment agent and vertical alignment type liquid crystal display element | |
| TWI428370B (en) | Liquid crystal aligning agent and liquid crystal display element | |
| TWI537308B (en) | Liquid-crystal alignment material, liquid-crystal alignment film and liquid-crystal display device | |
| TWI468438B (en) | Liquid crystal alignment agent |